{
    "studies": [
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT01328951",
                    "orgStudyIdInfo": {
                        "id": "BO25460"
                    },
                    "organization": {
                        "fullName": "Hoffmann-La Roche",
                        "class": "INDUSTRY"
                    },
                    "briefTitle": "A Study of First-line Maintenance Erlotinib Versus Erlotinib at Disease Progression in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) Who Have Not Progressed Following Platinum-Based Chemotherapy",
                    "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled Phase III Study of First-Line Maintenance Tarceva Versus Tarceva at the Time of Disease Progression in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Who Have Not Progressed Following 4 Cycles of Platinum-Based Chemotherapy"
                },
                "statusModule": {
                    "statusVerifiedDate": "2016-06",
                    "overallStatus": "COMPLETED",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2011-09"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2015-12",
                        "type": "ACTUAL"
                    },
                    "completionDateStruct": {
                        "date": "2016-01",
                        "type": "ACTUAL"
                    },
                    "studyFirstSubmitDate": "2011-04-04",
                    "studyFirstSubmitQcDate": "2011-04-04",
                    "studyFirstPostDateStruct": {
                        "date": "2011-04-05",
                        "type": "ESTIMATED"
                    },
                    "resultsFirstSubmitDate": "2016-01-29",
                    "resultsFirstSubmitQcDate": "2016-01-29",
                    "resultsFirstPostDateStruct": {
                        "date": "2016-02-29",
                        "type": "ESTIMATED"
                    },
                    "lastUpdateSubmitDate": "2016-09-06",
                    "lastUpdatePostDateStruct": {
                        "date": "2016-10-28",
                        "type": "ESTIMATED"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR"
                    },
                    "leadSponsor": {
                        "name": "Hoffmann-La Roche",
                        "class": "INDUSTRY"
                    }
                },
                "descriptionModule": {
                    "briefSummary": "This double-blind, placebo-controlled study will evaluate the benefit of first-line maintenance erlotinib (Tarceva) versus erlotinib at the time of disease progression in participants with advanced NSCLC who have not progressed following 4 cycles of platinum based-chemotherapy and whose tumor does not harbor an epidermal growth factor receptor (EGFR)-activating mutation. Participants will be randomized to receive either erlotinib 150 milligrams (mg) orally (PO) once daily or placebo. Participants who progress on placebo will receive erlotinib 150 mg PO once daily as second-line therapy, and those who progress on erlotinib may switch to a non-investigational, second-line chemotherapy. Treatments will continue until disease progression, death, or unacceptable toxicity. Participants may also be entered into a final Survival Follow-Up (SFU) period upon treatment discontinuation."
                },
                "conditionsModule": {
                    "conditions": [
                        "Non-Squamous Non-Small Cell Lung Cancer"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "PHASE3"
                    ],
                    "designInfo": {
                        "allocation": "RANDOMIZED",
                        "interventionModel": "PARALLEL",
                        "primaryPurpose": "TREATMENT",
                        "maskingInfo": {
                            "masking": "DOUBLE",
                            "whoMasked": [
                                "PARTICIPANT",
                                "INVESTIGATOR"
                            ]
                        }
                    },
                    "enrollmentInfo": {
                        "count": 643,
                        "type": "ACTUAL"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "Early Erlotinib",
                            "type": "EXPERIMENTAL",
                            "description": "Participants will receive blinded erlotinib as 150 mg PO once daily in the maintenance setting until disease progression, death, or unacceptable toxicity. Those who demonstrate disease progression may be unblinded to receive an approved second-line therapy (but not EGFR targeted therapies) until disease progression, death, or unacceptable toxicity. Participants may be observed during a final SFU period after discontinuation from study treatment.",
                            "interventionNames": [
                                "Drug: Erlotinib",
                                "Drug: Second-Line Chemotherapy"
                            ]
                        },
                        {
                            "label": "Late Erlotinib",
                            "type": "PLACEBO_COMPARATOR",
                            "description": "Participants will receive blinded placebo tablets PO once daily in the maintenance setting until disease progression, death, or unacceptable toxicity. Those who demonstrate disease progression may be unblinded to receive second-line erlotinib as 150 mg PO once daily until disease progression, death, or unacceptable toxicity. Participants may be observed during a final SFU period after discontinuation from study treatment.",
                            "interventionNames": [
                                "Drug: Placebo",
                                "Drug: Erlotinib"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "DRUG",
                            "name": "Placebo",
                            "description": "Placebo will be administered PO once daily as first-line maintenance until disease progression, death, or unacceptable toxicity.",
                            "armGroupLabels": [
                                "Late Erlotinib"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "Erlotinib",
                            "description": "Erlotinib will be administered as 150 mg PO once daily until disease progression, death, or unacceptable toxicity, as first-line maintenance or as second-line therapy for those who progress while receiving placebo.",
                            "armGroupLabels": [
                                "Early Erlotinib",
                                "Late Erlotinib"
                            ],
                            "otherNames": [
                                "Tarceva"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "Second-Line Chemotherapy",
                            "description": "Participants who progress on first-line maintenance erlotinib may receive an approved second-line therapy (but not EGFR targeted therapies) until disease progression, death, or unacceptable toxicity. The selected chemotherapy will be non-investigational and chosen at the discretion of the Investigator.",
                            "armGroupLabels": [
                                "Early Erlotinib"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "Percentage of Participants Who Died During the Overall Study",
                            "description": "Participants were followed for survival until death or premature withdrawal. The percentage of participants who died during the Overall Study (BP, OLP, or SFU) was calculated.",
                            "timeFrame": "Up to approximately 3.5 years (visits at Baseline and Weeks 6, 12, and 18 and every 12 weeks until/at disease progression during BP; per local standards during OLP; then every 12 weeks during SFU until death)"
                        },
                        {
                            "measure": "Overall Survival (OS) as Median Time to Event During the Overall Study",
                            "description": "Participants were followed for survival until death or premature withdrawal. OS was defined as the interval between date of randomization and date of death from any cause. Median time to event during the Overall Study (BP, OLP, or SFU) was estimated using the Kaplan-Meier method and expressed in months.",
                            "timeFrame": "Up to approximately 3.5 years (visits at Baseline and Weeks 6, 12, and 18 and every 12 weeks until/at disease progression during BP; per local standards during OLP; then every 12 weeks during SFU until death)"
                        },
                        {
                            "measure": "Percentage of Participants Event-Free (Alive) at 1 Year During the Overall Study",
                            "description": "Participants were followed for survival until death or premature withdrawal. The percentage of participants event-free (i.e., still alive) at 1 year during the Overall Study was calculated.",
                            "timeFrame": "At 1 year"
                        }
                    ],
                    "secondaryOutcomes": [
                        {
                            "measure": "Percentage of Participants Who Died or Experienced Disease Progression During Blinded Treatment",
                            "description": "Tumor response was evaluated using Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1. Disease progression was defined as a greater than or equal to (\u2265) 20 percent (%) and \u22655-millimeter (mm) increase in the sum of target lesion diameters in reference to the smallest sum on study and/or substantial worsening in non-target disease. The percentage of participants who died or experienced disease progression during the BP was calculated.",
                            "timeFrame": "Up to approximately 3.5 years (visits at Baseline and Weeks 6, 12, and 18 and every 12 weeks until/at disease progression during BP)"
                        },
                        {
                            "measure": "Progression-Free Survival (PFS) as Median Time to Event During Blinded Treatment",
                            "description": "Tumor response was evaluated using RECIST version 1.1. Disease progression was defined as a \u226520% and \u22655-mm increase in the sum of target lesion diameters in reference to the smallest sum on study and/or substantial worsening in non-target disease. PFS was defined as the interval between date of randomization and date of first documented death or disease progression. Median time to event during the BP was estimated using the Kaplan-Meier method and expressed in weeks.",
                            "timeFrame": "Up to approximately 3.5 years (visits at Baseline and Weeks 6, 12, and 18 and every 12 weeks until/at disease progression during BP)"
                        },
                        {
                            "measure": "Percentage of Participants Event-Free (Alive and No Disease Progression) at 6 Months During Blinded Treatment",
                            "description": "Tumor response was evaluated using RECIST version 1.1. Disease progression was defined as a \u226520% and \u22655-mm increase in the sum of target lesion diameters in reference to the smallest sum on study and/or substantial worsening in non-target disease. The percentage of participants event-free (i.e., still alive and without disease progression) at 6 months during the BP was calculated.",
                            "timeFrame": "At 6 months"
                        },
                        {
                            "measure": "Percentage of Participants With Complete Response (CR) or Partial Response (PR) According to RECIST During Blinded Treatment",
                            "description": "Tumor response was evaluated using RECIST version 1.1. CR was defined as disappearance of all target and non-target lesions and short-axis reduction to less than (\\<) 10 mm of any pathological lymph nodes. PR was defined as a \u226530% decrease in the sum of target lesion diameters in reference to the Baseline sum. The percentage of participants with a best overall response of either CR or PR (i.e., the objective response rate \\[ORR\\]) during the BP was calculated, and corresponding 95% CI was constructed using the Pearson-Clopper method.",
                            "timeFrame": "Up to approximately 3.5 years (visits at Baseline and Weeks 6, 12, and 18 and every 12 weeks until/at disease progression during BP)"
                        },
                        {
                            "measure": "Percentage of Participants by Best Overall Response According to RECIST During Blinded Treatment",
                            "description": "Tumor response was evaluated using RECIST version 1.1. CR was defined as disappearance of all target and non-target lesions and short-axis reduction to \\<10 mm of any pathological lymph nodes. PR was defined as a \u226530% decrease in the sum of target lesion diameters in reference to the Baseline sum. Stable disease (SD) was defined as neither sufficient shrinkage in target lesions to qualify for PR nor sufficient growth to qualify for disease progression. Disease progression (progressive disease/PD) was defined as a \u226520% and \u22655-mm increase in the sum of target lesion diameters in reference to the smallest sum on study and/or substantial worsening in non-target disease. The percentage of participants with each level of best tumor response during the BP was calculated, and corresponding 95% CI was constructed using the Pearson-Clopper method.",
                            "timeFrame": "Up to approximately 3.5 years (visits at Baseline and Weeks 6, 12, and 18 and every 12 weeks until/at disease progression during BP)"
                        },
                        {
                            "measure": "Percentage of Participants With CR, PR, or SD According to RECIST During Blinded Treatment",
                            "description": "Tumor response was evaluated using RECIST version 1.1. CR was defined as disappearance of all target and non-target lesions and short-axis reduction to \\<10 mm of any pathological lymph nodes. PR was defined as a \u226530% decrease in the sum of target lesion diameters in reference to the Baseline sum. SD was defined as neither sufficient shrinkage in target lesions to qualify for PR nor sufficient growth to qualify for disease progression. The percentage of participants with a best overall response of CR, PR, or SD (i.e., the disease control rate \\[DCR\\]) during the BP was calculated, and corresponding 95% CI was constructed using the Pearson-Clopper method.",
                            "timeFrame": "Up to approximately 3.5 years (visits at Baseline and Weeks 6, 12, and 18 and every 12 weeks until/at disease progression during BP)"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n* Adults greater than or equal to (\u2265) 18 years of age, or legal age of consent if greater than 18\n* Advanced or recurrent (Stage IIIB) or metastatic (Stage IV) NSCLC\n* Completion of 4 cycles of platinum-based chemotherapy without progression (end of last chemotherapy cycle less than or equal to \\[\u2264\\] 28 days prior to randomization)\n* Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1\n\nExclusion Criteria:\n\n* Prior exposure to agents directed at human epidermal growth factor receptor (HER) axis (e.g. erlotinib, gefitinib, cetuximab)\n* Participants whose tumors harbor an EGFR-activating mutation\n* Prior chemotherapy or therapy with systemic anti-neoplastic therapy for advanced disease before Screening\n* Use of pemetrexed in maintenance setting (pemetrexed allowed during the chemotherapy run-in)\n* Participants who have undergone complete tumor resection after responding to the platinum-based chemotherapy during the Screening phase\n* Any other malignancies within 5 years, except for curatively resected carcinoma in situ of the cervix, basal or squamous cell skin cancer, ductal carcinoma in situ, or organ-confined prostate cancer\n* Central nervous system (CNS) metastases or spinal cord compression that has not been definitely treated with surgery and/or radiation, or treated CNS metastases or spinal cord compression without stable disease for \u22652 months\n* Human immunodeficiency virus (HIV), hepatitis B, or hepatitis C infection\n* Any inflammatory changes of the surface of the eye",
                    "healthyVolunteers": false,
                    "sex": "ALL",
                    "minimumAge": "18 Years",
                    "stdAges": [
                        "ADULT",
                        "OLDER_ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "overallOfficials": [
                        {
                            "name": "Clinical Trials",
                            "affiliation": "Hoffmann-La Roche",
                            "role": "STUDY_DIRECTOR"
                        }
                    ],
                    "locations": [
                        {
                            "city": "Gilroy",
                            "state": "California",
                            "zip": "95020",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 37.00578,
                                "lon": -121.56828
                            }
                        },
                        {
                            "city": "Washington",
                            "state": "District of Columbia",
                            "zip": "20010",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 38.89511,
                                "lon": -77.03637
                            }
                        },
                        {
                            "city": "Kansas City",
                            "state": "Missouri",
                            "zip": "64132",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.09973,
                                "lon": -94.57857
                            }
                        },
                        {
                            "city": "Missoula",
                            "state": "Montana",
                            "zip": "59802",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 46.87215,
                                "lon": -113.994
                            }
                        },
                        {
                            "city": "Lebanon",
                            "state": "New Hampshire",
                            "zip": "03756",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 43.64229,
                                "lon": -72.25176
                            }
                        },
                        {
                            "city": "Dayton",
                            "state": "Ohio",
                            "zip": "45420",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.75895,
                                "lon": -84.19161
                            }
                        },
                        {
                            "city": "Chattanooga",
                            "state": "Tennessee",
                            "zip": "37404",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 35.04563,
                                "lon": -85.30968
                            }
                        },
                        {
                            "city": "Spokane",
                            "state": "Washington",
                            "zip": "99218",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 47.65966,
                                "lon": -117.42908
                            }
                        },
                        {
                            "city": "Tacoma",
                            "state": "Washington",
                            "zip": "98405",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 47.25288,
                                "lon": -122.44429
                            }
                        },
                        {
                            "city": "Belo Horizonte",
                            "state": "MG",
                            "zip": "30150-281",
                            "country": "Brazil",
                            "geoPoint": {
                                "lat": -19.92083,
                                "lon": -43.93778
                            }
                        },
                        {
                            "city": "Iju\u00ed",
                            "state": "RO",
                            "zip": "98700-000",
                            "country": "Brazil",
                            "geoPoint": {
                                "lat": -28.38778,
                                "lon": -53.91472
                            }
                        },
                        {
                            "city": "Lajeado",
                            "state": "RS",
                            "zip": "95900-000",
                            "country": "Brazil",
                            "geoPoint": {
                                "lat": -29.46694,
                                "lon": -51.96139
                            }
                        },
                        {
                            "city": "Porto Alegre",
                            "state": "RS",
                            "zip": "90020-090",
                            "country": "Brazil",
                            "geoPoint": {
                                "lat": -30.03306,
                                "lon": -51.23
                            }
                        },
                        {
                            "city": "Porto Alegre",
                            "state": "RS",
                            "zip": "90035-003",
                            "country": "Brazil",
                            "geoPoint": {
                                "lat": -30.03306,
                                "lon": -51.23
                            }
                        },
                        {
                            "city": "Porto Alegre",
                            "state": "RS",
                            "zip": "90430-090",
                            "country": "Brazil",
                            "geoPoint": {
                                "lat": -30.03306,
                                "lon": -51.23
                            }
                        },
                        {
                            "city": "Porto Alegre",
                            "state": "RS",
                            "zip": "90470340",
                            "country": "Brazil",
                            "geoPoint": {
                                "lat": -30.03306,
                                "lon": -51.23
                            }
                        },
                        {
                            "city": "Florianopolis",
                            "state": "SC",
                            "zip": "88034-000",
                            "country": "Brazil",
                            "geoPoint": {
                                "lat": -27.59667,
                                "lon": -48.54917
                            }
                        },
                        {
                            "city": "Santo Andr\u00e9",
                            "state": "SP",
                            "zip": "09060-650",
                            "country": "Brazil",
                            "geoPoint": {
                                "lat": -23.66389,
                                "lon": -46.53833
                            }
                        },
                        {
                            "city": "Gabrovo",
                            "zip": "5300",
                            "country": "Bulgaria",
                            "geoPoint": {
                                "lat": 42.87472,
                                "lon": 25.33417
                            }
                        },
                        {
                            "city": "Haskovo",
                            "zip": "6300",
                            "country": "Bulgaria",
                            "geoPoint": {
                                "lat": 41.93415,
                                "lon": 25.55557
                            }
                        },
                        {
                            "city": "Plovdiv",
                            "zip": "4004",
                            "country": "Bulgaria",
                            "geoPoint": {
                                "lat": 42.15,
                                "lon": 24.75
                            }
                        },
                        {
                            "city": "Ruse",
                            "zip": "7000",
                            "country": "Bulgaria",
                            "geoPoint": {
                                "lat": 43.85639,
                                "lon": 25.97083
                            }
                        },
                        {
                            "city": "Sofia",
                            "zip": "1233",
                            "country": "Bulgaria",
                            "geoPoint": {
                                "lat": 42.69751,
                                "lon": 23.32415
                            }
                        },
                        {
                            "city": "Sofia",
                            "zip": "1303",
                            "country": "Bulgaria",
                            "geoPoint": {
                                "lat": 42.69751,
                                "lon": 23.32415
                            }
                        },
                        {
                            "city": "Sofia",
                            "zip": "1527",
                            "country": "Bulgaria",
                            "geoPoint": {
                                "lat": 42.69751,
                                "lon": 23.32415
                            }
                        },
                        {
                            "city": "Sofia",
                            "zip": "1606",
                            "country": "Bulgaria",
                            "geoPoint": {
                                "lat": 42.69751,
                                "lon": 23.32415
                            }
                        },
                        {
                            "city": "Sofia",
                            "zip": "1756",
                            "country": "Bulgaria",
                            "geoPoint": {
                                "lat": 42.69751,
                                "lon": 23.32415
                            }
                        },
                        {
                            "city": "Sofia",
                            "zip": "1784",
                            "country": "Bulgaria",
                            "geoPoint": {
                                "lat": 42.69751,
                                "lon": 23.32415
                            }
                        },
                        {
                            "city": "Varna",
                            "zip": "9010",
                            "country": "Bulgaria",
                            "geoPoint": {
                                "lat": 43.21667,
                                "lon": 27.91667
                            }
                        },
                        {
                            "city": "Windsor",
                            "state": "Ontario",
                            "zip": "N8W 2X3",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 42.30008,
                                "lon": -83.01654
                            }
                        },
                        {
                            "city": "Montreal",
                            "state": "Quebec",
                            "zip": "H3T 1E2",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 45.50884,
                                "lon": -73.58781
                            }
                        },
                        {
                            "city": "Regina",
                            "state": "Saskatchewan",
                            "zip": "S4T 7T1",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 50.45008,
                                "lon": -104.6178
                            }
                        },
                        {
                            "city": "Quebec",
                            "zip": "G1V 4G5",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 46.81228,
                                "lon": -71.21454
                            }
                        },
                        {
                            "city": "Beijing",
                            "zip": "100142",
                            "country": "China",
                            "geoPoint": {
                                "lat": 39.9075,
                                "lon": 116.39723
                            }
                        },
                        {
                            "city": "Beijing",
                            "zip": "100730",
                            "country": "China",
                            "geoPoint": {
                                "lat": 39.9075,
                                "lon": 116.39723
                            }
                        },
                        {
                            "city": "Changchun",
                            "zip": "130012",
                            "country": "China",
                            "geoPoint": {
                                "lat": 43.88,
                                "lon": 125.32278
                            }
                        },
                        {
                            "city": "Fuzhou",
                            "zip": "350014",
                            "country": "China",
                            "geoPoint": {
                                "lat": 26.06139,
                                "lon": 119.30611
                            }
                        },
                        {
                            "city": "Guangzhou",
                            "zip": "510515",
                            "country": "China",
                            "geoPoint": {
                                "lat": 23.11667,
                                "lon": 113.25
                            }
                        },
                        {
                            "city": "Guangzhou",
                            "country": "China",
                            "geoPoint": {
                                "lat": 23.11667,
                                "lon": 113.25
                            }
                        },
                        {
                            "city": "Harbin",
                            "zip": "150081",
                            "country": "China",
                            "geoPoint": {
                                "lat": 45.75,
                                "lon": 126.65
                            }
                        },
                        {
                            "city": "Shanghai",
                            "zip": "200030",
                            "country": "China",
                            "geoPoint": {
                                "lat": 31.22222,
                                "lon": 121.45806
                            }
                        },
                        {
                            "city": "Shanghai",
                            "zip": "200433",
                            "country": "China",
                            "geoPoint": {
                                "lat": 31.22222,
                                "lon": 121.45806
                            }
                        },
                        {
                            "city": "Shantou",
                            "zip": "515041",
                            "country": "China",
                            "geoPoint": {
                                "lat": 23.36814,
                                "lon": 116.71479
                            }
                        },
                        {
                            "city": "Shenyang",
                            "zip": "110001",
                            "country": "China",
                            "geoPoint": {
                                "lat": 41.79222,
                                "lon": 123.43278
                            }
                        },
                        {
                            "city": "Suzhou",
                            "zip": "215004",
                            "country": "China",
                            "geoPoint": {
                                "lat": 31.30408,
                                "lon": 120.59538
                            }
                        },
                        {
                            "city": "Tianjin",
                            "zip": "300060",
                            "country": "China",
                            "geoPoint": {
                                "lat": 39.14222,
                                "lon": 117.17667
                            }
                        },
                        {
                            "city": "Wuhan",
                            "zip": "430071",
                            "country": "China",
                            "geoPoint": {
                                "lat": 30.58333,
                                "lon": 114.26667
                            }
                        },
                        {
                            "city": "Xi'an",
                            "zip": "710061",
                            "country": "China",
                            "geoPoint": {
                                "lat": 34.25833,
                                "lon": 108.92861
                            }
                        },
                        {
                            "city": "Ceske Budejovice",
                            "zip": "370 87",
                            "country": "Czech Republic",
                            "geoPoint": {
                                "lat": 48.97447,
                                "lon": 14.47434
                            }
                        },
                        {
                            "city": "Jindrichuv Hradec",
                            "zip": "377 01",
                            "country": "Czech Republic",
                            "geoPoint": {
                                "lat": 49.14404,
                                "lon": 15.00301
                            }
                        },
                        {
                            "city": "Nymburk",
                            "zip": "288 01",
                            "country": "Czech Republic",
                            "geoPoint": {
                                "lat": 50.18605,
                                "lon": 15.04167
                            }
                        },
                        {
                            "city": "Ostrava - Poruba",
                            "zip": "708 52",
                            "country": "Czech Republic",
                            "geoPoint": {
                                "lat": 49.83465,
                                "lon": 18.28204
                            }
                        },
                        {
                            "city": "Praha 8",
                            "zip": "180 81",
                            "country": "Czech Republic",
                            "geoPoint": {
                                "lat": 50.08804,
                                "lon": 14.42076
                            }
                        },
                        {
                            "city": "Praha",
                            "zip": "150 06",
                            "country": "Czech Republic",
                            "geoPoint": {
                                "lat": 50.08804,
                                "lon": 14.42076
                            }
                        },
                        {
                            "city": "Tabor",
                            "zip": "390 03",
                            "country": "Czech Republic",
                            "geoPoint": {
                                "lat": 49.41441,
                                "lon": 14.6578
                            }
                        },
                        {
                            "city": "Bayonne",
                            "zip": "64109",
                            "country": "France",
                            "geoPoint": {
                                "lat": 43.48333,
                                "lon": -1.48333
                            }
                        },
                        {
                            "city": "Compiegne",
                            "zip": "60321",
                            "country": "France",
                            "geoPoint": {
                                "lat": 49.41794,
                                "lon": 2.82606
                            }
                        },
                        {
                            "city": "Gap",
                            "zip": "05007",
                            "country": "France",
                            "geoPoint": {
                                "lat": 44.56667,
                                "lon": 6.08333
                            }
                        },
                        {
                            "city": "Libourne",
                            "zip": "33505",
                            "country": "France",
                            "geoPoint": {
                                "lat": 44.91667,
                                "lon": -0.23333
                            }
                        },
                        {
                            "city": "Lille",
                            "zip": "59020",
                            "country": "France",
                            "geoPoint": {
                                "lat": 50.63297,
                                "lon": 3.05858
                            }
                        },
                        {
                            "city": "Nantes",
                            "zip": "44202",
                            "country": "France",
                            "geoPoint": {
                                "lat": 47.21725,
                                "lon": -1.55336
                            }
                        },
                        {
                            "city": "St Brieuc",
                            "zip": "22027",
                            "country": "France",
                            "geoPoint": {
                                "lat": 48.51513,
                                "lon": -2.76838
                            }
                        },
                        {
                            "city": "Villefranche-sur-Saone",
                            "zip": "69655",
                            "country": "France",
                            "geoPoint": {
                                "lat": 45.98333,
                                "lon": 4.71667
                            }
                        },
                        {
                            "city": "Budapest",
                            "zip": "1121",
                            "country": "Hungary",
                            "geoPoint": {
                                "lat": 47.49801,
                                "lon": 19.03991
                            }
                        },
                        {
                            "city": "Budapest",
                            "zip": "1122",
                            "country": "Hungary",
                            "geoPoint": {
                                "lat": 47.49801,
                                "lon": 19.03991
                            }
                        },
                        {
                            "city": "Budapest",
                            "zip": "1125",
                            "country": "Hungary",
                            "geoPoint": {
                                "lat": 47.49801,
                                "lon": 19.03991
                            }
                        },
                        {
                            "city": "Budapest",
                            "zip": "1145",
                            "country": "Hungary",
                            "geoPoint": {
                                "lat": 47.49801,
                                "lon": 19.03991
                            }
                        },
                        {
                            "city": "Deszk",
                            "zip": "6772",
                            "country": "Hungary",
                            "geoPoint": {
                                "lat": 46.21802,
                                "lon": 20.24322
                            }
                        },
                        {
                            "city": "Farkasgyepu",
                            "zip": "8582",
                            "country": "Hungary",
                            "geoPoint": {
                                "lat": 47.2,
                                "lon": 17.63333
                            }
                        },
                        {
                            "city": "Gyor",
                            "zip": "9024",
                            "country": "Hungary",
                            "geoPoint": {
                                "lat": 47.68333,
                                "lon": 17.63512
                            }
                        },
                        {
                            "city": "Gyula",
                            "zip": "5703",
                            "country": "Hungary",
                            "geoPoint": {
                                "lat": 46.65,
                                "lon": 21.28333
                            }
                        },
                        {
                            "city": "Matrahaza",
                            "zip": "3233",
                            "country": "Hungary",
                            "geoPoint": {
                                "lat": 47.87124,
                                "lon": 19.97981
                            }
                        },
                        {
                            "city": "Miskolc",
                            "zip": "3526",
                            "country": "Hungary",
                            "geoPoint": {
                                "lat": 48.1,
                                "lon": 20.78333
                            }
                        },
                        {
                            "city": "Szolnok",
                            "zip": "5000",
                            "country": "Hungary",
                            "geoPoint": {
                                "lat": 47.18333,
                                "lon": 20.2
                            }
                        },
                        {
                            "city": "Sz\u00e9kesfeh\u00e9rv\u00e1r",
                            "zip": "8000",
                            "country": "Hungary",
                            "geoPoint": {
                                "lat": 47.18995,
                                "lon": 18.41034
                            }
                        },
                        {
                            "city": "Torokbalint",
                            "zip": "2045",
                            "country": "Hungary",
                            "geoPoint": {
                                "lat": 47.42931,
                                "lon": 18.91356
                            }
                        },
                        {
                            "city": "Zalaegerszeg",
                            "zip": "8900",
                            "country": "Hungary",
                            "geoPoint": {
                                "lat": 46.84,
                                "lon": 16.84389
                            }
                        },
                        {
                            "city": "Avellino",
                            "state": "Campania",
                            "zip": "83100",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 40.91494,
                                "lon": 14.79103
                            }
                        },
                        {
                            "city": "Bologna",
                            "state": "Emilia-Romagna",
                            "zip": "40138",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 44.49381,
                                "lon": 11.33875
                            }
                        },
                        {
                            "city": "Parma",
                            "state": "Emilia-Romagna",
                            "zip": "43100",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 44.79935,
                                "lon": 10.32618
                            }
                        },
                        {
                            "city": "Roma",
                            "state": "Lazio",
                            "zip": "00144",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 41.89193,
                                "lon": 12.51133
                            }
                        },
                        {
                            "city": "Roma",
                            "state": "Lazio",
                            "zip": "00151",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 41.89193,
                                "lon": 12.51133
                            }
                        },
                        {
                            "city": "Roma",
                            "state": "Lazio",
                            "zip": "00168",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 41.89193,
                                "lon": 12.51133
                            }
                        },
                        {
                            "city": "Legnago",
                            "state": "Lombardia",
                            "zip": "37045",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 45.19365,
                                "lon": 11.30227
                            }
                        },
                        {
                            "city": "Treviglio",
                            "state": "Lombardia",
                            "zip": "24047",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 45.52081,
                                "lon": 9.59102
                            }
                        },
                        {
                            "city": "S. Giovanni Rotondo",
                            "state": "Puglia",
                            "zip": "71013",
                            "country": "Italy"
                        },
                        {
                            "city": "Livorno",
                            "state": "Toscana",
                            "zip": "57124",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 43.54427,
                                "lon": 10.32615
                            }
                        },
                        {
                            "city": "Pisa",
                            "state": "Toscana",
                            "zip": "56100",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 43.70853,
                                "lon": 10.4036
                            }
                        },
                        {
                            "city": "Verona",
                            "state": "Veneto",
                            "zip": "37134",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 45.4299,
                                "lon": 10.98444
                            }
                        },
                        {
                            "city": "Gyeonggi-do",
                            "zip": "463-707",
                            "country": "Korea, Republic of",
                            "geoPoint": {
                                "lat": 37.58944,
                                "lon": 126.76917
                            }
                        },
                        {
                            "city": "Seoul",
                            "zip": "03722",
                            "country": "Korea, Republic of",
                            "geoPoint": {
                                "lat": 37.566,
                                "lon": 126.9784
                            }
                        },
                        {
                            "city": "Seoul",
                            "zip": "06351",
                            "country": "Korea, Republic of",
                            "geoPoint": {
                                "lat": 37.566,
                                "lon": 126.9784
                            }
                        },
                        {
                            "city": "Seoul",
                            "zip": "150-713",
                            "country": "Korea, Republic of",
                            "geoPoint": {
                                "lat": 37.566,
                                "lon": 126.9784
                            }
                        },
                        {
                            "city": "Suwon",
                            "zip": "442-723",
                            "country": "Korea, Republic of",
                            "geoPoint": {
                                "lat": 37.29111,
                                "lon": 127.00889
                            }
                        },
                        {
                            "city": "Daugavpils",
                            "zip": "5417",
                            "country": "Latvia",
                            "geoPoint": {
                                "lat": 55.88333,
                                "lon": 26.53333
                            }
                        },
                        {
                            "city": "Riga",
                            "zip": "LV-1079",
                            "country": "Latvia",
                            "geoPoint": {
                                "lat": 56.946,
                                "lon": 24.10589
                            }
                        },
                        {
                            "city": "Riga",
                            "zip": "LV1002",
                            "country": "Latvia",
                            "geoPoint": {
                                "lat": 56.946,
                                "lon": 24.10589
                            }
                        },
                        {
                            "city": "Kaunas",
                            "zip": "50009",
                            "country": "Lithuania",
                            "geoPoint": {
                                "lat": 54.90272,
                                "lon": 23.90961
                            }
                        },
                        {
                            "city": "Vilnius",
                            "zip": "08660",
                            "country": "Lithuania",
                            "geoPoint": {
                                "lat": 54.68916,
                                "lon": 25.2798
                            }
                        },
                        {
                            "city": "Arnhem",
                            "zip": "6800 TA",
                            "country": "Netherlands",
                            "geoPoint": {
                                "lat": 51.98,
                                "lon": 5.91111
                            }
                        },
                        {
                            "city": "Heerlen",
                            "zip": "6419 PC",
                            "country": "Netherlands",
                            "geoPoint": {
                                "lat": 50.88365,
                                "lon": 5.98154
                            }
                        },
                        {
                            "city": "Hoorn",
                            "zip": "1625 HV",
                            "country": "Netherlands",
                            "geoPoint": {
                                "lat": 52.6425,
                                "lon": 5.05978
                            }
                        },
                        {
                            "city": "Sittard-Geleen",
                            "zip": "6162 BG",
                            "country": "Netherlands"
                        },
                        {
                            "city": "Zutphen",
                            "zip": "7207 AE",
                            "country": "Netherlands",
                            "geoPoint": {
                                "lat": 52.13833,
                                "lon": 6.20139
                            }
                        },
                        {
                            "city": "Brzoz\u00f3w",
                            "zip": "36-200",
                            "country": "Poland",
                            "geoPoint": {
                                "lat": 49.69501,
                                "lon": 22.01926
                            }
                        },
                        {
                            "city": "Krakow",
                            "zip": "31-115",
                            "country": "Poland",
                            "geoPoint": {
                                "lat": 50.06143,
                                "lon": 19.93658
                            }
                        },
                        {
                            "city": "Poznan",
                            "zip": "60-569",
                            "country": "Poland",
                            "geoPoint": {
                                "lat": 52.40692,
                                "lon": 16.92993
                            }
                        },
                        {
                            "city": "Wodzislaw Slaski",
                            "zip": "44-300",
                            "country": "Poland",
                            "geoPoint": {
                                "lat": 50.00377,
                                "lon": 18.47205
                            }
                        },
                        {
                            "city": "Zamosc",
                            "zip": "22-400",
                            "country": "Poland",
                            "geoPoint": {
                                "lat": 50.72314,
                                "lon": 23.25196
                            }
                        },
                        {
                            "city": "Baia Mare",
                            "zip": "430031",
                            "country": "Romania",
                            "geoPoint": {
                                "lat": 47.65529,
                                "lon": 23.57381
                            }
                        },
                        {
                            "city": "Braila",
                            "zip": "810325",
                            "country": "Romania",
                            "geoPoint": {
                                "lat": 45.26667,
                                "lon": 27.98333
                            }
                        },
                        {
                            "city": "Brasov",
                            "zip": "500091",
                            "country": "Romania",
                            "geoPoint": {
                                "lat": 45.64861,
                                "lon": 25.60613
                            }
                        },
                        {
                            "city": "Brasov",
                            "zip": "500152",
                            "country": "Romania",
                            "geoPoint": {
                                "lat": 45.64861,
                                "lon": 25.60613
                            }
                        },
                        {
                            "city": "Bucuresti",
                            "zip": "010976",
                            "country": "Romania",
                            "geoPoint": {
                                "lat": 44.42802,
                                "lon": 26.09665
                            }
                        },
                        {
                            "city": "Bucuresti",
                            "zip": "022328",
                            "country": "Romania",
                            "geoPoint": {
                                "lat": 44.42802,
                                "lon": 26.09665
                            }
                        },
                        {
                            "city": "Cluj-Napoca",
                            "zip": "400015",
                            "country": "Romania",
                            "geoPoint": {
                                "lat": 46.76667,
                                "lon": 23.6
                            }
                        },
                        {
                            "city": "Cluj-Napoca",
                            "zip": "400058",
                            "country": "Romania",
                            "geoPoint": {
                                "lat": 46.76667,
                                "lon": 23.6
                            }
                        },
                        {
                            "city": "Cluj-Napoca",
                            "zip": "400132",
                            "country": "Romania",
                            "geoPoint": {
                                "lat": 46.76667,
                                "lon": 23.6
                            }
                        },
                        {
                            "city": "Oradea",
                            "zip": "410167",
                            "country": "Romania",
                            "geoPoint": {
                                "lat": 47.0458,
                                "lon": 21.91833
                            }
                        },
                        {
                            "city": "Ploiesti",
                            "zip": "100337",
                            "country": "Romania",
                            "geoPoint": {
                                "lat": 44.95,
                                "lon": 26.01667
                            }
                        },
                        {
                            "city": "Targu-Mures",
                            "zip": "540136",
                            "country": "Romania",
                            "geoPoint": {
                                "lat": 46.54245,
                                "lon": 24.55747
                            }
                        },
                        {
                            "city": "Banska Bystrica",
                            "zip": "975 17",
                            "country": "Slovakia",
                            "geoPoint": {
                                "lat": 48.73946,
                                "lon": 19.15349
                            }
                        },
                        {
                            "city": "Bardejov",
                            "zip": "085 01",
                            "country": "Slovakia",
                            "geoPoint": {
                                "lat": 49.29175,
                                "lon": 21.27271
                            }
                        },
                        {
                            "city": "Kosice",
                            "zip": "04001",
                            "country": "Slovakia",
                            "geoPoint": {
                                "lat": 48.71395,
                                "lon": 21.25808
                            }
                        },
                        {
                            "city": "Nove Zamky",
                            "zip": "940 02",
                            "country": "Slovakia",
                            "geoPoint": {
                                "lat": 47.98544,
                                "lon": 18.16195
                            }
                        },
                        {
                            "city": "Poprad",
                            "zip": "058 01",
                            "country": "Slovakia",
                            "geoPoint": {
                                "lat": 49.06144,
                                "lon": 20.29798
                            }
                        },
                        {
                            "city": "Rimavska Sobota",
                            "zip": "97901",
                            "country": "Slovakia",
                            "geoPoint": {
                                "lat": 48.38284,
                                "lon": 20.02239
                            }
                        },
                        {
                            "city": "Cape Town",
                            "zip": "7570",
                            "country": "South Africa",
                            "geoPoint": {
                                "lat": -33.92584,
                                "lon": 18.42322
                            }
                        },
                        {
                            "city": "Cape Town",
                            "zip": "7700",
                            "country": "South Africa",
                            "geoPoint": {
                                "lat": -33.92584,
                                "lon": 18.42322
                            }
                        },
                        {
                            "city": "George",
                            "zip": "6530",
                            "country": "South Africa",
                            "geoPoint": {
                                "lat": -33.963,
                                "lon": 22.46173
                            }
                        },
                        {
                            "city": "Port Elizabeth",
                            "zip": "6045",
                            "country": "South Africa",
                            "geoPoint": {
                                "lat": -33.91799,
                                "lon": 25.57007
                            }
                        },
                        {
                            "city": "Pretoria",
                            "zip": "0002",
                            "country": "South Africa",
                            "geoPoint": {
                                "lat": -25.74486,
                                "lon": 28.18783
                            }
                        },
                        {
                            "city": "Kaohsiung",
                            "zip": "00833",
                            "country": "Taiwan",
                            "geoPoint": {
                                "lat": 22.61626,
                                "lon": 120.31333
                            }
                        },
                        {
                            "city": "Taichung",
                            "zip": "40447",
                            "country": "Taiwan",
                            "geoPoint": {
                                "lat": 24.1469,
                                "lon": 120.6839
                            }
                        },
                        {
                            "city": "Taichung",
                            "zip": "40705",
                            "country": "Taiwan",
                            "geoPoint": {
                                "lat": 24.1469,
                                "lon": 120.6839
                            }
                        },
                        {
                            "city": "Taipei",
                            "zip": "00112",
                            "country": "Taiwan",
                            "geoPoint": {
                                "lat": 25.04776,
                                "lon": 121.53185
                            }
                        },
                        {
                            "city": "Taipei",
                            "zip": "100",
                            "country": "Taiwan",
                            "geoPoint": {
                                "lat": 25.04776,
                                "lon": 121.53185
                            }
                        },
                        {
                            "city": "Taipei",
                            "zip": "112",
                            "country": "Taiwan",
                            "geoPoint": {
                                "lat": 25.04776,
                                "lon": 121.53185
                            }
                        },
                        {
                            "city": "Taipei",
                            "zip": "11490",
                            "country": "Taiwan",
                            "geoPoint": {
                                "lat": 25.04776,
                                "lon": 121.53185
                            }
                        },
                        {
                            "city": "Bangkok",
                            "zip": "10700",
                            "country": "Thailand",
                            "geoPoint": {
                                "lat": 13.75398,
                                "lon": 100.50144
                            }
                        },
                        {
                            "city": "Hat Yai",
                            "zip": "90110",
                            "country": "Thailand",
                            "geoPoint": {
                                "lat": 7.00836,
                                "lon": 100.47668
                            }
                        },
                        {
                            "city": "Muang",
                            "zip": "50200",
                            "country": "Thailand"
                        },
                        {
                            "city": "Muang",
                            "zip": "57000",
                            "country": "Thailand"
                        },
                        {
                            "city": "Dnipropetrovsk",
                            "zip": "49102",
                            "country": "Ukraine",
                            "geoPoint": {
                                "lat": 48.4593,
                                "lon": 35.03864
                            }
                        },
                        {
                            "city": "Donetsk",
                            "zip": "83092",
                            "country": "Ukraine",
                            "geoPoint": {
                                "lat": 48.023,
                                "lon": 37.80224
                            }
                        },
                        {
                            "city": "Kharkiv",
                            "zip": "61024",
                            "country": "Ukraine",
                            "geoPoint": {
                                "lat": 49.98081,
                                "lon": 36.25272
                            }
                        },
                        {
                            "city": "Kirovograd",
                            "zip": "25011",
                            "country": "Ukraine"
                        },
                        {
                            "city": "Kyiv",
                            "zip": "03022",
                            "country": "Ukraine",
                            "geoPoint": {
                                "lat": 50.45466,
                                "lon": 30.5238
                            }
                        },
                        {
                            "city": "Kyiv",
                            "zip": "03115",
                            "country": "Ukraine",
                            "geoPoint": {
                                "lat": 50.45466,
                                "lon": 30.5238
                            }
                        },
                        {
                            "city": "Kyiv",
                            "zip": "04107",
                            "country": "Ukraine",
                            "geoPoint": {
                                "lat": 50.45466,
                                "lon": 30.5238
                            }
                        },
                        {
                            "city": "Lutsk",
                            "zip": "63000",
                            "country": "Ukraine",
                            "geoPoint": {
                                "lat": 50.75932,
                                "lon": 25.34244
                            }
                        },
                        {
                            "city": "Sumy",
                            "zip": "40005",
                            "country": "Ukraine",
                            "geoPoint": {
                                "lat": 50.9216,
                                "lon": 34.80029
                            }
                        },
                        {
                            "city": "Uzhgorod",
                            "zip": "88000",
                            "country": "Ukraine",
                            "geoPoint": {
                                "lat": 48.61667,
                                "lon": 22.3
                            }
                        },
                        {
                            "city": "Vinnytsya",
                            "zip": "21029",
                            "country": "Ukraine",
                            "geoPoint": {
                                "lat": 49.23278,
                                "lon": 28.48097
                            }
                        },
                        {
                            "city": "Zaporizhzhya",
                            "zip": "69040",
                            "country": "Ukraine",
                            "geoPoint": {
                                "lat": 50.60727,
                                "lon": 31.78792
                            }
                        }
                    ]
                }
            },
            "resultsSection": {
                "participantFlowModule": {
                    "preAssignmentDetails": "The study consisted of three periods: a Blinded Phase (BP), an Open-Label Phase (OLP), and final Survival Follow-Up (SFU). These periods were not necessarily sequential, because the OLP could be \"skipped\" in select participants. Therefore, the reasons for discontinuation are presented altogether within the Overall Study.",
                    "groups": [
                        {
                            "id": "FG000",
                            "title": "Late Erlotinib",
                            "description": "Participants received blinded placebo tablets orally (PO) once daily during the BP in the maintenance setting until disease progression, death, or unacceptable toxicity. Those who demonstrated disease progression were unblinded and could receive second-line erlotinib tablets during the OLP as 150 mg PO once daily, provided by the Sponsor. This treatment continued until disease progression, death, or unacceptable toxicity. If disease progression or unacceptable toxicity occurred during the OLP, the participant entered a final SFU period. Participants could also enter the SFU period directly after the BP if they were unable to receive second-line treatment per protocol."
                        },
                        {
                            "id": "FG001",
                            "title": "Early Erlotinib",
                            "description": "Participants received blinded erlotinib tablets, 150 mg PO once daily during the BP in the maintenance setting until disease progression, death, or unacceptable toxicity. Those who demonstrated disease progression were unblinded and could receive an approved second-line therapy (but not epidermal growth factor receptor \\[EGFR\\] targeted therapies) or best supportive care (BSC) as chosen by the investigator during the OLP. This treatment continued until disease progression, death, or unacceptable toxicity. If disease progression or unacceptable toxicity occurred during the OLP, the participant entered a final SFU period. Participants could also enter the SFU period directly after the BP if they were unable to receive second-line treatment per protocol."
                        }
                    ],
                    "periods": [
                        {
                            "title": "Overall Study",
                            "milestones": [
                                {
                                    "type": "STARTED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "321"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "322"
                                        }
                                    ]
                                },
                                {
                                    "type": "COMPLETED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "0"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "0"
                                        }
                                    ]
                                },
                                {
                                    "type": "NOT COMPLETED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "321"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "322"
                                        }
                                    ]
                                }
                            ],
                            "dropWithdraws": [
                                {
                                    "type": "Disease Progression",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "17"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "14"
                                        }
                                    ]
                                },
                                {
                                    "type": "Adverse Event",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "2"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "0"
                                        }
                                    ]
                                },
                                {
                                    "type": "Death",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "243"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "258"
                                        }
                                    ]
                                },
                                {
                                    "type": "Lost to Follow-up",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "6"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "7"
                                        }
                                    ]
                                },
                                {
                                    "type": "Withdrawal by Subject",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "6"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "6"
                                        }
                                    ]
                                },
                                {
                                    "type": "Study Closed by the Sponsor",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "36"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "31"
                                        }
                                    ]
                                },
                                {
                                    "type": "Other",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "11"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "6"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "baselineCharacteristicsModule": {
                    "populationDescription": "Intent-to-Treat (ITT) Population: All participants who were randomized to treatment.",
                    "groups": [
                        {
                            "id": "BG000",
                            "title": "Late Erlotinib",
                            "description": "Participants received blinded placebo tablets PO once daily during the BP in the maintenance setting until disease progression, death, or unacceptable toxicity. Those who demonstrated disease progression were unblinded and could receive second-line erlotinib tablets during the OLP as 150 mg PO once daily, provided by the Sponsor. This treatment continued until disease progression, death, or unacceptable toxicity. If disease progression or unacceptable toxicity occurred during the OLP, the participant entered a final SFU period. Participants could also enter the SFU period directly after the BP if they were unable to receive second-line treatment per protocol."
                        },
                        {
                            "id": "BG001",
                            "title": "Early Erlotinib",
                            "description": "Participants received blinded erlotinib tablets, 150 mg PO once daily during the BP in the maintenance setting until disease progression, death, or unacceptable toxicity. Those who demonstrated disease progression were unblinded and could receive an approved second-line therapy (but not EGFR targeted therapies) or BSC as chosen by the investigator during the OLP. This treatment continued until disease progression, death, or unacceptable toxicity. If disease progression or unacceptable toxicity occurred during the OLP, the participant entered a final SFU period. Participants could also enter the SFU period directly after the BP if they were unable to receive second-line treatment per protocol."
                        },
                        {
                            "id": "BG002",
                            "title": "Total",
                            "description": "Total of all reporting groups"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "BG000",
                                    "value": "321"
                                },
                                {
                                    "groupId": "BG001",
                                    "value": "322"
                                },
                                {
                                    "groupId": "BG002",
                                    "value": "643"
                                }
                            ]
                        }
                    ],
                    "measures": [
                        {
                            "title": "Age, Continuous",
                            "paramType": "MEAN",
                            "dispersionType": "STANDARD_DEVIATION",
                            "unitOfMeasure": "years",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "60.6",
                                                    "spread": "9.1"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "60.8",
                                                    "spread": "8.8"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "60.7",
                                                    "spread": "8.9"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Sex: Female, Male",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "title": "Female",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "77"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "84"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "161"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Male",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "244"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "238"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "482"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "outcomeMeasuresModule": {
                    "outcomeMeasures": [
                        {
                            "type": "PRIMARY",
                            "title": "Percentage of Participants Who Died During the Overall Study",
                            "description": "Participants were followed for survival until death or premature withdrawal. The percentage of participants who died during the Overall Study (BP, OLP, or SFU) was calculated.",
                            "populationDescription": "ITT Population.",
                            "reportingStatus": "POSTED",
                            "paramType": "NUMBER",
                            "unitOfMeasure": "percentage of participants",
                            "timeFrame": "Up to approximately 3.5 years (visits at Baseline and Weeks 6, 12, and 18 and every 12 weeks until/at disease progression during BP; per local standards during OLP; then every 12 weeks during SFU until death)",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Late Erlotinib",
                                    "description": "Participants received blinded placebo tablets PO once daily during the BP in the maintenance setting until disease progression, death, or unacceptable toxicity. Those who demonstrated disease progression were unblinded and could receive second-line erlotinib tablets during the OLP as 150 mg PO once daily, provided by the Sponsor. This treatment continued until disease progression, death, or unacceptable toxicity. If disease progression or unacceptable toxicity occurred during the OLP, the participant entered a final SFU period. Participants could also enter the SFU period directly after the BP if they were unable to receive second-line treatment per protocol."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Early Erlotinib",
                                    "description": "Participants received blinded erlotinib tablets, 150 mg PO once daily during the BP in the maintenance setting until disease progression, death, or unacceptable toxicity. Those who demonstrated disease progression were unblinded and could receive an approved second-line therapy (but not EGFR targeted therapies) or BSC as chosen by the investigator during the OLP. This treatment continued until disease progression, death, or unacceptable toxicity. If disease progression or unacceptable toxicity occurred during the OLP, the participant entered a final SFU period. Participants could also enter the SFU period directly after the BP if they were unable to receive second-line treatment per protocol."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "321"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "322"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "73.2"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "75.2"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "PRIMARY",
                            "title": "Overall Survival (OS) as Median Time to Event During the Overall Study",
                            "description": "Participants were followed for survival until death or premature withdrawal. OS was defined as the interval between date of randomization and date of death from any cause. Median time to event during the Overall Study (BP, OLP, or SFU) was estimated using the Kaplan-Meier method and expressed in months.",
                            "populationDescription": "ITT Population.",
                            "reportingStatus": "POSTED",
                            "paramType": "MEDIAN",
                            "dispersionType": "95% Confidence Interval",
                            "unitOfMeasure": "months",
                            "timeFrame": "Up to approximately 3.5 years (visits at Baseline and Weeks 6, 12, and 18 and every 12 weeks until/at disease progression during BP; per local standards during OLP; then every 12 weeks during SFU until death)",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Late Erlotinib",
                                    "description": "Participants received blinded placebo tablets PO once daily during the BP in the maintenance setting until disease progression, death, or unacceptable toxicity. Those who demonstrated disease progression were unblinded and could receive second-line erlotinib tablets during the OLP as 150 mg PO once daily, provided by the Sponsor. This treatment continued until disease progression, death, or unacceptable toxicity. If disease progression or unacceptable toxicity occurred during the OLP, the participant entered a final SFU period. Participants could also enter the SFU period directly after the BP if they were unable to receive second-line treatment per protocol."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Early Erlotinib",
                                    "description": "Participants received blinded erlotinib tablets, 150 mg PO once daily during the BP in the maintenance setting until disease progression, death, or unacceptable toxicity. Those who demonstrated disease progression were unblinded and could receive an approved second-line therapy (but not EGFR targeted therapies) or BSC as chosen by the investigator during the OLP. This treatment continued until disease progression, death, or unacceptable toxicity. If disease progression or unacceptable toxicity occurred during the OLP, the participant entered a final SFU period. Participants could also enter the SFU period directly after the BP if they were unable to receive second-line treatment per protocol."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "321"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "322"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "9.46",
                                                    "lowerLimit": "8.38",
                                                    "upperLimit": "11.33"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "9.72",
                                                    "lowerLimit": "8.57",
                                                    "upperLimit": "11.17"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "groupDescription": "Unstratified Analysis.",
                                    "testedNonInferiority": false,
                                    "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                    "pValue": "0.8183",
                                    "statisticalMethod": "Log Rank",
                                    "paramType": "Hazard Ratio (HR)",
                                    "paramValue": "1.02",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "0.85",
                                    "ciUpperLimit": "1.22",
                                    "estimateComment": "The HR and 95% confidence interval (CI) were estimated by Cox regression."
                                },
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "groupDescription": "Stratified Analysis: Stratified according to tumor histology, stage of disease, objective response at Baseline, bevacizumab use, smoking status, and region of enrollment.",
                                    "testedNonInferiority": false,
                                    "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                    "pValue": "0.5256",
                                    "statisticalMethod": "Log Rank",
                                    "paramType": "Hazard Ratio (HR)",
                                    "paramValue": "1.07",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "0.87",
                                    "ciUpperLimit": "1.32",
                                    "estimateComment": "The HR and 95% CI were estimated by Cox regression."
                                }
                            ]
                        },
                        {
                            "type": "PRIMARY",
                            "title": "Percentage of Participants Event-Free (Alive) at 1 Year During the Overall Study",
                            "description": "Participants were followed for survival until death or premature withdrawal. The percentage of participants event-free (i.e., still alive) at 1 year during the Overall Study was calculated.",
                            "populationDescription": "ITT Population.",
                            "reportingStatus": "POSTED",
                            "paramType": "NUMBER",
                            "dispersionType": "95% Confidence Interval",
                            "unitOfMeasure": "percentage of participants",
                            "timeFrame": "At 1 year",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Late Erlotinib",
                                    "description": "Participants received blinded placebo tablets PO once daily during the BP in the maintenance setting until disease progression, death, or unacceptable toxicity. Those who demonstrated disease progression were unblinded and could receive second-line erlotinib tablets during the OLP as 150 mg PO once daily, provided by the Sponsor. This treatment continued until disease progression, death, or unacceptable toxicity. If disease progression or unacceptable toxicity occurred during the OLP, the participant entered a final SFU period. Participants could also enter the SFU period directly after the BP if they were unable to receive second-line treatment per protocol."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Early Erlotinib",
                                    "description": "Participants received blinded erlotinib tablets, 150 mg PO once daily during the BP in the maintenance setting until disease progression, death, or unacceptable toxicity. Those who demonstrated disease progression were unblinded and could receive an approved second-line therapy (but not EGFR targeted therapies) or BSC as chosen by the investigator during the OLP. This treatment continued until disease progression, death, or unacceptable toxicity. If disease progression or unacceptable toxicity occurred during the OLP, the participant entered a final SFU period. Participants could also enter the SFU period directly after the BP if they were unable to receive second-line treatment per protocol."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "321"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "322"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "41.75",
                                                    "lowerLimit": "36.20",
                                                    "upperLimit": "47.30"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "42.15",
                                                    "lowerLimit": "36.60",
                                                    "upperLimit": "47.70"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "testedNonInferiority": false,
                                    "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                    "pValue": "0.9207",
                                    "statisticalMethod": "Chi-squared",
                                    "paramType": "Difference in Event-Free Rate",
                                    "paramValue": "-0.40",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "-8.25",
                                    "ciUpperLimit": "7.45"
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Percentage of Participants Who Died or Experienced Disease Progression During Blinded Treatment",
                            "description": "Tumor response was evaluated using Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1. Disease progression was defined as a greater than or equal to (\u2265) 20 percent (%) and \u22655-millimeter (mm) increase in the sum of target lesion diameters in reference to the smallest sum on study and/or substantial worsening in non-target disease. The percentage of participants who died or experienced disease progression during the BP was calculated.",
                            "populationDescription": "ITT Population.",
                            "reportingStatus": "POSTED",
                            "paramType": "NUMBER",
                            "unitOfMeasure": "percentage of participants",
                            "timeFrame": "Up to approximately 3.5 years (visits at Baseline and Weeks 6, 12, and 18 and every 12 weeks until/at disease progression during BP)",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Placebo (Late Erlotinib)",
                                    "description": "Participants received blinded placebo tablets PO once daily during the BP in the maintenance setting until disease progression, death, or unacceptable toxicity."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Erlotinib (Early Erlotinib)",
                                    "description": "Participants received blinded erlotinib tablets, 150 mg PO once daily during the BP in the maintenance setting until disease progression, death, or unacceptable toxicity."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "321"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "322"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "95.0"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "94.1"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Progression-Free Survival (PFS) as Median Time to Event During Blinded Treatment",
                            "description": "Tumor response was evaluated using RECIST version 1.1. Disease progression was defined as a \u226520% and \u22655-mm increase in the sum of target lesion diameters in reference to the smallest sum on study and/or substantial worsening in non-target disease. PFS was defined as the interval between date of randomization and date of first documented death or disease progression. Median time to event during the BP was estimated using the Kaplan-Meier method and expressed in weeks.",
                            "populationDescription": "ITT Population.",
                            "reportingStatus": "POSTED",
                            "paramType": "MEDIAN",
                            "dispersionType": "95% Confidence Interval",
                            "unitOfMeasure": "weeks",
                            "timeFrame": "Up to approximately 3.5 years (visits at Baseline and Weeks 6, 12, and 18 and every 12 weeks until/at disease progression during BP)",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Placebo (Late Erlotinib)",
                                    "description": "Participants received blinded placebo tablets PO once daily during the BP in the maintenance setting until disease progression, death, or unacceptable toxicity."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Erlotinib (Early Erlotinib)",
                                    "description": "Participants received blinded erlotinib tablets, 150 mg PO once daily during the BP in the maintenance setting until disease progression, death, or unacceptable toxicity."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "321"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "322"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "12.00",
                                                    "lowerLimit": "11.71",
                                                    "upperLimit": "12.29"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "13.00",
                                                    "lowerLimit": "12.14",
                                                    "upperLimit": "17.43"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "groupDescription": "Unstratified Analysis.",
                                    "testedNonInferiority": false,
                                    "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                    "pValue": "0.4759",
                                    "statisticalMethod": "Log Rank",
                                    "paramType": "Hazard Ratio (HR)",
                                    "paramValue": "0.94",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "0.80",
                                    "ciUpperLimit": "1.11",
                                    "estimateComment": "The HR and 95% CI were estimated by Cox regression."
                                },
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "groupDescription": "Stratified Analysis: Stratified according to tumor histology, stage of disease, objective response at Baseline, bevacizumab use, smoking status, and region of enrollment.",
                                    "testedNonInferiority": false,
                                    "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                    "pValue": "0.1635",
                                    "statisticalMethod": "Log Rank",
                                    "paramType": "Hazard Ratio (HR)",
                                    "paramValue": "0.87",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "0.72",
                                    "ciUpperLimit": "1.06",
                                    "estimateComment": "The HR and 95% CI were estimated by Cox regression."
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Percentage of Participants Event-Free (Alive and No Disease Progression) at 6 Months During Blinded Treatment",
                            "description": "Tumor response was evaluated using RECIST version 1.1. Disease progression was defined as a \u226520% and \u22655-mm increase in the sum of target lesion diameters in reference to the smallest sum on study and/or substantial worsening in non-target disease. The percentage of participants event-free (i.e., still alive and without disease progression) at 6 months during the BP was calculated.",
                            "populationDescription": "ITT Population.",
                            "reportingStatus": "POSTED",
                            "paramType": "NUMBER",
                            "dispersionType": "95% Confidence Interval",
                            "unitOfMeasure": "percentage of participants",
                            "timeFrame": "At 6 months",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Placebo (Late Erlotinib)",
                                    "description": "Participants received blinded placebo tablets PO once daily during the BP in the maintenance setting until disease progression, death, or unacceptable toxicity."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Erlotinib (Early Erlotinib)",
                                    "description": "Participants received blinded erlotinib tablets, 150 mg PO once daily during the BP in the maintenance setting until disease progression, death, or unacceptable toxicity."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "321"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "322"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "24.22",
                                                    "lowerLimit": "19.50",
                                                    "upperLimit": "28.94"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "27.11",
                                                    "lowerLimit": "22.19",
                                                    "upperLimit": "32.02"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "testedNonInferiority": false,
                                    "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                    "pValue": "0.4069",
                                    "statisticalMethod": "Chi-squared",
                                    "paramType": "Difference in Event-Free Rate",
                                    "paramValue": "-2.89",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "-9.70",
                                    "ciUpperLimit": "3.93"
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Percentage of Participants With Complete Response (CR) or Partial Response (PR) According to RECIST During Blinded Treatment",
                            "description": "Tumor response was evaluated using RECIST version 1.1. CR was defined as disappearance of all target and non-target lesions and short-axis reduction to less than (\\<) 10 mm of any pathological lymph nodes. PR was defined as a \u226530% decrease in the sum of target lesion diameters in reference to the Baseline sum. The percentage of participants with a best overall response of either CR or PR (i.e., the objective response rate \\[ORR\\]) during the BP was calculated, and corresponding 95% CI was constructed using the Pearson-Clopper method.",
                            "populationDescription": "ITT Population.",
                            "reportingStatus": "POSTED",
                            "paramType": "NUMBER",
                            "dispersionType": "95% Confidence Interval",
                            "unitOfMeasure": "percentage of participants",
                            "timeFrame": "Up to approximately 3.5 years (visits at Baseline and Weeks 6, 12, and 18 and every 12 weeks until/at disease progression during BP)",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Placebo (Late Erlotinib)",
                                    "description": "Participants received blinded placebo tablets PO once daily during the BP in the maintenance setting until disease progression, death, or unacceptable toxicity."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Erlotinib (Early Erlotinib)",
                                    "description": "Participants received blinded erlotinib tablets, 150 mg PO once daily during the BP in the maintenance setting until disease progression, death, or unacceptable toxicity."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "321"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "322"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "3.7",
                                                    "lowerLimit": "1.95",
                                                    "upperLimit": "6.44"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "6.5",
                                                    "lowerLimit": "4.08",
                                                    "upperLimit": "9.80"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "testedNonInferiority": false,
                                    "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                    "pValue": "0.1097",
                                    "statisticalMethod": "Chi-squared",
                                    "paramType": "Difference in Response Rate",
                                    "paramValue": "2.78",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "-0.78",
                                    "ciUpperLimit": "6.35",
                                    "estimateComment": "The 95% CI for difference in response rates was constructed using the Anderson-Hauck method."
                                },
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "testedNonInferiority": false,
                                    "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                    "paramType": "Odds Ratio (OR)",
                                    "paramValue": "1.80",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "0.87",
                                    "ciUpperLimit": "3.72",
                                    "estimateComment": "The 95% CI for OR was constructed using the Wald method."
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Percentage of Participants by Best Overall Response According to RECIST During Blinded Treatment",
                            "description": "Tumor response was evaluated using RECIST version 1.1. CR was defined as disappearance of all target and non-target lesions and short-axis reduction to \\<10 mm of any pathological lymph nodes. PR was defined as a \u226530% decrease in the sum of target lesion diameters in reference to the Baseline sum. Stable disease (SD) was defined as neither sufficient shrinkage in target lesions to qualify for PR nor sufficient growth to qualify for disease progression. Disease progression (progressive disease/PD) was defined as a \u226520% and \u22655-mm increase in the sum of target lesion diameters in reference to the smallest sum on study and/or substantial worsening in non-target disease. The percentage of participants with each level of best tumor response during the BP was calculated, and corresponding 95% CI was constructed using the Pearson-Clopper method.",
                            "populationDescription": "ITT Population.",
                            "reportingStatus": "POSTED",
                            "paramType": "NUMBER",
                            "dispersionType": "95% Confidence Interval",
                            "unitOfMeasure": "percentage of participants",
                            "timeFrame": "Up to approximately 3.5 years (visits at Baseline and Weeks 6, 12, and 18 and every 12 weeks until/at disease progression during BP)",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Placebo (Late Erlotinib)",
                                    "description": "Participants received blinded placebo tablets PO once daily during the BP in the maintenance setting until disease progression, death, or unacceptable toxicity."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Erlotinib (Early Erlotinib)",
                                    "description": "Participants received blinded erlotinib tablets, 150 mg PO once daily during the BP in the maintenance setting until disease progression, death, or unacceptable toxicity."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "321"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "322"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "title": "CR",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "0.6",
                                                    "lowerLimit": "0.08",
                                                    "upperLimit": "2.23"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "0.9",
                                                    "lowerLimit": "0.19",
                                                    "upperLimit": "2.70"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "PR",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "3.1",
                                                    "lowerLimit": "1.50",
                                                    "upperLimit": "5.65"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "5.6",
                                                    "lowerLimit": "3.35",
                                                    "upperLimit": "8.69"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "SD",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "55.5",
                                                    "lowerLimit": "49.83",
                                                    "upperLimit": "60.97"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "54.7",
                                                    "lowerLimit": "49.04",
                                                    "upperLimit": "60.19"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "PD",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "38.6",
                                                    "lowerLimit": "33.27",
                                                    "upperLimit": "44.20"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "32.3",
                                                    "lowerLimit": "27.22",
                                                    "upperLimit": "37.71"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Missing",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.2",
                                                    "lowerLimit": "0.88",
                                                    "upperLimit": "4.44"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "6.5",
                                                    "lowerLimit": "4.08",
                                                    "upperLimit": "9.80"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Percentage of Participants With CR, PR, or SD According to RECIST During Blinded Treatment",
                            "description": "Tumor response was evaluated using RECIST version 1.1. CR was defined as disappearance of all target and non-target lesions and short-axis reduction to \\<10 mm of any pathological lymph nodes. PR was defined as a \u226530% decrease in the sum of target lesion diameters in reference to the Baseline sum. SD was defined as neither sufficient shrinkage in target lesions to qualify for PR nor sufficient growth to qualify for disease progression. The percentage of participants with a best overall response of CR, PR, or SD (i.e., the disease control rate \\[DCR\\]) during the BP was calculated, and corresponding 95% CI was constructed using the Pearson-Clopper method.",
                            "populationDescription": "ITT Population.",
                            "reportingStatus": "POSTED",
                            "paramType": "NUMBER",
                            "dispersionType": "95% Confidence Interval",
                            "unitOfMeasure": "percentage of participants",
                            "timeFrame": "Up to approximately 3.5 years (visits at Baseline and Weeks 6, 12, and 18 and every 12 weeks until/at disease progression during BP)",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Placebo (Late Erlotinib)",
                                    "description": "Participants received blinded placebo tablets PO once daily during the BP in the maintenance setting until disease progression, death, or unacceptable toxicity."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Erlotinib (Early Erlotinib)",
                                    "description": "Participants received blinded erlotinib tablets, 150 mg PO once daily during the BP in the maintenance setting until disease progression, death, or unacceptable toxicity."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "321"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "322"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "59.2",
                                                    "lowerLimit": "53.59",
                                                    "upperLimit": "64.62"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "61.2",
                                                    "lowerLimit": "55.62",
                                                    "upperLimit": "66.53"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "testedNonInferiority": false,
                                    "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                    "pValue": "0.6062",
                                    "statisticalMethod": "Chi-squared",
                                    "paramType": "Difference in Response Rate",
                                    "paramValue": "1.99",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "-5.74",
                                    "ciUpperLimit": "9.72",
                                    "estimateComment": "The 95% CI for difference in response rates was constructed using the Anderson-Hauck method."
                                },
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "testedNonInferiority": false,
                                    "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                    "paramType": "Odds Ratio (OR)",
                                    "paramValue": "1.09",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "0.79",
                                    "ciUpperLimit": "1.49",
                                    "estimateComment": "The 95% CI for OR was constructed using the Wald method."
                                }
                            ]
                        }
                    ]
                },
                "adverseEventsModule": {
                    "frequencyThreshold": "5",
                    "timeFrame": "Up to approximately 4.5 years (visits at Baseline and Weeks 6, 12, and 18 and every 12 weeks until disease progression, death, or unacceptable toxicity during BP; per local standards and 28 days after last visit during OLP)",
                    "description": "Safety Population: All participants who received at least one dose of study treatment, according to drug actually received. Non-serious adverse events (NSAEs) were not collected in the OLP. Hence, 0 participants would be affected and at risk in \"Other (Not Including Serious) Adverse Events\". However, an NSAE in 1 participant was reported to Roche outside protocol (see \"Rash\"). Other NSAEs that may have occurred during the OLP are not included in the table because they were not reported to Roche.",
                    "eventGroups": [
                        {
                            "id": "EG000",
                            "title": "Placebo (Late Erlotinib)",
                            "description": "Participants received blinded placebo tablets PO once daily during the BP in the maintenance setting until disease progression, death, or unacceptable toxicity.",
                            "seriousNumAffected": 27,
                            "seriousNumAtRisk": 319,
                            "otherNumAffected": 107,
                            "otherNumAtRisk": 319
                        },
                        {
                            "id": "EG001",
                            "title": "Erlotinib (Early Erlotinib)",
                            "description": "Participants received blinded erlotinib tablets, 150 mg PO once daily during the BP in the maintenance setting until disease progression, death, or unacceptable toxicity.",
                            "seriousNumAffected": 36,
                            "seriousNumAtRisk": 322,
                            "otherNumAffected": 206,
                            "otherNumAtRisk": 322
                        },
                        {
                            "id": "EG002",
                            "title": "Second-Line Erlotinib (Late Erlotinib)",
                            "description": "Participants who received blinded placebo and who demonstrated disease progression were unblinded and could receive second-line erlotinib as 150-mg tablets PO once daily, provided by the Sponsor. This treatment continued during the OLP until disease progression, death, or unacceptable toxicity.",
                            "seriousNumAffected": 23,
                            "seriousNumAtRisk": 248,
                            "otherNumAffected": 1,
                            "otherNumAtRisk": 1
                        },
                        {
                            "id": "EG003",
                            "title": "Second-Line Chemotherapy (Early Erlotinib)",
                            "description": "Participants who received blinded erlotinib and who demonstrated disease progression were unblinded and could receive an approved second-line therapy (but not EGFR targeted therapies) or BSC as chosen by the investigator. This treatment continued during the OLP until disease progression, death, or unacceptable toxicity.",
                            "seriousNumAffected": 8,
                            "seriousNumAtRisk": 162,
                            "otherNumAffected": 0,
                            "otherNumAtRisk": 0
                        }
                    ],
                    "seriousEvents": [
                        {
                            "term": "Pulmonary embolism",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 4,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Chronic obstructive pulmonary disease",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 3,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Haemoptysis",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 2,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Interstitial lung disease",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 2,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Pleural effusion",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Pleuritic pain",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Pneumonia aspiration",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Respiratory failure",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Dyspnoea",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 3,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 1,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Pneumonia",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 3,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 4,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 2,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 1,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Abscess oral",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Lobar pneumonia",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Peritonitis",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Pharyngitis",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Respiratory tract infection",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Septic shock",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Urinary tract infection",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Impetigo",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Sepsis",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 1,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Cerebrovascular accident",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 2,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Cerebral ischaemia",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Dizziness",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Hydrocephalus",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Hypoglycaemic coma",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Paraparesis",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Syncope",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Femur fracture",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Fracture",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Hip fracture",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Ilium fracture",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Limb injury",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Spinal compression fracture",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Subdural haematoma",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Tracheal obstruction",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Cardio-respiratory arrest",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Cardiopulmonary failure",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Myocardial infarction",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Pericardial effusion",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Ventricular extrasystoles",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Acute myocardial infarction",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Arrhythmia",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Atrial fibrillation",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 1,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Cardiac failure",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Diarrhoea",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 2,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Gastritis erosive",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Haemorroids thrombosed",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Nausea",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Vomiting",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Gastric ulcer",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 2,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Deep vein thrombosis",
                            "organSystem": "Vascular disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 1,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Hypotension",
                            "organSystem": "Vascular disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Superior vena cava syndrome",
                            "organSystem": "Vascular disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Thrombosis",
                            "organSystem": "Vascular disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Peripheral ischaemia",
                            "organSystem": "Vascular disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Anaemia",
                            "organSystem": "Blood and lymphatic system disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 2,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Leukopenia",
                            "organSystem": "Blood and lymphatic system disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 1,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Neutropenia",
                            "organSystem": "Blood and lymphatic system disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 1,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Fatigue",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 2,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Asthenia",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Death",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Hyperthermia",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 1,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Impaired healing",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Perforated ulcer",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Pyrexia",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Dehydration",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Diabetes mellitus",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Metabolic acidosis",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Hypokalaemia",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 1,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Confusional state",
                            "organSystem": "Psychiatric disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 2,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Depression",
                            "organSystem": "Psychiatric disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Acute kidney injury",
                            "organSystem": "Renal and urinary disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 1,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Urinary retention",
                            "organSystem": "Renal and urinary disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Osteonecrosis of jaw",
                            "organSystem": "Musculoskeletal and connective tissue disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Musculoskeletal pain",
                            "organSystem": "Musculoskeletal and connective tissue disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Skin mass",
                            "organSystem": "Skin and subcutaneous tissue disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Rash",
                            "organSystem": "Skin and subcutaneous tissue disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Finger amputation",
                            "organSystem": "Surgical and medical procedures",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Meningeal neoplasm",
                            "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Retinal artery occlusion",
                            "organSystem": "Eye disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Jaundice",
                            "organSystem": "Hepatobiliary disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        },
                        {
                            "term": "Liver injury",
                            "organSystem": "Hepatobiliary disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 248
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 162
                                }
                            ]
                        }
                    ],
                    "otherEvents": [
                        {
                            "term": "Diarrhoea",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 14,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 78,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 0
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 0
                                }
                            ]
                        },
                        {
                            "term": "Chest pain",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 11,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 17,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 0
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 0
                                }
                            ]
                        },
                        {
                            "term": "Fatigue",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 20,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 21,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 0
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 0
                                }
                            ]
                        },
                        {
                            "term": "Decreased appetite",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 11,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 21,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 0
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 0
                                }
                            ]
                        },
                        {
                            "term": "Cough",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 37,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 31,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 0
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 0
                                }
                            ]
                        },
                        {
                            "term": "Dyspnoea",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 23,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 27,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 0
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 0
                                }
                            ]
                        },
                        {
                            "term": "Pruritus",
                            "organSystem": "Skin and subcutaneous tissue disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 3,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 17,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 0
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 0
                                }
                            ]
                        },
                        {
                            "term": "Rash",
                            "organSystem": "Skin and subcutaneous tissue disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "notes": "Per protocol, NSAEs were not collected in the OLP. However, an NSAE in 1 participant in the \"Second-Line Erlotinib (Late Erlotinib)\" arm was reported outside protocol and coded with MedDRA (18.1). As such, this single event is presented in the table.",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 32,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 127,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 1
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 0
                                }
                            ]
                        },
                        {
                            "term": "Rash maculo-papular",
                            "organSystem": "Skin and subcutaneous tissue disorders",
                            "sourceVocabulary": "MedDRA (18.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 3,
                                    "numAtRisk": 319
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 17,
                                    "numAtRisk": 322
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 0
                                },
                                {
                                    "groupId": "EG003",
                                    "numAffected": 0,
                                    "numAtRisk": 0
                                }
                            ]
                        }
                    ]
                },
                "moreInfoModule": {
                    "limitationsAndCaveats": {
                        "description": "Following the final analysis, the study was closed and all remaining participants were withdrawn from the study and considered \"Not Completed\" (as presented in the Participant Flow). However, the overall status of study was confirmed as completed."
                    },
                    "certainAgreement": {
                        "piSponsorEmployee": false,
                        "restrictionType": "OTHER",
                        "restrictiveAgreement": true,
                        "otherDetails": "The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights."
                    },
                    "pointOfContact": {
                        "title": "Medical Communications",
                        "organization": "Hoffmann-La Roche",
                        "email": "genentech@druginfo.com",
                        "phone": "800-821-8590"
                    }
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2023-11-09",
                    "removedCountries": [
                        "Germany"
                    ],
                    "modelPredictions": {
                        "bmiLimits": {
                            "minBmi": 0.0,
                            "maxBmi": 101.0
                        }
                    }
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D000008175",
                            "term": "Lung Neoplasms"
                        },
                        {
                            "id": "D000002289",
                            "term": "Carcinoma, Non-Small-Cell Lung"
                        },
                        {
                            "id": "D000018450",
                            "term": "Disease Progression"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D000012142",
                            "term": "Respiratory Tract Neoplasms"
                        },
                        {
                            "id": "D000013899",
                            "term": "Thoracic Neoplasms"
                        },
                        {
                            "id": "D000009371",
                            "term": "Neoplasms by Site"
                        },
                        {
                            "id": "D000009369",
                            "term": "Neoplasms"
                        },
                        {
                            "id": "D000008171",
                            "term": "Lung Diseases"
                        },
                        {
                            "id": "D000012140",
                            "term": "Respiratory Tract Diseases"
                        },
                        {
                            "id": "D000002283",
                            "term": "Carcinoma, Bronchogenic"
                        },
                        {
                            "id": "D000001984",
                            "term": "Bronchial Neoplasms"
                        },
                        {
                            "id": "D000020969",
                            "term": "Disease Attributes"
                        },
                        {
                            "id": "D000010335",
                            "term": "Pathologic Processes"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M20249",
                            "name": "Disease Progression",
                            "asFound": "Disease Progression",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M10862",
                            "name": "Lung Neoplasms",
                            "asFound": "Lung Cancer",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M5236",
                            "name": "Carcinoma, Non-Small-Cell Lung",
                            "asFound": "Non-Small Cell Lung Cancer",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M5224",
                            "name": "Carcinoma",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M14669",
                            "name": "Respiratory Tract Neoplasms",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M16348",
                            "name": "Thoracic Neoplasms",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M10858",
                            "name": "Lung Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M14667",
                            "name": "Respiratory Tract Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M5230",
                            "name": "Carcinoma, Bronchogenic",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M4950",
                            "name": "Bronchial Neoplasms",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M22390",
                            "name": "Disease Attributes",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BC23",
                            "name": "Symptoms and General Pathology"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        },
                        {
                            "abbrev": "BC04",
                            "name": "Neoplasms"
                        },
                        {
                            "abbrev": "BC08",
                            "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                        }
                    ]
                },
                "interventionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D000069347",
                            "term": "Erlotinib Hydrochloride"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D000000970",
                            "term": "Antineoplastic Agents"
                        },
                        {
                            "id": "D000047428",
                            "term": "Protein Kinase Inhibitors"
                        },
                        {
                            "id": "D000004791",
                            "term": "Enzyme Inhibitors"
                        },
                        {
                            "id": "D000045504",
                            "term": "Molecular Mechanisms of Pharmacological Action"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M398",
                            "name": "Erlotinib Hydrochloride",
                            "asFound": "Dose level",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M25510",
                            "name": "Protein Kinase Inhibitors",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M7641",
                            "name": "Enzyme Inhibitors",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "ANeo",
                            "name": "Antineoplastic Agents"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Drugs and Chemicals"
                        }
                    ]
                }
            },
            "hasResults": true
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT01466751",
                    "orgStudyIdInfo": {
                        "id": "IRB-19338"
                    },
                    "organization": {
                        "fullName": "Stanford University",
                        "class": "OTHER"
                    },
                    "briefTitle": "Neurobehavioral Intervention as a Novel Treatment Approach for Emotion-Regulatory Deficits",
                    "officialTitle": "Neurobehavioral Intervention as a Novel Treatment Approach for Emotion-Regulatory Deficits"
                },
                "statusModule": {
                    "statusVerifiedDate": "2019-03",
                    "overallStatus": "COMPLETED",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2011-01"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2013-01",
                        "type": "ACTUAL"
                    },
                    "completionDateStruct": {
                        "date": "2013-12",
                        "type": "ACTUAL"
                    },
                    "studyFirstSubmitDate": "2011-11-03",
                    "studyFirstSubmitQcDate": "2011-11-07",
                    "studyFirstPostDateStruct": {
                        "date": "2011-11-08",
                        "type": "ESTIMATED"
                    },
                    "resultsFirstSubmitDate": "2015-07-15",
                    "resultsFirstSubmitQcDate": "2019-03-22",
                    "resultsFirstPostDateStruct": {
                        "date": "2019-06-20",
                        "type": "ACTUAL"
                    },
                    "lastUpdateSubmitDate": "2019-03-22",
                    "lastUpdatePostDateStruct": {
                        "date": "2019-06-20",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "PRINCIPAL_INVESTIGATOR",
                        "investigatorFullName": "Amit Etkin",
                        "investigatorTitle": "Principle Investigator",
                        "investigatorAffiliation": "Stanford University"
                    },
                    "leadSponsor": {
                        "name": "Stanford University",
                        "class": "OTHER"
                    }
                },
                "oversightModule": {
                    "oversightHasDmc": false
                },
                "descriptionModule": {
                    "briefSummary": "The present study will explore the effectiveness of a computer based neurobehavioral intervention in alleviating symptoms and improving emotion regulation in psychiatric populations. It will increase understanding of psychopathology at a neural-circuit level and aid development of new non-pharmacological treatment for emotion regulatory deficits."
                },
                "conditionsModule": {
                    "conditions": [
                        "Anxiety",
                        "Depression"
                    ],
                    "keywords": [
                        "Computerized neurobehavioral intervention"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "NA"
                    ],
                    "designInfo": {
                        "allocation": "RANDOMIZED",
                        "interventionModel": "PARALLEL",
                        "primaryPurpose": "BASIC_SCIENCE",
                        "maskingInfo": {
                            "masking": "SINGLE",
                            "whoMasked": [
                                "PARTICIPANT"
                            ]
                        }
                    },
                    "enrollmentInfo": {
                        "count": 28,
                        "type": "ACTUAL"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "Engaging computerized tasks",
                            "type": "ACTIVE_COMPARATOR",
                            "description": "Participants will log into a personalized website and engage in computerized tasks online.",
                            "interventionNames": [
                                "Behavioral: Computerized Neurobehavioral Intervention"
                            ]
                        },
                        {
                            "label": "Neurobehavioral computerized tasks",
                            "type": "EXPERIMENTAL",
                            "description": "Participants will log into a personalized website and engage in computerized tasks online.",
                            "interventionNames": [
                                "Behavioral: Computerized Neurobehavioral Intervention"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "BEHAVIORAL",
                            "name": "Computerized Neurobehavioral Intervention",
                            "description": "Targeted, computerized interventions completed from the participants' own home on a computer.",
                            "armGroupLabels": [
                                "Engaging computerized tasks",
                                "Neurobehavioral computerized tasks"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "Reaction Time to Facial Affect Identification During Emotional Conflict",
                            "description": "A standardized set of facial emotions (fear and happy) were presented for a duration of about 1 second in quick succession (a new face every 3-5 seconds). Across each face was written an emotional word (\"FEAR\" or \"HAPPY\"), which could be either congruent or incongruent with the facial expression. The participant was instructed to identify the facial emotion as quickly as possible and ignore the overlaid emotion word. The outcome measure of interest was the average speed (across all trials presented) within which an individual could correctly identify the facial emotion as a function of time (pre or post-intervention), treatment arm (control or intervention), facial affect (fear or happy), and congruency of word and facial affect (congruent or incongruent).",
                            "timeFrame": "Baseline, 3-month"
                        },
                        {
                            "measure": "Amygdala Blood Oxygenation-level Dependent Response (BOLD) Activation to Face Affect Identification During Emotional Conflict",
                            "description": "The degree of differential BOLD signal change (T2\\*-weighted contrast in a defined region of the brain as measured by functional magnetic resonance imaging) within each individual, averaged across trials, during facial affect identification (fear or happy) and induction of emotional conflict (when the emotion word \"FEAR\" or \"HAPPY\" was either congruent or incongruent with the facial expression). We examined the differential degree of amygdala BOLD signal change as a function of emotion type (fear or happy), congruency (congruent or incongruent), and hemisphere (left or right) at baseline and 3 months.",
                            "timeFrame": "Baseline, 3 Months"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n* current anxiety or depression symptoms\n* internet access\n\nExclusion Criteria:\n\n* lifetime psychotic disorder, past-year substance dependence",
                    "healthyVolunteers": false,
                    "sex": "ALL",
                    "minimumAge": "18 Years",
                    "maximumAge": "65 Years",
                    "stdAges": [
                        "ADULT",
                        "OLDER_ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "overallOfficials": [
                        {
                            "name": "Greg Fonzo, PhD",
                            "affiliation": "Stanford University",
                            "role": "STUDY_DIRECTOR"
                        }
                    ],
                    "locations": [
                        {
                            "facility": "Stanford University, Department of Psychiatry and Behavioral Sciences",
                            "city": "Stanford",
                            "state": "California",
                            "zip": "94305",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 37.42411,
                                "lon": -122.16608
                            }
                        }
                    ]
                }
            },
            "resultsSection": {
                "participantFlowModule": {
                    "groups": [
                        {
                            "id": "FG000",
                            "title": "Neurobehavioral Computerized Tasks",
                            "description": "Participants will log into a personalized website and engage in computerized tasks online.\n\nComputerized Neurobehavioral Intervention: Targeted, computerized interventions completed from the participants' own home on a computer."
                        },
                        {
                            "id": "FG001",
                            "title": "Engaging Computerized Tasks",
                            "description": "Participants will log into a personalized website and engage in computerized tasks online.\n\nComputerized Neurobehavioral Intervention: Targeted, computerized interventions completed from the participants' own home on a computer."
                        }
                    ],
                    "periods": [
                        {
                            "title": "Overall Study",
                            "milestones": [
                                {
                                    "type": "STARTED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "14"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "14"
                                        }
                                    ]
                                },
                                {
                                    "type": "COMPLETED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "13"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "14"
                                        }
                                    ]
                                },
                                {
                                    "type": "NOT COMPLETED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "1"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "baselineCharacteristicsModule": {
                    "groups": [
                        {
                            "id": "BG000",
                            "title": "Engaging Computerized Tasks",
                            "description": "Participants will log into a personalized website and engage in computerized tasks online.\n\nComputerized Neurobehavioral Intervention: Targeted, computerized interventions completed from the participants' own home on a computer."
                        },
                        {
                            "id": "BG001",
                            "title": "Neurobehavioral Computerized Tasks",
                            "description": "Participants will log into a personalized website and engage in computerized tasks online.\n\nComputerized Neurobehavioral Intervention: Targeted, computerized interventions completed from the participants' own home on a computer."
                        },
                        {
                            "id": "BG002",
                            "title": "Total",
                            "description": "Total of all reporting groups"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "BG000",
                                    "value": "14"
                                },
                                {
                                    "groupId": "BG001",
                                    "value": "14"
                                },
                                {
                                    "groupId": "BG002",
                                    "value": "28"
                                }
                            ]
                        }
                    ],
                    "measures": [
                        {
                            "title": "Age, Continuous",
                            "paramType": "MEAN",
                            "dispersionType": "STANDARD_DEVIATION",
                            "unitOfMeasure": "years",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "35",
                                                    "spread": "10"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "36",
                                                    "spread": "12"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "35.5",
                                                    "spread": "11"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Sex: Female, Male",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "title": "Female",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "11"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "10"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "21"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Male",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "3"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "4"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "7"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Race (NIH/OMB)",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "title": "American Indian or Alaska Native",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "0"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Asian",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "3"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "4"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "7"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Native Hawaiian or Other Pacific Islander",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "1"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Black or African American",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "1"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "White",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "9"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "8"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "17"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "More than one race",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "2"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Unknown or Not Reported",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "0"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Region of Enrollment",
                            "paramType": "NUMBER",
                            "unitOfMeasure": "participants",
                            "classes": [
                                {
                                    "title": "United States",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "14"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "14"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "28"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "outcomeMeasuresModule": {
                    "outcomeMeasures": [
                        {
                            "type": "PRIMARY",
                            "title": "Reaction Time to Facial Affect Identification During Emotional Conflict",
                            "description": "A standardized set of facial emotions (fear and happy) were presented for a duration of about 1 second in quick succession (a new face every 3-5 seconds). Across each face was written an emotional word (\"FEAR\" or \"HAPPY\"), which could be either congruent or incongruent with the facial expression. The participant was instructed to identify the facial emotion as quickly as possible and ignore the overlaid emotion word. The outcome measure of interest was the average speed (across all trials presented) within which an individual could correctly identify the facial emotion as a function of time (pre or post-intervention), treatment arm (control or intervention), facial affect (fear or happy), and congruency of word and facial affect (congruent or incongruent).",
                            "populationDescription": "Participants who complete the protocol were included in the analysis.",
                            "reportingStatus": "POSTED",
                            "paramType": "MEAN",
                            "dispersionType": "Standard Deviation",
                            "unitOfMeasure": "milliseconds",
                            "timeFrame": "Baseline, 3-month",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Engaging Computerized Tasks",
                                    "description": "Participants will log into a personalized website and engage in computerized tasks online.\n\nComputerized Neurobehavioral Intervention: Targeted, computerized interventions completed from the participants' own home on a computer."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Neurobehavioral Computerized Tasks",
                                    "description": "Participants will log into a personalized website and engage in computerized tasks online.\n\nComputerized Neurobehavioral Intervention: Targeted, computerized interventions completed from the participants' own home on a computer."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "12"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "12"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "title": "Baseline Congruent Fear",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "802.15",
                                                    "spread": "155.14"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "889.14",
                                                    "spread": "135.65"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Baseline Incongruent Fear",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "848.79",
                                                    "spread": "142.18"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "937.97",
                                                    "spread": "151.94"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Baseline Congruent Happy",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "764.08",
                                                    "spread": "130.52"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "868.45",
                                                    "spread": "131.05"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Baseline Incongruent Happy",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "830.06",
                                                    "spread": "142.29"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "961.49",
                                                    "spread": "134.32"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "3 Month Congruent Fear",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "814.58",
                                                    "spread": "158.56"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "872.84",
                                                    "spread": "178.04"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "3 Month Incongruent Fear",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "863.80",
                                                    "spread": "144.65"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "909.89",
                                                    "spread": "193.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "3 Month Congruent Happy",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "796.54",
                                                    "spread": "130.62"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "824.36",
                                                    "spread": "196.77"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "3 Month Incongruent Happy",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "878.40",
                                                    "spread": "175.54"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "890.90",
                                                    "spread": "196.22"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "groupDescription": "A linear mixed model was utilized to test the null hypothesis that the intervention groups would show equivalent performance change on the outcome measure from baseline to the 3 month time points.",
                                    "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                    "pValue": "0.004",
                                    "pValueComment": "A-priori threshold for statistical significance: p \\< 0.05. No correction for multiple comparisons. The omnibus effect from the linear mixed model for the Treatment Arm x Time Interaction was utilized to establish significance of the effect.",
                                    "statisticalMethod": "Mixed Models Analysis",
                                    "statisticalComment": "Numerator degrees of freedom=1, Denominator degrees of freedom = 168",
                                    "paramType": "Type III Tests of Fixed Effects",
                                    "paramValue": "8.687",
                                    "ciNumSides": "TWO_SIDED"
                                }
                            ]
                        },
                        {
                            "type": "PRIMARY",
                            "title": "Amygdala Blood Oxygenation-level Dependent Response (BOLD) Activation to Face Affect Identification During Emotional Conflict",
                            "description": "The degree of differential BOLD signal change (T2\\*-weighted contrast in a defined region of the brain as measured by functional magnetic resonance imaging) within each individual, averaged across trials, during facial affect identification (fear or happy) and induction of emotional conflict (when the emotion word \"FEAR\" or \"HAPPY\" was either congruent or incongruent with the facial expression). We examined the differential degree of amygdala BOLD signal change as a function of emotion type (fear or happy), congruency (congruent or incongruent), and hemisphere (left or right) at baseline and 3 months.",
                            "reportingStatus": "POSTED",
                            "paramType": "MEAN",
                            "dispersionType": "Standard Deviation",
                            "unitOfMeasure": "Percentage of BOLD signal change",
                            "timeFrame": "Baseline, 3 Months",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Neurobehavioral Computerized Tasks",
                                    "description": "Participants will log into a personalized website and engage in computerized tasks online.\n\nComputerized Neurobehavioral Intervention: Targeted, computerized interventions completed from the participants' own home on a computer."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Engaging Computerized Tasks",
                                    "description": "Participants will log into a personalized website and engage in computerized tasks online.\n\nComputerized Neurobehavioral Intervention: Targeted, computerized interventions completed from the participants' own home on a computer."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "14"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "14"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "title": "Baseline Left Amygdala Fear",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "0.21",
                                                    "spread": "0.93"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "0.16",
                                                    "spread": "0.54"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Baseline Left Amygdala Happy",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "0.25",
                                                    "spread": "1.05"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "-0.29",
                                                    "spread": "0.79"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Baseline Right Amygdala Fear",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "0.04",
                                                    "spread": "1.24"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "0.02",
                                                    "spread": "0.60"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Baseline Right Amygdala Happy",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "-0.30",
                                                    "spread": "0.86"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "-0.23",
                                                    "spread": "0.85"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "3 Month Left Amygdala Fear",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "0.13",
                                                    "spread": "0.85"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "0.38",
                                                    "spread": "0.79"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "3 Month Left Amygdala Happy",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "-0.03",
                                                    "spread": "0.76"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "0.18",
                                                    "spread": "1.02"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "3 Month Right Amygdala Fear",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "0.05",
                                                    "spread": "0.66"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "0.21",
                                                    "spread": "0.92"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "3 Month Right Amygdala Happy",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "-0.10",
                                                    "spread": "0.85"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "0.05",
                                                    "spread": "0.85"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "groupDescription": "A linear mixed model was used to test the null hypothesis that the two treatment groups would display no differential changes in amygdala BOLD signal from baseline to 3 months as a main effect or in interaction with facial affect type (fear or happy) or by brain hemisphere (left or right).",
                                    "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                    "pValue": "0.156",
                                    "pValueComment": "No adjustment for multiple comparisons. The a priori threshold was: p \\< 0.05.",
                                    "statisticalMethod": "Mixed Models Analysis",
                                    "statisticalComment": "Numerator degrees of freedom: 1, Denominator degrees of freedom: 168",
                                    "paramType": "Type III Tests of Fixed Effects",
                                    "paramValue": "2.032",
                                    "ciNumSides": "TWO_SIDED"
                                }
                            ]
                        }
                    ]
                },
                "adverseEventsModule": {
                    "frequencyThreshold": "0",
                    "eventGroups": [
                        {
                            "id": "EG000",
                            "title": "Engaging Computerized Tasks",
                            "description": "Participants will log into a personalized website and engage in computerized tasks online.\n\nComputerized Neurobehavioral Intervention: Targeted, computerized interventions completed from the participants' own home on a computer.",
                            "deathsNumAffected": 0,
                            "deathsNumAtRisk": 14,
                            "seriousNumAffected": 0,
                            "seriousNumAtRisk": 14,
                            "otherNumAffected": 0,
                            "otherNumAtRisk": 14
                        },
                        {
                            "id": "EG001",
                            "title": "Neurobehavioral Computerized Tasks",
                            "description": "Participants will log into a personalized website and engage in computerized tasks online.\n\nComputerized Neurobehavioral Intervention: Targeted, computerized interventions completed from the participants' own home on a computer.",
                            "deathsNumAffected": 0,
                            "deathsNumAtRisk": 14,
                            "seriousNumAffected": 0,
                            "seriousNumAtRisk": 14,
                            "otherNumAffected": 0,
                            "otherNumAtRisk": 14
                        }
                    ]
                },
                "moreInfoModule": {
                    "certainAgreement": {
                        "piSponsorEmployee": false,
                        "restrictiveAgreement": false
                    },
                    "pointOfContact": {
                        "title": "Amit Etkin",
                        "organization": "Stanford University",
                        "email": "amitetkin@stanford.edu",
                        "phone": "650-725-5736"
                    }
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2023-11-09",
                    "modelPredictions": {
                        "bmiLimits": {
                            "minBmi": 0.0,
                            "maxBmi": 101.0
                        }
                    }
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D000003863",
                            "term": "Depression"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D000001526",
                            "term": "Behavioral Symptoms"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M6748",
                            "name": "Depression",
                            "asFound": "Depression",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M6751",
                            "name": "Depressive Disorder",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M4014",
                            "name": "Anxiety Disorders",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M4508",
                            "name": "Behavioral Symptoms",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BXM",
                            "name": "Behaviors and Mental Disorders"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        }
                    ]
                }
            },
            "hasResults": true
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT01111851",
                    "orgStudyIdInfo": {
                        "id": "0869-183"
                    },
                    "secondaryIdInfos": [
                        {
                            "id": "2010_531"
                        }
                    ],
                    "organization": {
                        "fullName": "Merck Sharp & Dohme LLC",
                        "class": "INDUSTRY"
                    },
                    "briefTitle": "Aprepitant and Fosaprepitant Time-on-Target PET (Positron Emission Tomography) Study (0869-183)",
                    "officialTitle": "MK0869 and MK0517 Time-on-Target PET Study"
                },
                "statusModule": {
                    "statusVerifiedDate": "2015-02",
                    "overallStatus": "COMPLETED",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2010-04"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2010-10",
                        "type": "ACTUAL"
                    },
                    "completionDateStruct": {
                        "date": "2010-10",
                        "type": "ACTUAL"
                    },
                    "studyFirstSubmitDate": "2010-04-26",
                    "studyFirstSubmitQcDate": "2010-04-26",
                    "studyFirstPostDateStruct": {
                        "date": "2010-04-28",
                        "type": "ESTIMATED"
                    },
                    "resultsFirstSubmitDate": "2011-09-29",
                    "resultsFirstSubmitQcDate": "2011-09-29",
                    "resultsFirstPostDateStruct": {
                        "date": "2011-11-03",
                        "type": "ESTIMATED"
                    },
                    "lastUpdateSubmitDate": "2015-02-06",
                    "lastUpdatePostDateStruct": {
                        "date": "2015-02-25",
                        "type": "ESTIMATED"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR"
                    },
                    "leadSponsor": {
                        "name": "Merck Sharp & Dohme LLC",
                        "class": "INDUSTRY"
                    }
                },
                "oversightModule": {
                    "oversightHasDmc": false
                },
                "descriptionModule": {
                    "briefSummary": "This study will evaluate if the mean value of brain neurokinin 1 (NK1)-receptor occupancy of participants treated with aprepitant is similar to that of participants treated with fosaprepitant at certain timepoints.",
                    "detailedDescription": "The third arm of the study (Aprepitant 250 mg) will only be conducted if the real-time assessment of the NK1-receptor occupancy data between fosaprepitant 150 mg \\& aprepitant 165 mg reveals that the primary hypothesis will not be supported."
                },
                "conditionsModule": {
                    "conditions": [
                        "Chemotherapy-Induced Nausea and Vomiting (CINV)"
                    ],
                    "keywords": [
                        "NK1-receptor occupancy"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "PHASE1"
                    ],
                    "designInfo": {
                        "allocation": "RANDOMIZED",
                        "interventionModel": "PARALLEL",
                        "primaryPurpose": "TREATMENT",
                        "maskingInfo": {
                            "masking": "NONE"
                        }
                    },
                    "enrollmentInfo": {
                        "count": 16,
                        "type": "ACTUAL"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "Fosaprepitant 150 mg",
                            "type": "EXPERIMENTAL",
                            "description": "Fosaprepitant 150 mg",
                            "interventionNames": [
                                "Drug: Fosaprepitant 150 mg",
                                "Drug: Dexamethasone (12-8-16-16 mg)",
                                "Drug: Ondansetron",
                                "Drug: MK0999"
                            ]
                        },
                        {
                            "label": "Aprepitant 165 mg",
                            "type": "EXPERIMENTAL",
                            "description": "Aprepitant 165 mg",
                            "interventionNames": [
                                "Drug: Aprepitant 165 mg",
                                "Drug: Dexamethasone (12-8-16-16 mg)",
                                "Drug: Ondansetron",
                                "Drug: MK0999"
                            ]
                        },
                        {
                            "label": "Aprepitant 250 mg",
                            "type": "EXPERIMENTAL",
                            "description": "Aprepitant 250 mg",
                            "interventionNames": [
                                "Drug: Aprepitant 250 mg",
                                "Drug: Dexamethasone (12-8-8-16 mg)",
                                "Drug: Ondansetron",
                                "Drug: MK0999"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "DRUG",
                            "name": "Fosaprepitant 150 mg",
                            "description": "a single intravenous infusion of 150 mg fosaprepitant dimeglumine over 20 minutes on Day 1 15 minutes after consumption of a standard light breakfast meal",
                            "armGroupLabels": [
                                "Fosaprepitant 150 mg"
                            ],
                            "otherNames": [
                                "MK0517"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "Aprepitant 165 mg",
                            "description": "a single oral 165 mg aprepitant capsule 15 minutes after consumption of a standard light breakfast meal",
                            "armGroupLabels": [
                                "Aprepitant 165 mg"
                            ],
                            "otherNames": [
                                "MK0869"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "Aprepitant 250 mg",
                            "description": "a single oral 250 mg dose achieved by administering two 125 mg aprepitant capsules 15 minutes after consumption of a standard light breakfast meal",
                            "armGroupLabels": [
                                "Aprepitant 250 mg"
                            ],
                            "otherNames": [
                                "MK0869"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "Dexamethasone (12-8-16-16 mg)",
                            "description": "Dexamethasone 12 mg will be administered orally 30 minutes after the start of fosaprepitant dimeglumine or 30 minutes after aprepitant on Day 1; Oral doses of dexamethasone will be administered on Day 2 (8 mg), Day 3 (8 mg twice daily), and Day 4 (8 mg twice daily) with or without a meal.",
                            "armGroupLabels": [
                                "Aprepitant 165 mg",
                                "Fosaprepitant 150 mg"
                            ],
                            "otherNames": [
                                "Dexamethasone"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "Dexamethasone (12-8-8-16 mg)",
                            "description": "Dexamethasone 12 mg will be administered orally 30 minutes after after aprepitant on Day 1; Oral doses of dexamethasone will be administered on Day 2 (8 mg), Day 3 (8 mg), and Day 4 (8 mg twice daily) with or without a meal.",
                            "armGroupLabels": [
                                "Aprepitant 250 mg"
                            ],
                            "otherNames": [
                                "Dexamethasone"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "Ondansetron",
                            "description": "The intravenous (I.V.) infusion of ondansetron 32 mg will begin 30 minutes after the start of fosaprepitant dimeglumine or 30 minutes after aprepitant on Day 1 and will be administered as a 15-minute infusion",
                            "armGroupLabels": [
                                "Aprepitant 165 mg",
                                "Aprepitant 250 mg",
                                "Fosaprepitant 150 mg"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "MK0999",
                            "description": "I.V. infusion of MK0999 containing \\~100 MBq (\\~3 mCi) containing \u2264 5 ug of MK0999)",
                            "armGroupLabels": [
                                "Aprepitant 165 mg",
                                "Aprepitant 250 mg",
                                "Fosaprepitant 150 mg"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "Brain NK1-receptor Occupancy at 24 Hours Post Dose",
                            "timeFrame": "24 hours post dose"
                        },
                        {
                            "measure": "Brain NK1-receptor Occupancy at 48 Hours Post Dose",
                            "timeFrame": "48 hours post dose"
                        }
                    ],
                    "secondaryOutcomes": [
                        {
                            "measure": "Brain NK1-receptor Occupancy at the Time of the Maximum Concentration (Tmax)",
                            "timeFrame": "30 minutes after the end of the 20-minute infusion of fosaprepitant or at 4 hours after oral dosing of aprepitant"
                        },
                        {
                            "measure": "Brain NK1-receptor Occupancy at 120 Hours Post Dose",
                            "timeFrame": "120 hours post dose"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n* Generally healthy\n* Female participants must be of non-childbearing potential\n* Non-smoker or has not used nicotine or nicotine-containing products for at least 6 months\n\nExclusion Criteria:\n\n* History of a clinically significant psychiatric disorder over the last 5 to 10 years\n* History of stroke, chronic seizures, or major neurological disorder\n* History of clinically significant endocrine, gastrointestinal, cardiovascular, hematological, hepatic, immunological, renal, respiratory, or genitourinary abnormalities or diseases\n* History of neoplastic disease\n* Excessive consumption of alcohol (3 drinks/day) or caffeinated beverages (6 servings/day)\n* Major surgery, donated or lost 1 unit of blood within 4 weeks\n* Participated in another investigational study within 4 weeks\n* History of significant drug allergy or any clinically significant adverse\n\nexperiences related to EMEND\u2122, dexamethasone, or ondansetron\n\n* History of significant multiple and/or severe allergies\n* History of anaphylactic reaction or significant intolerability to prescription or non-prescription drugs or food\n* Current drug/alcohol abuse, or history of such within 2 years\n* Participation in a PET study or other study involving administration of a radioactive substance or ionizing radiation within the prior 12 months\n* Extensive radiological examination within the prior 12 months\n* Magnetizable metal prostheses or devices (Magnetic Resonance Imaging (MRI) hazard)\n* History of claustrophobia",
                    "healthyVolunteers": true,
                    "sex": "ALL",
                    "minimumAge": "18 Years",
                    "maximumAge": "55 Years",
                    "stdAges": [
                        "ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "overallOfficials": [
                        {
                            "name": "Medical Monitor",
                            "affiliation": "Merck Sharp & Dohme LLC",
                            "role": "STUDY_DIRECTOR"
                        }
                    ]
                },
                "referencesModule": {
                    "references": [
                        {
                            "pmid": "22739139",
                            "type": "RESULT",
                            "citation": "Van Laere K, De Hoon J, Bormans G, Koole M, Derdelinckx I, De Lepeleire I, Declercq R, Sanabria Bohorquez SM, Hamill T, Mozley PD, Tatosian D, Xie W, Liu Y, Liu F, Zappacosta P, Mahon C, Butterfield KL, Rosen LB, Murphy MG, Hargreaves RJ, Wagner JA, Shadle CR. Equivalent dynamic human brain NK1-receptor occupancy following single-dose i.v. fosaprepitant vs. oral aprepitant as assessed by PET imaging. Clin Pharmacol Ther. 2012 Aug;92(2):243-50. doi: 10.1038/clpt.2012.62. Epub 2012 Jun 27."
                        }
                    ]
                }
            },
            "resultsSection": {
                "participantFlowModule": {
                    "preAssignmentDetails": "Aprepitant 250 mg was not evaluated because the assessment of the positron emission tomography (PET) scan data (neurokinin 1 (NK1)-receptor occupancy values at 24 \\& 48 hours postdose) from fosaprepitant 150 mg \\& aprepitant 165 mg revealed that the protocol's hypothesis was met; therefore, it was not necessary to evaluate aprepitant 250 mg.",
                    "groups": [
                        {
                            "id": "FG000",
                            "title": "Fosaprepitant 150 mg",
                            "description": "A single intravenous infusion of 150 mg fosaprepitant dimeglumine over 20 minutes, 15 minutes after consumption of a standard light breakfast meal on Day 1."
                        },
                        {
                            "id": "FG001",
                            "title": "Aprepitant 165 mg",
                            "description": "A single oral 165 mg aprepitant capsule 15 minutes after consumption of a standard light breakfast meal on Day 1."
                        }
                    ],
                    "periods": [
                        {
                            "title": "Overall Study",
                            "milestones": [
                                {
                                    "type": "STARTED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "8"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "8"
                                        }
                                    ]
                                },
                                {
                                    "type": "COMPLETED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "6"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "8"
                                        }
                                    ]
                                },
                                {
                                    "type": "NOT COMPLETED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "2"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "0"
                                        }
                                    ]
                                }
                            ],
                            "dropWithdraws": [
                                {
                                    "type": "All planned PET scans were not obtained.",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "2"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "baselineCharacteristicsModule": {
                    "groups": [
                        {
                            "id": "BG000",
                            "title": "Fosaprepitant 150 mg",
                            "description": "A single intravenous infusion of 150 mg fosaprepitant dimeglumine over 20 minutes, 15 minutes after consumption of a standard light breakfast meal on Day 1."
                        },
                        {
                            "id": "BG001",
                            "title": "Aprepitant 165 mg",
                            "description": "A single oral 165 mg aprepitant capsule 15 minutes after consumption of a standard light breakfast meal on Day 1."
                        },
                        {
                            "id": "BG002",
                            "title": "Total",
                            "description": "Total of all reporting groups"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "BG000",
                                    "value": "8"
                                },
                                {
                                    "groupId": "BG001",
                                    "value": "8"
                                },
                                {
                                    "groupId": "BG002",
                                    "value": "16"
                                }
                            ]
                        }
                    ],
                    "measures": [
                        {
                            "title": "Age, Customized",
                            "paramType": "NUMBER",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "title": "< = 18 years",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "0"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Between 18 and 55 years",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "8"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "8"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "16"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "> = 55 years",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "0"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Sex: Female, Male",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "title": "Female",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "0"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Male",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "8"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "8"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "16"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Region of Enrollment",
                            "paramType": "NUMBER",
                            "unitOfMeasure": "participants",
                            "classes": [
                                {
                                    "title": "Belgium",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "8"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "8"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "16"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "outcomeMeasuresModule": {
                    "outcomeMeasures": [
                        {
                            "type": "PRIMARY",
                            "title": "Brain NK1-receptor Occupancy at 24 Hours Post Dose",
                            "populationDescription": "All participants with at least 1 successful post dose PET\n\nscan were included in the analysis population.",
                            "reportingStatus": "POSTED",
                            "paramType": "GEOMETRIC_MEAN",
                            "dispersionType": "95% Confidence Interval",
                            "unitOfMeasure": "Percent of occupancy",
                            "timeFrame": "24 hours post dose",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Fosaprepitant 150 mg",
                                    "description": "A single intravenous infusion of 150 mg fosaprepitant dimeglumine over 20 minutes, 15 minutes after consumption of a standard light breakfast meal on Day 1."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Aprepitant 165 mg",
                                    "description": "A single oral 165 mg aprepitant capsule 15 minutes after consumption of a standard light breakfast meal on Day 1."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "5"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "5"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "100.40",
                                                    "lowerLimit": "99.51",
                                                    "upperLimit": "101.29"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "100.20",
                                                    "lowerLimit": "99.31",
                                                    "upperLimit": "101.09"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "testedNonInferiority": false,
                                    "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                    "paramType": "Geometric Mean Ratio of the LS Means",
                                    "paramValue": "1.00",
                                    "ciPctValue": "90",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "0.99",
                                    "ciUpperLimit": "1.01",
                                    "estimateComment": "The point estimate and 90% confidence interval (CI) were generated for the geometric mean ratio (GMR) \\[aprepitant\n\n165 mg/fosaprepitant 150 mg\\]."
                                }
                            ]
                        },
                        {
                            "type": "PRIMARY",
                            "title": "Brain NK1-receptor Occupancy at 48 Hours Post Dose",
                            "populationDescription": "All participants with at least 1 successful postdose PET\n\nscan were included in the analysis population.",
                            "reportingStatus": "POSTED",
                            "paramType": "GEOMETRIC_MEAN",
                            "dispersionType": "95% Confidence Interval",
                            "unitOfMeasure": "Percent of occupancy",
                            "timeFrame": "48 hours post dose",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Fosaprepitant 150 mg",
                                    "description": "A single intravenous infusion of 150 mg fosaprepitant dimeglumine over 20 minutes, 15 minutes after consumption of a standard light breakfast meal on Day 1."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Aprepitant 165 mg",
                                    "description": "A single oral 165 mg aprepitant capsule 15 minutes after consumption of a standard light breakfast meal on Day 1."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "5"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "98.62",
                                                    "lowerLimit": "96.91",
                                                    "upperLimit": "100.37"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "98.79",
                                                    "lowerLimit": "97.19",
                                                    "upperLimit": "100.42"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "testedNonInferiority": false,
                                    "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                    "paramType": "Geometric Mean Ratio of the LS means",
                                    "paramValue": "1.00",
                                    "ciPctValue": "90",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "0.98",
                                    "ciUpperLimit": "1.02",
                                    "estimateComment": "The point estimate and 90% confidence interval (CI) were generated for the geometric mean ratio (GMR) \\[aprepitant\n\n165 mg/fosaprepitant 150 mg\\]."
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Brain NK1-receptor Occupancy at the Time of the Maximum Concentration (Tmax)",
                            "populationDescription": "All participants with at least 1 successful postdose PET\n\nscan were included in the analysis population.",
                            "reportingStatus": "POSTED",
                            "paramType": "GEOMETRIC_MEAN",
                            "dispersionType": "95% Confidence Interval",
                            "unitOfMeasure": "Percent of occupancy",
                            "timeFrame": "30 minutes after the end of the 20-minute infusion of fosaprepitant or at 4 hours after oral dosing of aprepitant",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Fosaprepitant 150 mg",
                                    "description": "A single intravenous infusion of 150 mg fosaprepitant dimeglumine over 20 minutes, 15 minutes after consumption of a standard light breakfast meal on Day 1."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Aprepitant 165 mg",
                                    "description": "A single oral 165 mg aprepitant capsule 15 minutes after consumption of a standard light breakfast meal on Day 1."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "3"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "100.25",
                                                    "lowerLimit": "97.22",
                                                    "upperLimit": "103.39"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "99.99",
                                                    "lowerLimit": "97.47",
                                                    "upperLimit": "102.58"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "testedNonInferiority": false,
                                    "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                    "paramType": "Geometric Mean Ratio of the LS means",
                                    "paramValue": "1.00",
                                    "ciPctValue": "90",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "0.97",
                                    "ciUpperLimit": "1.03",
                                    "estimateComment": "The point estimate and 90% confidence interval (CI) were generated for the geometric mean ratio (GMR) \\[aprepitant\n\n165 mg/fosaprepitant 150 mg\\]."
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Brain NK1-receptor Occupancy at 120 Hours Post Dose",
                            "populationDescription": "All participants with at least 1 successful postdose PET\n\nscan were included in the analysis population.",
                            "reportingStatus": "POSTED",
                            "paramType": "GEOMETRIC_MEAN",
                            "dispersionType": "95% Confidence Interval",
                            "unitOfMeasure": "Percent of occupancy",
                            "timeFrame": "120 hours post dose",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Fosaprepitant 150 mg",
                                    "description": "A single intravenous infusion of 150 mg fosaprepitant dimeglumine over 20 minutes, 15 minutes after consumption of a standard light breakfast meal on Day 1."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Aprepitant 165 mg",
                                    "description": "A single oral 165 mg aprepitant capsule 15 minutes after consumption of a standard light breakfast meal on Day 1."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "3"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "59.93",
                                                    "lowerLimit": "34.37",
                                                    "upperLimit": "104.49"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "54.32",
                                                    "lowerLimit": "31.15",
                                                    "upperLimit": "94.71"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "testedNonInferiority": false,
                                    "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                    "paramType": "Geometric Mean Ratio of the LS means",
                                    "paramValue": "0.91",
                                    "ciPctValue": "90",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "0.50",
                                    "ciUpperLimit": "1.66",
                                    "estimateComment": "The point estimate and 90% confidence interval (CI) were generated for the geometric mean ratio (GMR) \\[aprepitant\n\n165 mg/fosaprepitant 150 mg\\]."
                                }
                            ]
                        }
                    ]
                },
                "adverseEventsModule": {
                    "frequencyThreshold": "5",
                    "eventGroups": [
                        {
                            "id": "EG000",
                            "title": "Fosaprepitant 150 mg",
                            "description": "A single intravenous infusion of 150 mg fosaprepitant dimeglumine over 20 minutes, 15 minutes after consumption of a standard light breakfast meal on Day 1.",
                            "seriousNumAffected": 0,
                            "seriousNumAtRisk": 8,
                            "otherNumAffected": 5,
                            "otherNumAtRisk": 8
                        },
                        {
                            "id": "EG001",
                            "title": "Aprepitant 165 mg",
                            "description": "A single oral 165 mg aprepitant capsule 15 minutes after consumption of a standard light breakfast meal on Day 1.",
                            "seriousNumAffected": 0,
                            "seriousNumAtRisk": 8,
                            "otherNumAffected": 8,
                            "otherNumAtRisk": 8
                        }
                    ],
                    "otherEvents": [
                        {
                            "term": "Vision blurred",
                            "organSystem": "Eye disorders",
                            "sourceVocabulary": "MedDRA 13.0",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 8
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 8
                                }
                            ]
                        },
                        {
                            "term": "Visual impairment",
                            "organSystem": "Eye disorders",
                            "sourceVocabulary": "MedDRA 13.0",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 8
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 8
                                }
                            ]
                        },
                        {
                            "term": "Abdominal distension",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA 13.0",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 8
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 4,
                                    "numAtRisk": 8
                                }
                            ]
                        },
                        {
                            "term": "Abdominal pain",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA 13.0",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 8
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 8
                                }
                            ]
                        },
                        {
                            "term": "Constipation",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA 13.0",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 8
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 8
                                }
                            ]
                        },
                        {
                            "term": "Gastroesophageal reflux disease",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA 13.0",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 2,
                                    "numAtRisk": 8
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 4,
                                    "numAtRisk": 8
                                }
                            ]
                        },
                        {
                            "term": "Fatigue",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA 13.0",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 8
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 8
                                }
                            ]
                        },
                        {
                            "term": "Influenza like illness",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA 13.0",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 8
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 8
                                }
                            ]
                        },
                        {
                            "term": "Bronchitis",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA 13.0",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 8
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 8
                                }
                            ]
                        },
                        {
                            "term": "Neutrophil count decreased",
                            "organSystem": "Investigations",
                            "sourceVocabulary": "MedDRA 13.0",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 8
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 8
                                }
                            ]
                        },
                        {
                            "term": "Positron emission tomogram abnormal",
                            "organSystem": "Investigations",
                            "sourceVocabulary": "MedDRA 13.0",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 8
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 8
                                }
                            ]
                        },
                        {
                            "term": "Dizziness",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA 13.0",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 2,
                                    "numAtRisk": 8
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 8
                                }
                            ]
                        },
                        {
                            "term": "Dizziness postural",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA 13.0",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 8
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 8
                                }
                            ]
                        },
                        {
                            "term": "Headache",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA 13.0",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 2,
                                    "numAtRisk": 8
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 8
                                }
                            ]
                        },
                        {
                            "term": "Insomnia",
                            "organSystem": "Psychiatric disorders",
                            "sourceVocabulary": "MedDRA 13.0",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 8
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 8
                                }
                            ]
                        },
                        {
                            "term": "Cough",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA 13.0",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 8
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 8
                                }
                            ]
                        },
                        {
                            "term": "Dry throat",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA 13.0",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 8
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 8
                                }
                            ]
                        },
                        {
                            "term": "Dyspnea",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA 13.0",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 8
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 8
                                }
                            ]
                        },
                        {
                            "term": "Hiccups",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA 13.0",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 8
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 4,
                                    "numAtRisk": 8
                                }
                            ]
                        },
                        {
                            "term": "Oropharyngeal pain",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA 13.0",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 8
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 8
                                }
                            ]
                        },
                        {
                            "term": "Acne",
                            "organSystem": "Skin and subcutaneous tissue disorders",
                            "sourceVocabulary": "MedDRA 13.0",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 8
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 8
                                }
                            ]
                        },
                        {
                            "term": "Flushing",
                            "organSystem": "Vascular disorders",
                            "sourceVocabulary": "MedDRA 13.0",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 3,
                                    "numAtRisk": 8
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 8
                                }
                            ]
                        }
                    ]
                },
                "moreInfoModule": {
                    "certainAgreement": {
                        "piSponsorEmployee": false,
                        "restrictionType": "OTHER",
                        "restrictiveAgreement": true,
                        "otherDetails": "The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication guidelines."
                    },
                    "pointOfContact": {
                        "title": "Senior Vice President, Global Clinical Development",
                        "organization": "Merck Sharp & Dohme Corp.",
                        "email": "ClinicalTrialsDisclosure@merck.com"
                    }
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2023-11-09",
                    "removedCountries": [
                        "Belgium"
                    ],
                    "modelPredictions": {
                        "bmiLimits": {
                            "minBmi": 0.0,
                            "maxBmi": 101.0
                        }
                    }
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D000014839",
                            "term": "Vomiting"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D000012817",
                            "term": "Signs and Symptoms, Digestive"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M11963",
                            "name": "Nausea",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M17272",
                            "name": "Vomiting",
                            "asFound": "Vomiting",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M15312",
                            "name": "Signs and Symptoms, Digestive",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BC23",
                            "name": "Symptoms and General Pathology"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        }
                    ]
                },
                "interventionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D000003907",
                            "term": "Dexamethasone"
                        },
                        {
                            "id": "C000018038",
                            "term": "Dexamethasone acetate"
                        },
                        {
                            "id": "D000017294",
                            "term": "Ondansetron"
                        },
                        {
                            "id": "D000077608",
                            "term": "Aprepitant"
                        },
                        {
                            "id": "C000579707",
                            "term": "Fosaprepitant"
                        },
                        {
                            "id": "C000101468",
                            "term": "BB 1101"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D000000893",
                            "term": "Anti-Inflammatory Agents"
                        },
                        {
                            "id": "D000000932",
                            "term": "Antiemetics"
                        },
                        {
                            "id": "D000001337",
                            "term": "Autonomic Agents"
                        },
                        {
                            "id": "D000018373",
                            "term": "Peripheral Nervous System Agents"
                        },
                        {
                            "id": "D000045505",
                            "term": "Physiological Effects of Drugs"
                        },
                        {
                            "id": "D000005765",
                            "term": "Gastrointestinal Agents"
                        },
                        {
                            "id": "D000005938",
                            "term": "Glucocorticoids"
                        },
                        {
                            "id": "D000006728",
                            "term": "Hormones"
                        },
                        {
                            "id": "D000006730",
                            "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"
                        },
                        {
                            "id": "D000018931",
                            "term": "Antineoplastic Agents, Hormonal"
                        },
                        {
                            "id": "D000000970",
                            "term": "Antineoplastic Agents"
                        },
                        {
                            "id": "D000011480",
                            "term": "Protease Inhibitors"
                        },
                        {
                            "id": "D000004791",
                            "term": "Enzyme Inhibitors"
                        },
                        {
                            "id": "D000045504",
                            "term": "Molecular Mechanisms of Pharmacological Action"
                        },
                        {
                            "id": "D000000982",
                            "term": "Antipruritics"
                        },
                        {
                            "id": "D000003879",
                            "term": "Dermatologic Agents"
                        },
                        {
                            "id": "D000058831",
                            "term": "Serotonin 5-HT3 Receptor Antagonists"
                        },
                        {
                            "id": "D000012702",
                            "term": "Serotonin Antagonists"
                        },
                        {
                            "id": "D000018490",
                            "term": "Serotonin Agents"
                        },
                        {
                            "id": "D000018377",
                            "term": "Neurotransmitter Agents"
                        },
                        {
                            "id": "D000064729",
                            "term": "Neurokinin-1 Receptor Antagonists"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M6792",
                            "name": "Dexamethasone",
                            "asFound": "High",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M235506",
                            "name": "Dexamethasone acetate",
                            "asFound": "High",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M19278",
                            "name": "Ondansetron",
                            "asFound": "Healthy Adult",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M1864",
                            "name": "Aprepitant",
                            "asFound": "Resting",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M44347",
                            "name": "Fosaprepitant",
                            "asFound": "Resting",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M199100",
                            "name": "BB 1101",
                            "asFound": "High",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M3907",
                            "name": "Anti-Inflammatory Agents",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M3941",
                            "name": "Antiemetics",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M8571",
                            "name": "Gastrointestinal Agents",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M8737",
                            "name": "Glucocorticoids",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M9479",
                            "name": "Hormones",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M9478",
                            "name": "Hormone Antagonists",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M20656",
                            "name": "Antineoplastic Agents, Hormonal",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M19299",
                            "name": "HIV Protease Inhibitors",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M14033",
                            "name": "Protease Inhibitors",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M7641",
                            "name": "Enzyme Inhibitors",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M6764",
                            "name": "Dermatologic Agents",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M15202",
                            "name": "Serotonin",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M28936",
                            "name": "Serotonin 5-HT3 Receptor Antagonists",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M20194",
                            "name": "Neurotransmitter Agents",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M15851",
                            "name": "Substance P",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M17678",
                            "name": "Neurokinin A",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M30066",
                            "name": "Neurokinin-1 Receptor Antagonists",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "Infl",
                            "name": "Anti-Inflammatory Agents"
                        },
                        {
                            "abbrev": "ANeo",
                            "name": "Antineoplastic Agents"
                        },
                        {
                            "abbrev": "AnEm",
                            "name": "Antiemetics"
                        },
                        {
                            "abbrev": "Gast",
                            "name": "Gastrointestinal Agents"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Drugs and Chemicals"
                        },
                        {
                            "abbrev": "Derm",
                            "name": "Dermatologic Agents"
                        },
                        {
                            "abbrev": "Infe",
                            "name": "Anti-Infective Agents"
                        }
                    ]
                }
            },
            "hasResults": true
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT02631551",
                    "orgStudyIdInfo": {
                        "id": "GPL/CT/2014/016/III"
                    },
                    "organization": {
                        "fullName": "Glenmark Specialty S.A.",
                        "class": "INDUSTRY"
                    },
                    "briefTitle": "Efficacy and Safety of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Seasonal Allergic Rhinitis (SAR)",
                    "officialTitle": "A Double-Blind, Randomized, Parallel-Group, Comparative Study to Evaluate the Efficacy, Safety and Tolerability of a Fixed Dose Combination GSP 301 Nasal Spray (NS) Compared With Placebo Nasal Spray and Individual Monotherapy Formulations (Comparators) in Subjects (Aged 12 Years and Older) With Seasonal Allergic Rhinitis (SAR)",
                    "acronym": "GSP 301-301"
                },
                "statusModule": {
                    "statusVerifiedDate": "2018-08",
                    "overallStatus": "COMPLETED",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2016-03"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2016-07",
                        "type": "ACTUAL"
                    },
                    "completionDateStruct": {
                        "date": "2016-07",
                        "type": "ACTUAL"
                    },
                    "studyFirstSubmitDate": "2015-12-10",
                    "studyFirstSubmitQcDate": "2015-12-13",
                    "studyFirstPostDateStruct": {
                        "date": "2015-12-16",
                        "type": "ESTIMATED"
                    },
                    "resultsFirstSubmitDate": "2018-07-18",
                    "resultsFirstSubmitQcDate": "2018-07-18",
                    "resultsFirstPostDateStruct": {
                        "date": "2018-08-15",
                        "type": "ACTUAL"
                    },
                    "dispFirstSubmitDate": "2017-05-17",
                    "dispFirstSubmitQcDate": "2017-05-17",
                    "dispFirstPostDateStruct": {
                        "date": "2017-05-19",
                        "type": "ACTUAL"
                    },
                    "lastUpdateSubmitDate": "2018-08-28",
                    "lastUpdatePostDateStruct": {
                        "date": "2018-09-25",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR"
                    },
                    "leadSponsor": {
                        "name": "Glenmark Specialty S.A.",
                        "class": "INDUSTRY"
                    }
                },
                "descriptionModule": {
                    "briefSummary": "Study to evaluate the efficacy and safety of GSP 301 NS compared to placebo NS and to individual monotherapies (comparators) as well as the efficacy of these monotherapies (comparators) versus placebo NS over 14 days of study treatment"
                },
                "conditionsModule": {
                    "conditions": [
                        "Seasonal Allergic Rhinitis"
                    ],
                    "keywords": [
                        "Seasonal Allergic Rhinitis"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "PHASE3"
                    ],
                    "designInfo": {
                        "allocation": "RANDOMIZED",
                        "interventionModel": "PARALLEL",
                        "primaryPurpose": "TREATMENT",
                        "maskingInfo": {
                            "masking": "DOUBLE",
                            "whoMasked": [
                                "PARTICIPANT",
                                "INVESTIGATOR"
                            ]
                        }
                    },
                    "enrollmentInfo": {
                        "count": 1180,
                        "type": "ACTUAL"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "GSP 301 NS",
                            "type": "EXPERIMENTAL",
                            "interventionNames": [
                                "Drug: GSP 301 NS"
                            ]
                        },
                        {
                            "label": "Olopatadine HCl NS",
                            "type": "ACTIVE_COMPARATOR",
                            "interventionNames": [
                                "Drug: Olopatadine HCl NS"
                            ]
                        },
                        {
                            "label": "Mometasone furoate NS",
                            "type": "ACTIVE_COMPARATOR",
                            "interventionNames": [
                                "Drug: Mometasone furoate NS"
                            ]
                        },
                        {
                            "label": "GSP 301 Placebo NS",
                            "type": "PLACEBO_COMPARATOR",
                            "interventionNames": [
                                "Drug: GSP 301 Placebo NS"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "DRUG",
                            "name": "GSP 301 NS",
                            "description": "FDC of olopatadine HCl and mometasone furoate: 2 sprays in each nostril twice daily for 14 days",
                            "armGroupLabels": [
                                "GSP 301 NS"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "Olopatadine HCl NS",
                            "description": "2 sprays in each nostril twice daily for 14 days",
                            "armGroupLabels": [
                                "Olopatadine HCl NS"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "Mometasone furoate NS",
                            "description": "2 sprays in each nostril twice daily for 14 days",
                            "armGroupLabels": [
                                "Mometasone furoate NS"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "GSP 301 Placebo NS",
                            "description": "2 sprays in each nostril twice daily for 14 days",
                            "armGroupLabels": [
                                "GSP 301 Placebo NS"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "Change in Average AM and PM Subject-reported 12-hour Reflective Total Nasal Symptoms Score (rTNSS) From Baseline to End of Treatment.",
                            "description": "Reflective Total Nasal Symptom Score (rTNSS) was calculated as the sum of 12-hour reflective scoring of the severity of four nasal symptoms (nasal congestion, rhinorrhea, nasal itching, sneezing). Subjects responded on a 4-point severity scale with scores ranging from 0 (no signs/symptoms evident) to 3 (severe signs/symptoms that is hard to tolerate). The rTNSS was calculated as the sum of the subject-reported severity scores for nasal symptoms, and value ranged from 0 (no signs/symptoms evident) to 12 (severe signs/symptoms that is hard to tolerate).",
                            "timeFrame": "14 days"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Aged 12 years and older inclusive of either sex.\n2. Documented clinical history of SAR (for at least 2 years preceding the Screening Visit \\[Visit 1\\]) with exacerbations (clinical evidence of active symptoms) during the spring allergy season (tree/grass pollen)\n3. A 12-hour reflective TNSS \u2265 8 out of a possible 12 and a congestion score of \u2265 2 for the AM assessment at the Screening Visit (Visit 1).\n\nExclusion Criteria:\n\n1. Pregnant or lactating women.\n2. Plans to travel outside the known pollen area for the investigative site for \\> 24 hours during the last 7 days of run in period.\n3. History of anaphylaxis and/or other severe local reaction(s) to skin testing.\n4. History of positive test for HIV, Hepatitis B or Hepatitis C infection.\n5. Documented evidence of acute or significant chronic sinusitis or chronic purulent postnasal drip.\n6. Subjects with an active pulmonary disorder or infection.\n7. Subjects with posterior subcapsular cataracts or glaucoma",
                    "healthyVolunteers": false,
                    "sex": "ALL",
                    "minimumAge": "12 Years",
                    "stdAges": [
                        "CHILD",
                        "ADULT",
                        "OLDER_ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "overallOfficials": [
                        {
                            "name": "Sudeesh Tantry, PhD",
                            "affiliation": "Glenmark Pharmaceuticals",
                            "role": "STUDY_DIRECTOR"
                        }
                    ],
                    "locations": [
                        {
                            "facility": "Investigational Site 20",
                            "city": "Mission Viejo",
                            "state": "California",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.60002,
                                "lon": -117.672
                            }
                        },
                        {
                            "facility": "Investigational Site 31",
                            "city": "San Diego",
                            "state": "California",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 32.71533,
                                "lon": -117.15726
                            }
                        },
                        {
                            "facility": "Investigational Site 29",
                            "city": "San Jose",
                            "state": "California",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 37.33939,
                                "lon": -121.89496
                            }
                        },
                        {
                            "facility": "Investigational Site 25",
                            "city": "Centennial",
                            "state": "Colorado",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.57916,
                                "lon": -104.87692
                            }
                        },
                        {
                            "facility": "Investigational Site 22",
                            "city": "Colorado Springs",
                            "state": "Colorado",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 38.83388,
                                "lon": -104.82136
                            }
                        },
                        {
                            "facility": "Investigational Site 10",
                            "city": "Jupiter",
                            "state": "Florida",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 26.93422,
                                "lon": -80.09421
                            }
                        },
                        {
                            "facility": "Investigational Site 30",
                            "city": "Miami",
                            "state": "Florida",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 25.77427,
                                "lon": -80.19366
                            }
                        },
                        {
                            "facility": "Investigational Site 37",
                            "city": "Marietta",
                            "state": "Georgia",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.9526,
                                "lon": -84.54993
                            }
                        },
                        {
                            "facility": "Investigational Site 15",
                            "city": "Stockbridge",
                            "state": "Georgia",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.54428,
                                "lon": -84.23381
                            }
                        },
                        {
                            "facility": "Investigational Site 23",
                            "city": "Stockbridge",
                            "state": "Georgia",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.54428,
                                "lon": -84.23381
                            }
                        },
                        {
                            "facility": "Investigational Site 11",
                            "city": "Louisville",
                            "state": "Kentucky",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 38.25424,
                                "lon": -85.75941
                            }
                        },
                        {
                            "facility": "Investigational Site 14",
                            "city": "Baltimore",
                            "state": "Maryland",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.29038,
                                "lon": -76.61219
                            }
                        },
                        {
                            "facility": "Investigational Site 33",
                            "city": "Wheaton",
                            "state": "Maryland",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.03983,
                                "lon": -77.05526
                            }
                        },
                        {
                            "facility": "Investigational Site 26",
                            "city": "Ypsilanti",
                            "state": "Michigan",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 42.24115,
                                "lon": -83.61299
                            }
                        },
                        {
                            "facility": "Investigational Site 19",
                            "city": "Minneapolis",
                            "state": "Minnesota",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 44.97997,
                                "lon": -93.26384
                            }
                        },
                        {
                            "facility": "Investigational Site 21",
                            "city": "Saint Louis",
                            "state": "Missouri",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 38.62727,
                                "lon": -90.19789
                            }
                        },
                        {
                            "facility": "Investigational Site 16",
                            "city": "Bellevue",
                            "state": "Nebraska",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.13667,
                                "lon": -95.89084
                            }
                        },
                        {
                            "facility": "Investigational Site 12",
                            "city": "Skillman",
                            "state": "New Jersey",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.42011,
                                "lon": -74.7146
                            }
                        },
                        {
                            "facility": "Investigational Site 36",
                            "city": "Rochester",
                            "state": "New York",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 43.15478,
                                "lon": -77.61556
                            }
                        },
                        {
                            "facility": "Investigational Site 18",
                            "city": "Raleigh",
                            "state": "North Carolina",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 35.7721,
                                "lon": -78.63861
                            }
                        },
                        {
                            "facility": "Investigational Site 27",
                            "city": "Cincinnati",
                            "state": "Ohio",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.12713,
                                "lon": -84.51435
                            }
                        },
                        {
                            "facility": "Investigational Site 34",
                            "city": "Middleburg Heights",
                            "state": "Ohio",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.36144,
                                "lon": -81.81291
                            }
                        },
                        {
                            "facility": "Investigational Site 32",
                            "city": "Medford",
                            "state": "Oregon",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 42.32652,
                                "lon": -122.87559
                            }
                        },
                        {
                            "facility": "Investigational Site 35",
                            "city": "Portland",
                            "state": "Oregon",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 45.52345,
                                "lon": -122.67621
                            }
                        },
                        {
                            "facility": "Investigational Site 13",
                            "city": "Orangeburg",
                            "state": "South Carolina",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.49182,
                                "lon": -80.85565
                            }
                        },
                        {
                            "facility": "Investigational Site 17",
                            "city": "Spartanburg",
                            "state": "South Carolina",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.94957,
                                "lon": -81.93205
                            }
                        },
                        {
                            "facility": "Investigational Site 3",
                            "city": "Austin",
                            "state": "Texas",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 30.26715,
                                "lon": -97.74306
                            }
                        },
                        {
                            "facility": "Investigational Site 5",
                            "city": "Austin",
                            "state": "Texas",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 30.26715,
                                "lon": -97.74306
                            }
                        },
                        {
                            "facility": "Investigational Site 8",
                            "city": "Austin",
                            "state": "Texas",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 30.26715,
                                "lon": -97.74306
                            }
                        },
                        {
                            "facility": "Investigational Site 1",
                            "city": "Kerrville",
                            "state": "Texas",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 30.04743,
                                "lon": -99.14032
                            }
                        },
                        {
                            "facility": "Investigational Site 7",
                            "city": "New Braunfels",
                            "state": "Texas",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 29.703,
                                "lon": -98.12445
                            }
                        },
                        {
                            "facility": "Investigational Site 2",
                            "city": "San Antonio",
                            "state": "Texas",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 29.42412,
                                "lon": -98.49363
                            }
                        },
                        {
                            "facility": "Investigational Site 4",
                            "city": "San Antonio",
                            "state": "Texas",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 29.42412,
                                "lon": -98.49363
                            }
                        },
                        {
                            "facility": "Investigational Site 6",
                            "city": "San Antonio",
                            "state": "Texas",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 29.42412,
                                "lon": -98.49363
                            }
                        },
                        {
                            "facility": "Investigational Site 9",
                            "city": "San Antonio",
                            "state": "Texas",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 29.42412,
                                "lon": -98.49363
                            }
                        },
                        {
                            "facility": "Investigational Site 28",
                            "city": "Waco",
                            "state": "Texas",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 31.54933,
                                "lon": -97.14667
                            }
                        },
                        {
                            "facility": "Investigational Site 24",
                            "city": "Draper",
                            "state": "Utah",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.52467,
                                "lon": -111.86382
                            }
                        }
                    ]
                },
                "referencesModule": {
                    "references": [
                        {
                            "pmid": "31053180",
                            "type": "DERIVED",
                            "citation": "Hampel FC, Pedinoff AJ, Jacobs RL, Caracta CF, Tantry SK. Olopatadine-mometasone combination nasal spray: Evaluation of efficacy and safety in patients with seasonal allergic rhinitis. Allergy Asthma Proc. 2019 Jul 3;40(4):261-272. doi: 10.2500/aap.2019.40.4223. Epub 2019 May 3."
                        }
                    ]
                }
            },
            "resultsSection": {
                "participantFlowModule": {
                    "groups": [
                        {
                            "id": "FG000",
                            "title": "GSP 301 NS",
                            "description": "2 sprays in each nostril twice daily for 14 days"
                        },
                        {
                            "id": "FG001",
                            "title": "Olopatadine HCl NS",
                            "description": "2 sprays in each nostril twice daily for 14 days"
                        },
                        {
                            "id": "FG002",
                            "title": "Mometasone Furoate NS",
                            "description": "2 sprays in each nostril twice daily for 14 days"
                        },
                        {
                            "id": "FG003",
                            "title": "GSP 301 Placebo NS",
                            "description": "2 sprays in each nostril twice daily for 14 days"
                        }
                    ],
                    "periods": [
                        {
                            "title": "Overall Study",
                            "milestones": [
                                {
                                    "type": "STARTED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "302"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "297"
                                        },
                                        {
                                            "groupId": "FG002",
                                            "numSubjects": "294"
                                        },
                                        {
                                            "groupId": "FG003",
                                            "numSubjects": "287"
                                        }
                                    ]
                                },
                                {
                                    "type": "COMPLETED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "289"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "278"
                                        },
                                        {
                                            "groupId": "FG002",
                                            "numSubjects": "283"
                                        },
                                        {
                                            "groupId": "FG003",
                                            "numSubjects": "276"
                                        }
                                    ]
                                },
                                {
                                    "type": "NOT COMPLETED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "13"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "19"
                                        },
                                        {
                                            "groupId": "FG002",
                                            "numSubjects": "11"
                                        },
                                        {
                                            "groupId": "FG003",
                                            "numSubjects": "11"
                                        }
                                    ]
                                }
                            ],
                            "dropWithdraws": [
                                {
                                    "type": "Adverse Event",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "1"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "2"
                                        },
                                        {
                                            "groupId": "FG002",
                                            "numSubjects": "4"
                                        },
                                        {
                                            "groupId": "FG003",
                                            "numSubjects": "0"
                                        }
                                    ]
                                },
                                {
                                    "type": "Lack of Efficacy",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "0"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "0"
                                        },
                                        {
                                            "groupId": "FG002",
                                            "numSubjects": "1"
                                        },
                                        {
                                            "groupId": "FG003",
                                            "numSubjects": "0"
                                        }
                                    ]
                                },
                                {
                                    "type": "Lost to Follow-up",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "1"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "2"
                                        },
                                        {
                                            "groupId": "FG002",
                                            "numSubjects": "0"
                                        },
                                        {
                                            "groupId": "FG003",
                                            "numSubjects": "3"
                                        }
                                    ]
                                },
                                {
                                    "type": "Withdrawal by Subject",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "2"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "2"
                                        },
                                        {
                                            "groupId": "FG002",
                                            "numSubjects": "0"
                                        },
                                        {
                                            "groupId": "FG003",
                                            "numSubjects": "5"
                                        }
                                    ]
                                },
                                {
                                    "type": "Protocol deviation",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "3"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "6"
                                        },
                                        {
                                            "groupId": "FG002",
                                            "numSubjects": "3"
                                        },
                                        {
                                            "groupId": "FG003",
                                            "numSubjects": "0"
                                        }
                                    ]
                                },
                                {
                                    "type": "Non-compliance with study procedures",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "0"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "0"
                                        },
                                        {
                                            "groupId": "FG002",
                                            "numSubjects": "1"
                                        },
                                        {
                                            "groupId": "FG003",
                                            "numSubjects": "1"
                                        }
                                    ]
                                },
                                {
                                    "type": "Non-compliance with study drug",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "1"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "0"
                                        },
                                        {
                                            "groupId": "FG002",
                                            "numSubjects": "0"
                                        },
                                        {
                                            "groupId": "FG003",
                                            "numSubjects": "0"
                                        }
                                    ]
                                },
                                {
                                    "type": "Other, specific reasons not collected",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "5"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "7"
                                        },
                                        {
                                            "groupId": "FG002",
                                            "numSubjects": "2"
                                        },
                                        {
                                            "groupId": "FG003",
                                            "numSubjects": "2"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "baselineCharacteristicsModule": {
                    "groups": [
                        {
                            "id": "BG000",
                            "title": "GSP 301 NS",
                            "description": "2 sprays in each nostril twice daily for 14 days"
                        },
                        {
                            "id": "BG001",
                            "title": "Olopatadine HCl NS",
                            "description": "2 sprays in each nostril twice daily for 14 days"
                        },
                        {
                            "id": "BG002",
                            "title": "Mometasone Furoate NS",
                            "description": "2 sprays in each nostril twice daily for 14 days"
                        },
                        {
                            "id": "BG003",
                            "title": "GSP 301 Placebo NS",
                            "description": "2 sprays in each nostril twice daily for 14 days"
                        },
                        {
                            "id": "BG004",
                            "title": "Total",
                            "description": "Total of all reporting groups"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "BG000",
                                    "value": "302"
                                },
                                {
                                    "groupId": "BG001",
                                    "value": "297"
                                },
                                {
                                    "groupId": "BG002",
                                    "value": "294"
                                },
                                {
                                    "groupId": "BG003",
                                    "value": "287"
                                },
                                {
                                    "groupId": "BG004",
                                    "value": "1180"
                                }
                            ]
                        }
                    ],
                    "measures": [
                        {
                            "title": "Age, Continuous",
                            "paramType": "MEAN",
                            "dispersionType": "STANDARD_DEVIATION",
                            "unitOfMeasure": "years",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "39.5",
                                                    "spread": "15.4"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "39.6",
                                                    "spread": "14.9"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "38.7",
                                                    "spread": "16.3"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "39.4",
                                                    "spread": "14.8"
                                                },
                                                {
                                                    "groupId": "BG004",
                                                    "value": "39.3",
                                                    "spread": "15.3"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Sex: Female, Male",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "calculatePct": false,
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "title": "Female",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "201"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "181"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "198"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "182"
                                                },
                                                {
                                                    "groupId": "BG004",
                                                    "value": "762"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Male",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "101"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "116"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "96"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "105"
                                                },
                                                {
                                                    "groupId": "BG004",
                                                    "value": "418"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Race (NIH/OMB)",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "calculatePct": false,
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "title": "American Indian or Alaska Native",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "2"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG004",
                                                    "value": "3"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Asian",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "2"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "4"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "7"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "7"
                                                },
                                                {
                                                    "groupId": "BG004",
                                                    "value": "20"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Native Hawaiian or Other Pacific Islander",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "2"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG004",
                                                    "value": "4"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Black or African American",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "56"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "67"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "59"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "48"
                                                },
                                                {
                                                    "groupId": "BG004",
                                                    "value": "230"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "White",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "241"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "219"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "224"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "231"
                                                },
                                                {
                                                    "groupId": "BG004",
                                                    "value": "915"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "More than one race",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG004",
                                                    "value": "0"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Unknown or Not Reported",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "2"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "3"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "3"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG004",
                                                    "value": "8"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "outcomeMeasuresModule": {
                    "outcomeMeasures": [
                        {
                            "type": "PRIMARY",
                            "title": "Change in Average AM and PM Subject-reported 12-hour Reflective Total Nasal Symptoms Score (rTNSS) From Baseline to End of Treatment.",
                            "description": "Reflective Total Nasal Symptom Score (rTNSS) was calculated as the sum of 12-hour reflective scoring of the severity of four nasal symptoms (nasal congestion, rhinorrhea, nasal itching, sneezing). Subjects responded on a 4-point severity scale with scores ranging from 0 (no signs/symptoms evident) to 3 (severe signs/symptoms that is hard to tolerate). The rTNSS was calculated as the sum of the subject-reported severity scores for nasal symptoms, and value ranged from 0 (no signs/symptoms evident) to 12 (severe signs/symptoms that is hard to tolerate).",
                            "populationDescription": "The Full Analysis Set (FAS) was defined as all subjects who were randomized and received at least one dose of investigational product and had at least one post-baseline primary efficacy assessment. This was the primary analysis set for efficacy analyses.",
                            "reportingStatus": "POSTED",
                            "paramType": "MEAN",
                            "dispersionType": "Standard Deviation",
                            "unitOfMeasure": "units on a scale",
                            "timeFrame": "14 days",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "GSP 301 NS",
                                    "description": "2 sprays in each nostril twice daily for 14 days"
                                },
                                {
                                    "id": "OG001",
                                    "title": "Olopatadine HCl NS",
                                    "description": "2 sprays in each nostril twice daily for 14 days"
                                },
                                {
                                    "id": "OG002",
                                    "title": "Mometasone Furoate NS",
                                    "description": "2 sprays in each nostril twice daily for 14 days"
                                },
                                {
                                    "id": "OG003",
                                    "title": "GSP 301 Placebo NS",
                                    "description": "2 sprays in each nostril twice daily for 14 days"
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "299"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "294"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "294"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "283"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "title": "Baseline",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "10.1",
                                                    "spread": "1.2"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "10.3",
                                                    "spread": "1.3"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "10.2",
                                                    "spread": "1.2"
                                                },
                                                {
                                                    "groupId": "OG003",
                                                    "value": "10.2",
                                                    "spread": "1.2"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Change from baseline to end of treatment",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "-3.6",
                                                    "spread": "3.2"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "-3.2",
                                                    "spread": "3.1"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "-3.5",
                                                    "spread": "3.3"
                                                },
                                                {
                                                    "groupId": "OG003",
                                                    "value": "-2.8",
                                                    "spread": "3.2"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG003"
                                    ],
                                    "groupDescription": "GSP 301 NS vs GSP 301 placebo NS comparison for rTNSS was tested at 0.05 significance level.",
                                    "nonInferiorityType": "SUPERIORITY",
                                    "pValue": "<0.0001",
                                    "statisticalMethod": "Mixed Models Analysis"
                                },
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "groupDescription": "GSP 301 NS vs Olopatadine HCl NS comparison for rTNSS was tested at 0.05 significance level.",
                                    "nonInferiorityType": "SUPERIORITY",
                                    "pValue": "0.0029",
                                    "statisticalMethod": "Mixed Models Analysis"
                                },
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG002"
                                    ],
                                    "groupDescription": "GSP 301 NS vs Mometasone furoate NS comparison for rTNSS was tested at 0.05 significance level.",
                                    "nonInferiorityType": "SUPERIORITY",
                                    "pValue": "0.0587",
                                    "statisticalMethod": "Mixed Models Analysis"
                                },
                                {
                                    "groupIds": [
                                        "OG001",
                                        "OG003"
                                    ],
                                    "groupDescription": "Olopatadine HCl NS vs GSP 301 Placebo NS comparison for rTNSS was tested at 0.05 significance level.",
                                    "nonInferiorityType": "SUPERIORITY",
                                    "pValue": "0.0755",
                                    "statisticalMethod": "Mixed Models Analysis"
                                },
                                {
                                    "groupIds": [
                                        "OG002",
                                        "OG003"
                                    ],
                                    "groupDescription": "Mometasone furoate NS vs GSP 301 Placebo NS comparison for rTNSS was tested at 0.05 significance level.",
                                    "nonInferiorityType": "SUPERIORITY",
                                    "pValue": "0.0043",
                                    "statisticalMethod": "Mixed Models Analysis"
                                }
                            ]
                        }
                    ]
                },
                "adverseEventsModule": {
                    "frequencyThreshold": "5",
                    "timeFrame": "The AEs and SAEs were collected from the time of signing the informed consent form until the end of study i.e., screening visit followed by 7-10 days of placebo run-in period and 14 days of treatment.",
                    "eventGroups": [
                        {
                            "id": "EG000",
                            "title": "GSP 301 NS",
                            "description": "2 sprays in each nostril twice daily for 14 days",
                            "deathsNumAffected": 0,
                            "deathsNumAtRisk": 302,
                            "seriousNumAffected": 1,
                            "seriousNumAtRisk": 302,
                            "otherNumAffected": 0,
                            "otherNumAtRisk": 302
                        },
                        {
                            "id": "EG001",
                            "title": "Olopatadine HCl NS",
                            "description": "2 sprays in each nostril twice daily for 14 days",
                            "deathsNumAffected": 0,
                            "deathsNumAtRisk": 297,
                            "seriousNumAffected": 0,
                            "seriousNumAtRisk": 297,
                            "otherNumAffected": 0,
                            "otherNumAtRisk": 297
                        },
                        {
                            "id": "EG002",
                            "title": "Mometasone Furoate NS",
                            "description": "2 sprays in each nostril twice daily for 14 days",
                            "deathsNumAffected": 0,
                            "deathsNumAtRisk": 294,
                            "seriousNumAffected": 0,
                            "seriousNumAtRisk": 294,
                            "otherNumAffected": 0,
                            "otherNumAtRisk": 294
                        },
                        {
                            "id": "EG003",
                            "title": "GSP 301 Placebo NS",
                            "description": "2 sprays in each nostril twice daily for 14 days",
                            "deathsNumAffected": 0,
                            "deathsNumAtRisk": 287,
                            "seriousNumAffected": 0,
                            "seriousNumAtRisk": 287,
                            "otherNumAffected": 0,
                            "otherNumAtRisk": 287
                        }
                    ],
                    "seriousEvents": [
                        {
                            "term": "Abortion spontaneous",
                            "organSystem": "Pregnancy, puerperium and perinatal conditions",
                            "sourceVocabulary": "MedDRA 18.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 302
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 297
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 294
                                },
                                {
                                    "groupId": "EG003",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 287
                                }
                            ]
                        }
                    ]
                },
                "moreInfoModule": {
                    "certainAgreement": {
                        "piSponsorEmployee": false,
                        "restrictionType": "OTHER",
                        "restrictiveAgreement": true,
                        "otherDetails": "Per the agreement, Sponsor reserves the right for publishing trial results and the Investigator cannot publish without written consent from the CRO/Sponsor."
                    },
                    "pointOfContact": {
                        "title": "Study Director",
                        "organization": "Glenmark Pharmaceuticals Ltd.",
                        "email": "clinicaltrialsdisclosuredesk@glenmarkpharma.com",
                        "phone": "(201) 684-8000"
                    }
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2023-11-09",
                    "modelPredictions": {
                        "bmiLimits": {
                            "minBmi": 0.0,
                            "maxBmi": 101.0
                        }
                    }
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D000012220",
                            "term": "Rhinitis"
                        },
                        {
                            "id": "D000065631",
                            "term": "Rhinitis, Allergic"
                        },
                        {
                            "id": "D000006255",
                            "term": "Rhinitis, Allergic, Seasonal"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D000012141",
                            "term": "Respiratory Tract Infections"
                        },
                        {
                            "id": "D000007239",
                            "term": "Infections"
                        },
                        {
                            "id": "D000009668",
                            "term": "Nose Diseases"
                        },
                        {
                            "id": "D000012140",
                            "term": "Respiratory Tract Diseases"
                        },
                        {
                            "id": "D000010038",
                            "term": "Otorhinolaryngologic Diseases"
                        },
                        {
                            "id": "D000012130",
                            "term": "Respiratory Hypersensitivity"
                        },
                        {
                            "id": "D000006969",
                            "term": "Hypersensitivity, Immediate"
                        },
                        {
                            "id": "D000006967",
                            "term": "Hypersensitivity"
                        },
                        {
                            "id": "D000007154",
                            "term": "Immune System Diseases"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M14739",
                            "name": "Rhinitis",
                            "asFound": "Rhinitis",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M30235",
                            "name": "Rhinitis, Allergic",
                            "asFound": "Allergic Rhinitis",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M9035",
                            "name": "Rhinitis, Allergic, Seasonal",
                            "asFound": "Seasonal Allergic Rhinitis",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M9973",
                            "name": "Infections",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M6058",
                            "name": "Communicable Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M14668",
                            "name": "Respiratory Tract Infections",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M12294",
                            "name": "Nose Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M14667",
                            "name": "Respiratory Tract Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M12651",
                            "name": "Otorhinolaryngologic Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M9708",
                            "name": "Hypersensitivity",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M14657",
                            "name": "Respiratory Hypersensitivity",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M9710",
                            "name": "Hypersensitivity, Immediate",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M9890",
                            "name": "Immune System Diseases",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BC01",
                            "name": "Infections"
                        },
                        {
                            "abbrev": "BC08",
                            "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                        },
                        {
                            "abbrev": "BC09",
                            "name": "Ear, Nose, and Throat Diseases"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        },
                        {
                            "abbrev": "BC20",
                            "name": "Immune System Diseases"
                        },
                        {
                            "abbrev": "BC23",
                            "name": "Symptoms and General Pathology"
                        }
                    ]
                },
                "interventionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D000068656",
                            "term": "Mometasone Furoate"
                        },
                        {
                            "id": "D000069605",
                            "term": "Olopatadine Hydrochloride"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D000000893",
                            "term": "Anti-Inflammatory Agents"
                        },
                        {
                            "id": "D000003879",
                            "term": "Dermatologic Agents"
                        },
                        {
                            "id": "D000018926",
                            "term": "Anti-Allergic Agents"
                        },
                        {
                            "id": "D000000894",
                            "term": "Anti-Inflammatory Agents, Non-Steroidal"
                        },
                        {
                            "id": "D000018712",
                            "term": "Analgesics, Non-Narcotic"
                        },
                        {
                            "id": "D000000700",
                            "term": "Analgesics"
                        },
                        {
                            "id": "D000018689",
                            "term": "Sensory System Agents"
                        },
                        {
                            "id": "D000018373",
                            "term": "Peripheral Nervous System Agents"
                        },
                        {
                            "id": "D000045505",
                            "term": "Physiological Effects of Drugs"
                        },
                        {
                            "id": "D000018501",
                            "term": "Antirheumatic Agents"
                        },
                        {
                            "id": "D000039563",
                            "term": "Histamine H1 Antagonists, Non-Sedating"
                        },
                        {
                            "id": "D000006634",
                            "term": "Histamine H1 Antagonists"
                        },
                        {
                            "id": "D000006633",
                            "term": "Histamine Antagonists"
                        },
                        {
                            "id": "D000018494",
                            "term": "Histamine Agents"
                        },
                        {
                            "id": "D000018377",
                            "term": "Neurotransmitter Agents"
                        },
                        {
                            "id": "D000045504",
                            "term": "Molecular Mechanisms of Pharmacological Action"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M290",
                            "name": "Mometasone Furoate",
                            "asFound": "Bag",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M491",
                            "name": "Olopatadine Hydrochloride",
                            "asFound": "Circulating Tumor Cells",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M3907",
                            "name": "Anti-Inflammatory Agents",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M6764",
                            "name": "Dermatologic Agents",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M20652",
                            "name": "Anti-Allergic Agents",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M3908",
                            "name": "Anti-Inflammatory Agents, Non-Steroidal",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M3722",
                            "name": "Analgesics",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M20476",
                            "name": "Analgesics, Non-Narcotic",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M20294",
                            "name": "Antirheumatic Agents",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M9400",
                            "name": "Histamine H1 Antagonists",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M9398",
                            "name": "Histamine",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M212106",
                            "name": "Histamine phosphate",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M24516",
                            "name": "Histamine H1 Antagonists, Non-Sedating",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M9399",
                            "name": "Histamine Antagonists",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M20194",
                            "name": "Neurotransmitter Agents",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "AAll",
                            "name": "Anti-Allergic Agents"
                        },
                        {
                            "abbrev": "Infl",
                            "name": "Anti-Inflammatory Agents"
                        },
                        {
                            "abbrev": "Derm",
                            "name": "Dermatologic Agents"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Drugs and Chemicals"
                        },
                        {
                            "abbrev": "ARhu",
                            "name": "Antirheumatic Agents"
                        },
                        {
                            "abbrev": "Analg",
                            "name": "Analgesics"
                        }
                    ]
                }
            },
            "hasResults": true
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT02058251",
                    "orgStudyIdInfo": {
                        "id": "018127-002 Seq. 1"
                    },
                    "organization": {
                        "fullName": "Medical University of South Carolina",
                        "class": "OTHER"
                    },
                    "briefTitle": "Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress",
                    "officialTitle": "Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress"
                },
                "statusModule": {
                    "statusVerifiedDate": "2018-12",
                    "overallStatus": "COMPLETED",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2014-02"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2017-01",
                        "type": "ACTUAL"
                    },
                    "completionDateStruct": {
                        "date": "2017-04",
                        "type": "ACTUAL"
                    },
                    "studyFirstSubmitDate": "2014-02-06",
                    "studyFirstSubmitQcDate": "2014-02-07",
                    "studyFirstPostDateStruct": {
                        "date": "2014-02-10",
                        "type": "ESTIMATED"
                    },
                    "resultsFirstSubmitDate": "2018-04-27",
                    "resultsFirstSubmitQcDate": "2018-12-03",
                    "resultsFirstPostDateStruct": {
                        "date": "2019-03-14",
                        "type": "ACTUAL"
                    },
                    "lastUpdateSubmitDate": "2018-12-03",
                    "lastUpdatePostDateStruct": {
                        "date": "2019-03-14",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR"
                    },
                    "leadSponsor": {
                        "name": "Medical University of South Carolina",
                        "class": "OTHER"
                    }
                },
                "oversightModule": {
                    "oversightHasDmc": true
                },
                "descriptionModule": {
                    "briefSummary": "In comparison to the general population, military personnel and veterans are at increased risk of developing both substance use disorders (SUDs) and post-traumatic stress disorder (PTSD). Despite promising developments in the past decade, the treatment of patients with SUDs and comorbid PTSD is woefully inadequate (Back, 2010; Back et al., 2014; Brady et al., 2007; McCauley et al., 2012). One of the adverse effects of abused drugs is their long-term negative impact on social behavior that is thought to involve oxytocin (OT) dysregulation (McGregor et al., 2008). In preclinical and clinical experiments, local, intra-nasal, or systemic OT administration decreases activation of the amygdala in response to visual fearful/threatening stimuli (Kirsch et al., 2005), ameliorates the effects of stressful events, and decreases drug-taking and seeking behavior (McGregor et al., 2008; Baskerville and Douglas, 2010; Carson et al., 2010a; Bowen et al., 2011; Cox et al 2013). However, little attention has been focused on whether OT decreases SUD vulnerability after exposure to traumatic stress in preclinical or clinical studies. This clinical project will determine whether intra-nasally administered OT will decrease craving (Aim 1) to use alcohol and decrease stress reactivity (Aim 2) following exposure to laboratory-induced stress (Trier Social Stress Task) among veterans with a dual diagnosis of alcohol use disorder and PTSD."
                },
                "conditionsModule": {
                    "conditions": [
                        "Alcohol Use Disorders"
                    ],
                    "keywords": [
                        "Alcohol",
                        "Oxytocin",
                        "Stress reactivity"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "PHASE1"
                    ],
                    "designInfo": {
                        "allocation": "RANDOMIZED",
                        "interventionModel": "FACTORIAL",
                        "primaryPurpose": "TREATMENT",
                        "maskingInfo": {
                            "masking": "DOUBLE",
                            "whoMasked": [
                                "PARTICIPANT",
                                "INVESTIGATOR"
                            ]
                        }
                    },
                    "enrollmentInfo": {
                        "count": 73,
                        "type": "ACTUAL"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "Oxytocin",
                            "type": "EXPERIMENTAL",
                            "description": "Each participant will self-administer a 40 IU dose of intranasal oxytocin.",
                            "interventionNames": [
                                "Drug: Oxytocin"
                            ]
                        },
                        {
                            "label": "Control",
                            "type": "PLACEBO_COMPARATOR",
                            "description": "Each participant will self-administer a 40 IU dose of intranasal saline.",
                            "interventionNames": [
                                "Drug: Placebo"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "DRUG",
                            "name": "Oxytocin",
                            "description": "One 40 IU dose of intranasal oxytocin will be self-administered (5 puffs in each nostril) by participants.",
                            "armGroupLabels": [
                                "Oxytocin"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "Placebo",
                            "description": "Each participant will self-administer a 40 IU dose of intranasal saline.",
                            "armGroupLabels": [
                                "Control"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "Alcohol Craving",
                            "description": "Using the Visual Analogue Scale (VAS), participants provided self-report ratings of subjective alcohol cravings on a scale of 1-10, with one being the lowest/better score, and 10 being the highest/worst outcome.",
                            "timeFrame": "2 hours"
                        }
                    ],
                    "secondaryOutcomes": [
                        {
                            "measure": "Stress Reactivity",
                            "description": "Salivary Cortisol (\u03bcg/dL). Greater cortisol levels are indicative of greater stress reactivity.",
                            "timeFrame": "2 hours"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n* Male or female; any race or ethnicity; age 21-65 years.\n* Female subjects will be required to complete the laboratory testing during the early to mid-follicular phase of their menstrual cycle (days 1-7 following the onset of menses).\n* Veteran of the US military; any service branch.\n* Able to provide informed consent and function at an intellectual level sufficient to allow accurate completion of the assessment instruments.\n* Subjects must be able to comprehend English.\n* Meet DSM-5 criteria for a current alcohol use disorder (assessed via the Mini International Neuropsychiatric Interview; MINI). Note that we will use the currently available diagnostic measure (MINI for DSM-IV) and will make appropriate modifications to update for compatibility with DSM-5.\n* Meet DSM-5 criteria for current PTSD (assessed via the Clinician Administered PTSD Scale; CAPS). Note that we will use the currently available assessment instrument (CAPS for DSM-IV), and will make appropriate modifications to update for compatibility with DSM-5.\n* A CAPS score of 50 or greater.\n* Subjects will be required to have at least 5 days of abstinence from alcohol or other substances (except caffeine or nicotine) prior to completing the laboratory testing, as verified by multiple methods including self-report, breathalyzer tests, and urine drug screen tests.\n* Subjects may also meet criteria for a mood disorder (except bipolar affective disorder, see Exclusion Criteria) or anxiety disorders (e.g., agoraphobia, social phobia, generalized anxiety disorder). The inclusion of subjects with affective and anxiety disorders is essential because of the marked frequency of the co-existence of mood and other anxiety disorders among patients with PTSD and alcohol use disorders.\n* Subjects taking psychotropic medications will be required to be maintained on a stable dose for at least eight weeks before study initiation. This is because initiation or change of psychotropic medications during the course of the trial may interfere with interpretation of results.\n* Must consent to random assignment to oxytocin or placebo.\n\nExclusion Criteria:\n\n* Subjects meeting DSM-5 criteria for a history of or current psychotic or bipolar affective disorders, or with current suicidal or homicidal ideation and intent. Those subjects will be referred clinically.\n* Subjects who would present a serious suicide risk or who are likely to require hospitalization during the course of the study. Those subjects will be referred clinically.\n* Subjects on maintenance anxiolytic, antidepressant, or mood stabilizing medications, which have been initiated during the past 8 weeks.\n* Subjects with a history of a major medical illness (e.g., endocrine, cardiovascular, central nervous system disorders, peripheral neuropathy, or pulmonary disease) or other acute or unstable medical condition that might interfere with safe conduct of the study or accurate interpretation of the results.\n* Subjects meeting DSM-5 criteria for another substance use disorder, except caffeine or nicotine, within the past 12 months.\n* Subjects experiencing withdrawal symptoms, as evidence by a score of 10 or above on the Clinical Institute Withdrawal Assessment of Alcohol (CIWA)\n* Females who are unable or unwilling to be scheduled for lab testing during the early to mid-follicular phase of their menstrual cycle.\n* Pregnant women will be excluded from the proposed study.",
                    "healthyVolunteers": false,
                    "sex": "ALL",
                    "minimumAge": "21 Years",
                    "maximumAge": "65 Years",
                    "stdAges": [
                        "ADULT",
                        "OLDER_ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "overallOfficials": [
                        {
                            "name": "Sudie E. Back, Ph.D.",
                            "affiliation": "Medical University of South Carolina",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "locations": [
                        {
                            "facility": "Medical University of South Carolina",
                            "city": "Charleston",
                            "state": "South Carolina",
                            "zip": "29425",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 32.77657,
                                "lon": -79.93092
                            }
                        }
                    ]
                },
                "referencesModule": {
                    "references": [
                        {
                            "pmid": "34121063",
                            "type": "DERIVED",
                            "citation": "Melkonian AJ, Flanagan JC, Calhoun CD, Hogan JN, Back SE. Craving Moderates the Effects of Intranasal Oxytocin on Anger in Response to Social Stress Among Veterans With Co-Occurring Posttraumatic Stress Disorder and Alcohol Use Disorder. J Clin Psychopharmacol. 2021 Jul-Aug 01;41(4):465-469. doi: 10.1097/JCP.0000000000001434."
                        },
                        {
                            "pmid": "30382728",
                            "type": "DERIVED",
                            "citation": "Flanagan JC, Allan NP, Calhoun CD, Badour CL, Moran-Santa Maria M, Brady KT, Back SE. Effects of oxytocin on stress reactivity and craving in veterans with co-occurring PTSD and alcohol use disorder. Exp Clin Psychopharmacol. 2019 Feb;27(1):45-54. doi: 10.1037/pha0000232. Epub 2018 Nov 1."
                        }
                    ]
                }
            },
            "resultsSection": {
                "participantFlowModule": {
                    "groups": [
                        {
                            "id": "FG000",
                            "title": "Oxytocin",
                            "description": "Each participant will self-administer a 40 IU dose of intranasal oxytocin.\n\nOxytocin: One 40 IU dose of intranasal oxytocin will be self-administered (5 puffs in each nostril) by participants."
                        },
                        {
                            "id": "FG001",
                            "title": "Control",
                            "description": "Each participant will self-administer a 40 IU dose of intranasal saline.\n\nPlacebo: Each participant will self-administer a 40 IU dose of intranasal saline."
                        }
                    ],
                    "periods": [
                        {
                            "title": "Overall Study",
                            "milestones": [
                                {
                                    "type": "STARTED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "35"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "38"
                                        }
                                    ]
                                },
                                {
                                    "type": "COMPLETED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "35"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "38"
                                        }
                                    ]
                                },
                                {
                                    "type": "NOT COMPLETED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "0"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "baselineCharacteristicsModule": {
                    "groups": [
                        {
                            "id": "BG000",
                            "title": "Oxytocin",
                            "description": "Each participant will self-administer a 40 IU dose of intranasal oxytocin.\n\nOxytocin: One 40 IU dose of intranasal oxytocin will be self-administered (5 puffs in each nostril) by participants."
                        },
                        {
                            "id": "BG001",
                            "title": "Control",
                            "description": "Each participant will self-administer a 40 IU dose of intranasal saline.\n\nPlacebo: Each participant will self-administer a 40 IU dose of intranasal saline."
                        },
                        {
                            "id": "BG002",
                            "title": "Total",
                            "description": "Total of all reporting groups"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "BG000",
                                    "value": "35"
                                },
                                {
                                    "groupId": "BG001",
                                    "value": "38"
                                },
                                {
                                    "groupId": "BG002",
                                    "value": "73"
                                }
                            ]
                        }
                    ],
                    "measures": [
                        {
                            "title": "Age, Continuous",
                            "paramType": "MEAN",
                            "dispersionType": "STANDARD_DEVIATION",
                            "unitOfMeasure": "years",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "48.94",
                                                    "spread": "9.75"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "47.82",
                                                    "spread": "11.27"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "48.36",
                                                    "spread": "10.51"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Sex: Female, Male",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "title": "Female",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "3"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "3"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "6"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Male",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "32"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "35"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "67"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Race (NIH/OMB)",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "title": "American Indian or Alaska Native",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "1"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Asian",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "0"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Native Hawaiian or Other Pacific Islander",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "0"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Black or African American",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "25"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "19"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "44"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "White",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "8"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "18"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "26"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "More than one race",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "2"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Unknown or Not Reported",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "0"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "outcomeMeasuresModule": {
                    "outcomeMeasures": [
                        {
                            "type": "PRIMARY",
                            "title": "Alcohol Craving",
                            "description": "Using the Visual Analogue Scale (VAS), participants provided self-report ratings of subjective alcohol cravings on a scale of 1-10, with one being the lowest/better score, and 10 being the highest/worst outcome.",
                            "populationDescription": "Main outcomes analyses were limited to male participants.",
                            "reportingStatus": "POSTED",
                            "paramType": "MEAN",
                            "dispersionType": "Standard Deviation",
                            "unitOfMeasure": "scores on a scale",
                            "timeFrame": "2 hours",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Oxytocin",
                                    "description": "Each participant will self-administer a 40 IU dose of intranasal oxytocin.\n\nOxytocin: One 40 IU dose of intranasal oxytocin will be self-administered (5 puffs in each nostril) by participants."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Control",
                                    "description": "Each participant will self-administer a 40 IU dose of intranasal saline.\n\nPlacebo: Each participant will self-administer a 40 IU dose of intranasal saline."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "32"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "35"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.89",
                                                    "spread": "2.63"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "3.08",
                                                    "spread": "2.71"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Stress Reactivity",
                            "description": "Salivary Cortisol (\u03bcg/dL). Greater cortisol levels are indicative of greater stress reactivity.",
                            "populationDescription": "Main outcomes analyses were limited to male participants.",
                            "reportingStatus": "POSTED",
                            "paramType": "MEAN",
                            "dispersionType": "Standard Deviation",
                            "unitOfMeasure": "\u03bcg/dL",
                            "timeFrame": "2 hours",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Oxytocin",
                                    "description": "Each participant will self-administer a 40 IU dose of intranasal oxytocin.\n\nOxytocin: One 40 IU dose of intranasal oxytocin will be self-administered (5 puffs in each nostril) by participants."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Control",
                                    "description": "Each participant will self-administer a 40 IU dose of intranasal saline.\n\nPlacebo: Each participant will self-administer a 40 IU dose of intranasal saline."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "32"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "35"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": ".14",
                                                    "spread": ".10"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": ".10",
                                                    "spread": ".10"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "adverseEventsModule": {
                    "frequencyThreshold": "0",
                    "timeFrame": "2 years",
                    "eventGroups": [
                        {
                            "id": "EG000",
                            "title": "Oxytocin",
                            "description": "Each participant will self-administer a 40 IU dose of intranasal oxytocin.\n\nOxytocin: One 40 IU dose of intranasal oxytocin will be self-administered (5 puffs in each nostril) by participants.",
                            "deathsNumAffected": 0,
                            "deathsNumAtRisk": 35,
                            "seriousNumAffected": 0,
                            "seriousNumAtRisk": 35,
                            "otherNumAffected": 0,
                            "otherNumAtRisk": 35
                        },
                        {
                            "id": "EG001",
                            "title": "Control",
                            "description": "Each participant will self-administer a 40 IU dose of intranasal saline.\n\nPlacebo: Each participant will self-administer a 40 IU dose of intranasal saline.",
                            "deathsNumAffected": 0,
                            "deathsNumAtRisk": 38,
                            "seriousNumAffected": 0,
                            "seriousNumAtRisk": 38,
                            "otherNumAffected": 0,
                            "otherNumAtRisk": 38
                        }
                    ]
                },
                "moreInfoModule": {
                    "certainAgreement": {
                        "piSponsorEmployee": false,
                        "restrictiveAgreement": false
                    },
                    "pointOfContact": {
                        "title": "Dr. Sudie Back",
                        "organization": "Medical University of South Carolina",
                        "email": "backs@musc.edu",
                        "phone": "843-792-5915"
                    }
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2023-11-09",
                    "modelPredictions": {
                        "bmiLimits": {
                            "minBmi": 0.0,
                            "maxBmi": 101.0
                        }
                    }
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D000019966",
                            "term": "Substance-Related Disorders"
                        },
                        {
                            "id": "D000000437",
                            "term": "Alcoholism"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D000064419",
                            "term": "Chemically-Induced Disorders"
                        },
                        {
                            "id": "D000001523",
                            "term": "Mental Disorders"
                        },
                        {
                            "id": "D000019973",
                            "term": "Alcohol-Related Disorders"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M3464",
                            "name": "Alcohol Drinking",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M21527",
                            "name": "Substance-Related Disorders",
                            "asFound": "Substance Use Disorders",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M3473",
                            "name": "Alcoholism",
                            "asFound": "Alcohol Use Disorder",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M29992",
                            "name": "Chemically-Induced Disorders",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M14163",
                            "name": "Psychotic Disorders",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M4505",
                            "name": "Mental Disorders",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M21532",
                            "name": "Alcohol-Related Disorders",
                            "relevance": "LOW"
                        },
                        {
                            "id": "T1303",
                            "name": "Chronic Graft Versus Host Disease",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BXM",
                            "name": "Behaviors and Mental Disorders"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        },
                        {
                            "abbrev": "BC25",
                            "name": "Substance Related Disorders"
                        },
                        {
                            "abbrev": "Rare",
                            "name": "Rare Diseases"
                        }
                    ]
                },
                "interventionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D000010121",
                            "term": "Oxytocin"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D000010120",
                            "term": "Oxytocics"
                        },
                        {
                            "id": "D000012102",
                            "term": "Reproductive Control Agents"
                        },
                        {
                            "id": "D000045505",
                            "term": "Physiological Effects of Drugs"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M3467",
                            "name": "Ethanol",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M12731",
                            "name": "Oxytocin",
                            "asFound": "Determined",
                            "relevance": "HIGH"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "Infe",
                            "name": "Anti-Infective Agents"
                        },
                        {
                            "abbrev": "CNSDep",
                            "name": "Central Nervous System Depressants"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Drugs and Chemicals"
                        },
                        {
                            "abbrev": "Repr",
                            "name": "Reproductive Control Agents"
                        }
                    ]
                }
            },
            "hasResults": true
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT01313351",
                    "orgStudyIdInfo": {
                        "id": "100310"
                    },
                    "organization": {
                        "fullName": "Lumos Diagnostics",
                        "class": "INDUSTRY"
                    },
                    "briefTitle": "RPS InflammaDry Detector\u2122 to Determine MMP-9 Levels in Tears",
                    "officialTitle": "A Clinical Evaluation of the RPS InflammaDry Detector's Sensitivity and Specificity Compared to the Clinical Diagnosis for Confirming Dry Eyes."
                },
                "statusModule": {
                    "statusVerifiedDate": "2022-11",
                    "overallStatus": "COMPLETED",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2010-11"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2011-10",
                        "type": "ACTUAL"
                    },
                    "completionDateStruct": {
                        "date": "2011-10",
                        "type": "ACTUAL"
                    },
                    "studyFirstSubmitDate": "2011-03-03",
                    "studyFirstSubmitQcDate": "2011-03-08",
                    "studyFirstPostDateStruct": {
                        "date": "2011-03-11",
                        "type": "ESTIMATED"
                    },
                    "resultsFirstSubmitDate": "2021-11-01",
                    "resultsFirstSubmitQcDate": "2022-01-11",
                    "resultsFirstPostDateStruct": {
                        "date": "2022-03-16",
                        "type": "ACTUAL"
                    },
                    "lastUpdateSubmitDate": "2022-11-11",
                    "lastUpdatePostDateStruct": {
                        "date": "2022-12-12",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR"
                    },
                    "leadSponsor": {
                        "name": "Rapid Pathogen Screening",
                        "class": "INDUSTRY"
                    }
                },
                "oversightModule": {
                    "oversightHasDmc": false,
                    "isFdaRegulatedDrug": false,
                    "isFdaRegulatedDevice": false
                },
                "descriptionModule": {
                    "briefSummary": "The RPS InflammaDry Detector\u2122 is intended to detect elevated MMP-9 in human tears to aid in the diagnosis of patients with signs or symptoms of dry eye disease, in conjunction with other methods of clinical evaluation.",
                    "detailedDescription": "The purpose of this clinical trial was to determine the sensitivity and specificity of InflammaDry compared with the clinical assessment of dry eyes.\n\nPatients were screened using clinical history and signs.\n\nClinical history was performed using the Ocular Surface Disease Index (OSDI) and evaluated for clinical signs:\n\n* positive vital staining of the ocular surface,\n* decreased tear breakup time (TBUT),\n* reduced corneal sensitivity, and\n* decreased functional visual acuity Last, an independent health care professional masked to the clinical evaluation was asked to analyze each InflammaDry test result, independently confirming each result."
                },
                "conditionsModule": {
                    "conditions": [
                        "Dry Eye"
                    ],
                    "keywords": [
                        "Dry eyes",
                        "Dysfunctional tear syndrome"
                    ]
                },
                "designModule": {
                    "studyType": "OBSERVATIONAL",
                    "patientRegistry": false,
                    "designInfo": {
                        "observationalModel": "COHORT",
                        "timePerspective": "PROSPECTIVE"
                    },
                    "enrollmentInfo": {
                        "count": 206,
                        "type": "ACTUAL"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "Device testing",
                            "description": "Tears were collected from subjects to apply to the RPS InflammaDry detector and were clinically evaluated.",
                            "interventionNames": [
                                "Device: RPS InflammaDry Detector\u2122"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "DEVICE",
                            "name": "RPS InflammaDry Detector\u2122",
                            "description": "A noninvasive immunoassay for detecting MMP-9 levels in tears",
                            "armGroupLabels": [
                                "Device testing"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "Sensitivity and Specificity of InflammaDry Detector Compared to Clinical Assessment at Confirming a Diagnosis of Dry Eyes.",
                            "description": "Patients were assessed for signs and Symptoms of Dry Eye using OSDI (Ocular Surface Disease Index), TBUT (Fluorescein Tear Break-up Time), Corneal fluorescein staining and Schirmer Tear Test and compared to the results of the tested device.\n\nSensitivity is the percentage of true positive cases correctly identified by the test, compared to clinical assessment.\n\nSpecificity is the percentage of true negative cases correctly identified by the test, compared to clinical assessment.",
                            "timeFrame": "15 minutes"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "INCLUSION CRITERIA\n\nPatients older than 18 years of age, who meet the following criteria related to the clinical history and signs will be enrolled:\n\nGroup 1: Clinical Dry Eyes\n\nClinical History Criteria\n\nAn Ocular Surface Disease Index (OSDI) of greater than or equal to 13 - \\[Appendix #2\\]\n\nClinical Signs Criteria - All of the following must be present\n\n1. Schirmer's Tear Test (with anesthesia) \\< 10 mm over 5 minutes\n2. Tear Film Break Up Time (TBUT) \\< 10 seconds\n3. Total Corneal Staining \u2265 1 \\[Appendix #1\\]\n\n   * At least 1/2 of all patients enrolled will have a Schirmer's Tear Test \\< 5 mm or demonstrate corneal staining \u2265 2 \\[Appendix #1\\]\n\nGroup 2: Clinical Normal Non-Dry Eyes\n\nClinical History Criteria\n\nAn Ocular Surface Disease Index (OSDI) of \\< 7 - \\[Appendix #2\\]\n\nClinical Signs Criteria - All 3 of the following must be present\n\n1. Schirmer's Tear Test (with anesthesia) \u2265 10 mm over 5 minutes\n2. Tear Film Break Up Time (TBUT) \u2265 10 seconds\n3. Total Corneal Staining = 0 \\[Appendix #1\\]\n\nEXCLUSION CRITERIA\n\n* Patients with allergy to corn starch, talcum powder, or dacron\n* Patients with prior eye injury, trauma, or ocular surgery within the previous 3 months\n* Patients with non-dry eye ocular inflammation, uveitis, history of herpetic keratitis or zoster keratitis\n* Patients with history of a recent ocular infection within the prior 1 month\n* Use of oral doxycycline or topical macrolides (AzaSite) within 1 month\n* Patients currently receiving, or received in the last 2 weeks of the study , certain medications including topical or systemic corticosteroids, topical or systemic Nonsteroidal (NSAIDs) therapy, topical cyclosporine, or other immunosuppressive therapy\n* Patients who are pregnant or lactating\n* Before initialization of the study, patients must not have used any topical medications, including artificial tears during the previous 2 hours\n* The use of Rigid-Gas permeable contact lenses or the use of soft-contact lenses within 1 month of the study",
                    "healthyVolunteers": true,
                    "sex": "ALL",
                    "minimumAge": "18 Years",
                    "stdAges": [
                        "ADULT",
                        "OLDER_ADULT"
                    ],
                    "studyPopulation": "Only patients who met the inclusion criteria were included in the study.",
                    "samplingMethod": "PROBABILITY_SAMPLE"
                },
                "contactsLocationsModule": {
                    "overallOfficials": [
                        {
                            "name": "Robert Sambursky, MD",
                            "affiliation": "Rapid Pathogen Screening, Inc.",
                            "role": "STUDY_DIRECTOR"
                        }
                    ],
                    "locations": [
                        {
                            "facility": "Manatee Sarasota Eye Clinic",
                            "city": "Bradenton",
                            "state": "Florida",
                            "zip": "34208",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 27.49893,
                                "lon": -82.57482
                            }
                        },
                        {
                            "facility": "Center for Excellence in Eye Care",
                            "city": "Miami",
                            "state": "Florida",
                            "zip": "33176",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 25.77427,
                                "lon": -80.19366
                            }
                        },
                        {
                            "facility": "St. John's Clinics",
                            "city": "Springfield",
                            "state": "Missouri",
                            "zip": "65804",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 37.21533,
                                "lon": -93.29824
                            }
                        },
                        {
                            "facility": "Ophthalmic Consultants of Long Island",
                            "city": "Lynbrook",
                            "state": "New York",
                            "zip": "11563",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.65483,
                                "lon": -73.6718
                            }
                        },
                        {
                            "facility": "Physician Eyecare of NY",
                            "city": "New York",
                            "state": "New York",
                            "zip": "10016",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.71427,
                                "lon": -74.00597
                            }
                        },
                        {
                            "facility": "Weill-Cornell Medical College",
                            "city": "New York",
                            "state": "New York",
                            "zip": "10021",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.71427,
                                "lon": -74.00597
                            }
                        },
                        {
                            "facility": "Black Hills Regional Eye Institute",
                            "city": "Rapid City",
                            "state": "South Dakota",
                            "zip": "57701",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 44.08054,
                                "lon": -103.23101
                            }
                        },
                        {
                            "facility": "William F. Davitt, III, MD",
                            "city": "El Paso",
                            "state": "Texas",
                            "zip": "79904-2037",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 31.75872,
                                "lon": -106.48693
                            }
                        }
                    ]
                },
                "referencesModule": {
                    "references": [
                        {
                            "pmid": "23307206",
                            "type": "DERIVED",
                            "citation": "Sambursky R, Davitt WF 3rd, Latkany R, Tauber S, Starr C, Friedberg M, Dirks MS, McDonald M. Sensitivity and specificity of a point-of-care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye. JAMA Ophthalmol. 2013 Jan;131(1):24-8. doi: 10.1001/jamaophthalmol.2013.561. Erratum In: JAMA Ophthalmol. 2013 Mar 1;131(3):364."
                        }
                    ]
                }
            },
            "resultsSection": {
                "participantFlowModule": {
                    "groups": [
                        {
                            "id": "FG000",
                            "title": "Device Testing",
                            "description": "Tears were collected from subjects to apply to the RPS InflammaDry detector and were clinically evaluated.\n\nRPS InflammaDry Detector\u2122: A noninvasive immunoassay for detecting MMP-9 levels in tears"
                        }
                    ],
                    "periods": [
                        {
                            "title": "Overall Study",
                            "milestones": [
                                {
                                    "type": "STARTED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "206"
                                        }
                                    ]
                                },
                                {
                                    "type": "COMPLETED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "206"
                                        }
                                    ]
                                },
                                {
                                    "type": "NOT COMPLETED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "baselineCharacteristicsModule": {
                    "groups": [
                        {
                            "id": "BG000",
                            "title": "InflammaDry Test",
                            "description": "Tears were collected from subjects to apply to the RPS InflammaDry detector and were clinically evaluated.\n\nRPS InflammaDry Detector\u2122: A noninvasive immunoassay for detecting MMP-9 levels in tears"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "BG000",
                                    "value": "206"
                                }
                            ]
                        }
                    ],
                    "measures": [
                        {
                            "title": "Age, Continuous",
                            "paramType": "MEAN",
                            "dispersionType": "FULL_RANGE",
                            "unitOfMeasure": "years",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "53",
                                                    "lowerLimit": "18",
                                                    "upperLimit": "88"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Sex: Female, Male",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "title": "Female",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "152"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Male",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "54"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Race/Ethnicity, Customized",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "title": "Race",
                                    "categories": [
                                        {
                                            "title": "White",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "136"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Black",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "11"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Hispanic",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "49"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Asian",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "9"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Other",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "1"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Region of Enrollment",
                            "paramType": "NUMBER",
                            "unitOfMeasure": "participants",
                            "classes": [
                                {
                                    "title": "United States",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "206"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "outcomeMeasuresModule": {
                    "outcomeMeasures": [
                        {
                            "type": "PRIMARY",
                            "title": "Sensitivity and Specificity of InflammaDry Detector Compared to Clinical Assessment at Confirming a Diagnosis of Dry Eyes.",
                            "description": "Patients were assessed for signs and Symptoms of Dry Eye using OSDI (Ocular Surface Disease Index), TBUT (Fluorescein Tear Break-up Time), Corneal fluorescein staining and Schirmer Tear Test and compared to the results of the tested device.\n\nSensitivity is the percentage of true positive cases correctly identified by the test, compared to clinical assessment.\n\nSpecificity is the percentage of true negative cases correctly identified by the test, compared to clinical assessment.",
                            "reportingStatus": "POSTED",
                            "paramType": "NUMBER",
                            "dispersionType": "95% Confidence Interval",
                            "unitOfMeasure": "percentage of cases",
                            "timeFrame": "15 minutes",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "InflammaDry Sensitivity",
                                    "description": "Percentage of True Positives when compared to Clinical Assessment"
                                },
                                {
                                    "id": "OG001",
                                    "title": "InflammaDry Specificity",
                                    "description": "Percentage of True Negatives when compared to Clinical Assessment"
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "143"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "63"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "85",
                                                    "lowerLimit": "77.6",
                                                    "upperLimit": "90.5"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "94",
                                                    "lowerLimit": "84.5",
                                                    "upperLimit": "98.2"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "adverseEventsModule": {
                    "frequencyThreshold": "0",
                    "timeFrame": "15 minutes",
                    "description": "Regular monitoring by sponsor and mandatory reporting by investigator",
                    "eventGroups": [
                        {
                            "id": "EG000",
                            "title": "Device Testing",
                            "description": "As reported by user",
                            "seriousNumAffected": 0,
                            "seriousNumAtRisk": 206,
                            "otherNumAffected": 0,
                            "otherNumAtRisk": 206
                        }
                    ]
                },
                "moreInfoModule": {
                    "certainAgreement": {
                        "piSponsorEmployee": false,
                        "restrictionType": "OTHER",
                        "restrictiveAgreement": true,
                        "otherDetails": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release."
                    },
                    "pointOfContact": {
                        "title": "Robert Sambursky, MD",
                        "organization": "Rapid Pathogen Screening, Inc",
                        "email": "rob.sambursky@lumosdiagnostics.com",
                        "phone": "9415581853"
                    }
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2023-11-09",
                    "modelPredictions": {
                        "bmiLimits": {
                            "minBmi": 0.0,
                            "maxBmi": 101.0
                        }
                    }
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D000015352",
                            "term": "Dry Eye Syndromes"
                        },
                        {
                            "id": "D000007638",
                            "term": "Keratoconjunctivitis Sicca"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D000007766",
                            "term": "Lacrimal Apparatus Diseases"
                        },
                        {
                            "id": "D000005128",
                            "term": "Eye Diseases"
                        },
                        {
                            "id": "D000007637",
                            "term": "Keratoconjunctivitis"
                        },
                        {
                            "id": "D000003231",
                            "term": "Conjunctivitis"
                        },
                        {
                            "id": "D000003229",
                            "term": "Conjunctival Diseases"
                        },
                        {
                            "id": "D000007634",
                            "term": "Keratitis"
                        },
                        {
                            "id": "D000003316",
                            "term": "Corneal Diseases"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M16045",
                            "name": "Syndrome",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M9708",
                            "name": "Hypersensitivity",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M17730",
                            "name": "Dry Eye Syndromes",
                            "asFound": "Dry Eye",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M10354",
                            "name": "Keratoconjunctivitis Sicca",
                            "asFound": "Dry Eye",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M14931",
                            "name": "Rupture",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M22475",
                            "name": "Lacerations",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M10353",
                            "name": "Keratoconjunctivitis",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M10476",
                            "name": "Lacrimal Apparatus Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M7961",
                            "name": "Eye Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M6145",
                            "name": "Conjunctivitis",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M6143",
                            "name": "Conjunctival Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M10350",
                            "name": "Keratitis",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M6229",
                            "name": "Corneal Diseases",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BC23",
                            "name": "Symptoms and General Pathology"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        },
                        {
                            "abbrev": "BC20",
                            "name": "Immune System Diseases"
                        },
                        {
                            "abbrev": "BC11",
                            "name": "Eye Diseases"
                        },
                        {
                            "abbrev": "BC26",
                            "name": "Wounds and Injuries"
                        }
                    ]
                }
            },
            "hasResults": true
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT01379651",
                    "orgStudyIdInfo": {
                        "id": "FBFBN"
                    },
                    "organization": {
                        "fullName": "Ospedale Buon Consiglio Fatebenefratelli",
                        "class": "OTHER"
                    },
                    "briefTitle": "Time-limited Specific Oral Tolerance Induction in Children With Severe Egg Allergy",
                    "officialTitle": "Specific Oral Tolerance Induction in Children With Severe Egg Allergy: A Randomized Controlled Trial Using a 6 Months Protocol",
                    "acronym": "EGGSOTI"
                },
                "statusModule": {
                    "statusVerifiedDate": "2011-09",
                    "overallStatus": "COMPLETED",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2008-01"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2010-06",
                        "type": "ACTUAL"
                    },
                    "completionDateStruct": {
                        "date": "2010-06",
                        "type": "ACTUAL"
                    },
                    "studyFirstSubmitDate": "2011-06-20",
                    "studyFirstSubmitQcDate": "2011-06-22",
                    "studyFirstPostDateStruct": {
                        "date": "2011-06-23",
                        "type": "ESTIMATED"
                    },
                    "resultsFirstSubmitDate": "2011-06-24",
                    "resultsFirstSubmitQcDate": "2011-08-01",
                    "resultsFirstPostDateStruct": {
                        "date": "2011-08-30",
                        "type": "ESTIMATED"
                    },
                    "lastUpdateSubmitDate": "2011-09-19",
                    "lastUpdatePostDateStruct": {
                        "date": "2011-09-20",
                        "type": "ESTIMATED"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "PRINCIPAL_INVESTIGATOR",
                        "investigatorFullName": "Iride Dello Iacono",
                        "investigatorTitle": "pediatrician",
                        "investigatorAffiliation": "Ospedale Buon Consiglio Fatebenefratelli"
                    },
                    "leadSponsor": {
                        "name": "Ospedale Buon Consiglio Fatebenefratelli",
                        "class": "OTHER"
                    }
                },
                "oversightModule": {
                    "oversightHasDmc": true
                },
                "descriptionModule": {
                    "briefSummary": "To evaluate the efficacy of a 6-month specific oral tolerance induction (SOTI) protocol in inducing tolerance (maximal dose of raw egg emulsion tolerated) in children with severe IgE-mediated egg allergy and a history of at least 1 anaphylactic reaction after accidental exposure to egg.",
                    "detailedDescription": "Oral immunotherapy consisted in the administration of increasing amounts of raw emulsion egg. The children started with 1 drop of undiluted raw egg emulsion (0.05 ml) flavored with vanilla and cacao, hidden by the parents in the child's breakfast (cow's milk, soymilk, fruit juice or other). The dose was doubled at intervals of about one month in the day hospital. The increases in dose were customized for each subject based on the frequency and severity of side effects, or when an inter-current illness or asthma worsening intervened during the SOTI.\n\nThe investigators limited the SOTI protocol to six months for all patients, irrespective of the dose reached, in order to favor the adherence of families to the study.\n\nWhen objective symptoms seemed more important (grade 2, 3 and 4 reaction), medical treatment was given. Subjects were discontinued from the study in case of severe adverse reactions (grade 5 reaction). Parents were advised they could telephone investigators 24 hours a day"
                },
                "conditionsModule": {
                    "conditions": [
                        "- Egg Hypersensitivity"
                    ],
                    "keywords": [
                        "Egg allergy,specific oral tolerance induction"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "PHASE1",
                        "PHASE2"
                    ],
                    "designInfo": {
                        "allocation": "RANDOMIZED",
                        "interventionModel": "SINGLE_GROUP",
                        "primaryPurpose": "TREATMENT",
                        "maskingInfo": {
                            "masking": "NONE"
                        }
                    },
                    "enrollmentInfo": {
                        "count": 20,
                        "type": "ACTUAL"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "Specific oral tolerance induction",
                            "type": "EXPERIMENTAL",
                            "description": "Specific oral tolerance induction consisted in the administration of increasing amounts of food antigen",
                            "interventionNames": [
                                "Other: Specific oral tolerance induction"
                            ]
                        },
                        {
                            "label": "control",
                            "type": "NO_INTERVENTION",
                            "description": "controls were kept on an egg-free diet for 6 months"
                        }
                    ],
                    "interventions": [
                        {
                            "type": "OTHER",
                            "name": "Specific oral tolerance induction",
                            "description": "Specific oral tolerance induction consisted in the administration of increasing amounts of raw emulsion egg",
                            "armGroupLabels": [
                                "Specific oral tolerance induction"
                            ],
                            "otherNames": [
                                "SOTI"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "Number of Children That Achieved Total (40 ml) or Partial (Less Than 40 ml But at Least 10 ml) Tolerance to Raw Egg",
                            "description": "To evaluate the efficacy of a 6-month Specific Oral Tolerance Induction (SOTI) protocol in inducing tolerance (maximal dose of raw egg emulsion tolerated after 6 months) in children with severe IgE-mediated egg allergy and a history of at least 1 anaphylactic reaction after accidental exposure to egg.",
                            "timeFrame": "baseline and 6 months"
                        }
                    ],
                    "secondaryOutcomes": [
                        {
                            "measure": "Changes in the Median Weal Diameter, Using Egg White SPTs, End-point SPT and PP",
                            "description": "Before and after SOTI, we evaluated the change in the median weal diameter in millimeters, using egg white SPTs, end-point SPT and PP.",
                            "timeFrame": "Baseline and 6 months"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n* at least 1 anaphylactic reaction (grade 3, 4 and 5 according to Sampson's grading after accidental exposure to trace amounts of egg or egg-derivative products, requiring emergency treatment, at least 1 year before enrollment\n* demonstration of egg white specific IgE by the skin prick test (SPT), end-point SPT, raw egg white prick-by-prick (PP) and egg white-specific IgE determination\n* positive double-blind placebo-controlled food challenge (DBPCFC) at a dose of less than 0.9 ml of raw emulsion egg\n\nExclusion Criteria:\n\n* age below 5 years\n* poorly controlled asthma\n* parents with a history of unreliable management of complications and treatment.",
                    "healthyVolunteers": false,
                    "sex": "ALL",
                    "minimumAge": "5 Years",
                    "maximumAge": "11 Years",
                    "stdAges": [
                        "CHILD"
                    ]
                },
                "contactsLocationsModule": {
                    "overallOfficials": [
                        {
                            "name": "Iride Dello Iacono, pediatrician",
                            "affiliation": "Unit of Pediatrics, Fatebenefratelli Hospital, Benevento, Italy",
                            "role": "STUDY_DIRECTOR"
                        }
                    ],
                    "locations": [
                        {
                            "facility": "Unit of Pediatrics, Fatebenefratelli Hospital",
                            "city": "Benevento",
                            "zip": "82100",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 41.1307,
                                "lon": 14.77816
                            }
                        }
                    ]
                },
                "referencesModule": {
                    "references": [
                        {
                            "pmid": "20355360",
                            "type": "BACKGROUND",
                            "citation": "Calvani M, Giorgio V, Miceli Sopo S. Specific oral tolerance induction for food. A systematic review. Eur Ann Allergy Clin Immunol. 2010 Feb;42(1):11-9."
                        },
                        {
                            "pmid": "12777599",
                            "type": "BACKGROUND",
                            "citation": "Sampson HA. Anaphylaxis and emergency treatment. Pediatrics. 2003 Jun;111(6 Pt 3):1601-8."
                        },
                        {
                            "pmid": "16455349",
                            "type": "BACKGROUND",
                            "citation": "Sicherer SH, Sampson HA. 9. Food allergy. J Allergy Clin Immunol. 2006 Feb;117(2 Suppl Mini-Primer):S470-5. doi: 10.1016/j.jaci.2005.05.048."
                        },
                        {
                            "pmid": "19076011",
                            "type": "BACKGROUND",
                            "citation": "Barbi E, Berti I, Longo G. Food allergy: from the of loss of tolerance induced by exclusion diets to specific oral tolerance induction. Recent Pat Inflamm Allergy Drug Discov. 2008 Nov;2(3):212-4. doi: 10.2174/187221308786241875."
                        }
                    ]
                }
            },
            "resultsSection": {
                "participantFlowModule": {
                    "preAssignmentDetails": "6 children(4 males and 2 females)were excluded from the study: one child because the parents had a history of unreliable management of complications and treatments;2 children because of poorly controlled asthma;3 children because of a positive double-blind placebo-controlled food challenge (DBPCFC) at a dose of raw egg emulsion higher than 0.9 ml.",
                    "recruitmentDetails": "26 children (14 boys, 12 girls; median age: 7 years 7 months; range 5-11 years), with severe IgE-mediated egg allergy (EA) were recruited from the Pediatric and Allergology Unit of the Fatebenefratelli Hospital in Benevento, Italy, from January 2008 to December 2009.",
                    "groups": [
                        {
                            "id": "FG000",
                            "title": "Specific Oral Tolerance Induction",
                            "description": "Specific oral tolerance induction consisted in the administration of increasing amounts of food antigen"
                        },
                        {
                            "id": "FG001",
                            "title": "Control",
                            "description": "controls were kept on an egg-free diet for 6 months"
                        }
                    ],
                    "periods": [
                        {
                            "title": "Overall Study",
                            "milestones": [
                                {
                                    "type": "STARTED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "10"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "10"
                                        }
                                    ]
                                },
                                {
                                    "type": "COMPLETED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "10"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "10"
                                        }
                                    ]
                                },
                                {
                                    "type": "NOT COMPLETED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "0"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "baselineCharacteristicsModule": {
                    "groups": [
                        {
                            "id": "BG000",
                            "title": "Specific Oral Tolerance Induction",
                            "description": "Specific oral tolerance induction consisted in the administration of increasing amounts of food antigen"
                        },
                        {
                            "id": "BG001",
                            "title": "Control",
                            "description": "controls were kept on an egg-free diet for 6 months"
                        },
                        {
                            "id": "BG002",
                            "title": "Total",
                            "description": "Total of all reporting groups"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "BG000",
                                    "value": "10"
                                },
                                {
                                    "groupId": "BG001",
                                    "value": "10"
                                },
                                {
                                    "groupId": "BG002",
                                    "value": "20"
                                }
                            ]
                        }
                    ],
                    "measures": [
                        {
                            "title": "Age, Categorical",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "title": "<=18 years",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "10"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "10"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "20"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Between 18 and 65 years",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "0"
                                                }
                                            ]
                                        },
                                        {
                                            "title": ">=65 years",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "0"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Age Continuous",
                            "paramType": "MEAN",
                            "dispersionType": "STANDARD_DEVIATION",
                            "unitOfMeasure": "years",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "7.033",
                                                    "spread": "1.768"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "7.676",
                                                    "spread": "3.203"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "7.354",
                                                    "spread": "2.607"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Sex: Female, Male",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "title": "Female",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "5"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "5"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "10"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Male",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "5"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "5"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "10"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Region of Enrollment",
                            "paramType": "NUMBER",
                            "unitOfMeasure": "participants",
                            "classes": [
                                {
                                    "title": "Italy",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "10"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "10"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "20"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "outcomeMeasuresModule": {
                    "outcomeMeasures": [
                        {
                            "type": "PRIMARY",
                            "title": "Number of Children That Achieved Total (40 ml) or Partial (Less Than 40 ml But at Least 10 ml) Tolerance to Raw Egg",
                            "description": "To evaluate the efficacy of a 6-month Specific Oral Tolerance Induction (SOTI) protocol in inducing tolerance (maximal dose of raw egg emulsion tolerated after 6 months) in children with severe IgE-mediated egg allergy and a history of at least 1 anaphylactic reaction after accidental exposure to egg.",
                            "reportingStatus": "POSTED",
                            "paramType": "NUMBER",
                            "unitOfMeasure": "participants",
                            "timeFrame": "baseline and 6 months",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Specific Oral Tolerance Induction",
                                    "description": "Specific oral tolerance induction consisted in the administration of increasing amounts of food antigen"
                                },
                                {
                                    "id": "OG001",
                                    "title": "Control",
                                    "description": "controls were kept on an egg-free diet for 6 months"
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "10"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "10"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "9"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "0"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Changes in the Median Weal Diameter, Using Egg White SPTs, End-point SPT and PP",
                            "description": "Before and after SOTI, we evaluated the change in the median weal diameter in millimeters, using egg white SPTs, end-point SPT and PP.",
                            "populationDescription": "We were unable to calculate sample size because no quantitative data about the clinical outcome could be hypothesized. Indeed, the few reports of food causing allergy, the protocol, the way of SOTI administration and food doses administered yielded reported variable results. the analysis was per intention to treat",
                            "reportingStatus": "POSTED",
                            "paramType": "MEDIAN",
                            "dispersionType": "Full Range",
                            "unitOfMeasure": "mm diameter",
                            "timeFrame": "Baseline and 6 months",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Specific Oral Tolerance Induction",
                                    "description": "Specific oral tolerance induction consisted in the administration of increasing amounts of food antigen"
                                },
                                {
                                    "id": "OG001",
                                    "title": "Control",
                                    "description": "controls were kept on an egg-free diet for 6 months"
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "10"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "10"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "5",
                                                    "lowerLimit": "4",
                                                    "upperLimit": "13"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "10",
                                                    "lowerLimit": "5.5",
                                                    "upperLimit": "15"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "adverseEventsModule": {
                    "frequencyThreshold": "0",
                    "timeFrame": "6 month",
                    "eventGroups": [
                        {
                            "id": "EG000",
                            "title": "Specific Oral Tolerance Induction",
                            "description": "Specific oral tolerance induction consisted in the administration of increasing amounts of food antigen",
                            "seriousNumAffected": 0,
                            "seriousNumAtRisk": 10,
                            "otherNumAffected": 10,
                            "otherNumAtRisk": 10
                        },
                        {
                            "id": "EG001",
                            "title": "Control",
                            "description": "controls were kept on an egg-free diet for 6 months",
                            "seriousNumAffected": 0,
                            "seriousNumAtRisk": 10,
                            "otherNumAffected": 3,
                            "otherNumAtRisk": 10
                        }
                    ],
                    "otherEvents": [
                        {
                            "term": "Allergic reaction",
                            "organSystem": "Immune system disorders",
                            "sourceVocabulary": "allergic reaction",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 53,
                                    "numAffected": 10,
                                    "numAtRisk": 10
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 5,
                                    "numAffected": 3,
                                    "numAtRisk": 10
                                }
                            ]
                        }
                    ]
                },
                "moreInfoModule": {
                    "certainAgreement": {
                        "piSponsorEmployee": true,
                        "restrictiveAgreement": false
                    },
                    "pointOfContact": {
                        "title": "Dr. Iride Dello Iacono",
                        "organization": "Unit of Pediatrics, Fatebenefratelli Hospital, Benevento, Italy",
                        "email": "iridedello@hotmail.com",
                        "phone": "+39 824 771111"
                    }
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2023-11-09",
                    "modelPredictions": {
                        "bmiLimits": {
                            "minBmi": 0.0,
                            "maxBmi": 101.0
                        }
                    }
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D000006967",
                            "term": "Hypersensitivity"
                        },
                        {
                            "id": "D000021181",
                            "term": "Egg Hypersensitivity"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D000007154",
                            "term": "Immune System Diseases"
                        },
                        {
                            "id": "D000005512",
                            "term": "Food Hypersensitivity"
                        },
                        {
                            "id": "D000006969",
                            "term": "Hypersensitivity, Immediate"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M9708",
                            "name": "Hypersensitivity",
                            "asFound": "Hypersensitivity",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M22399",
                            "name": "Egg Hypersensitivity",
                            "asFound": "Egg Hypersensitivity",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M9890",
                            "name": "Immune System Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M8326",
                            "name": "Food Hypersensitivity",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M9710",
                            "name": "Hypersensitivity, Immediate",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BC20",
                            "name": "Immune System Diseases"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        }
                    ]
                }
            },
            "hasResults": true
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT01574651",
                    "orgStudyIdInfo": {
                        "id": "CQVA149ADE01"
                    },
                    "secondaryIdInfos": [
                        {
                            "id": "2011-004870-26",
                            "type": "EUDRACT_NUMBER"
                        }
                    ],
                    "organization": {
                        "fullName": "Novartis",
                        "class": "INDUSTRY"
                    },
                    "briefTitle": "The Effect of QVA149 on Health Related Quality of Life in Patients With Chronic Obstructive Pulmonary Disease (COPD)",
                    "officialTitle": "A 26-week Treatment, Multicenter, Randomized, Parallel Group, Blinded Study to Assess the Efficacy and Safety of QVA149 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease Using Tiotropium Plus Formoterol as Control",
                    "acronym": "QUANTIFY"
                },
                "statusModule": {
                    "statusVerifiedDate": "2014-05",
                    "overallStatus": "COMPLETED",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2012-05"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2013-04",
                        "type": "ACTUAL"
                    },
                    "completionDateStruct": {
                        "date": "2013-04",
                        "type": "ACTUAL"
                    },
                    "studyFirstSubmitDate": "2012-04-06",
                    "studyFirstSubmitQcDate": "2012-04-06",
                    "studyFirstPostDateStruct": {
                        "date": "2012-04-10",
                        "type": "ESTIMATED"
                    },
                    "resultsFirstSubmitDate": "2014-03-27",
                    "resultsFirstSubmitQcDate": "2014-03-27",
                    "resultsFirstPostDateStruct": {
                        "date": "2014-04-29",
                        "type": "ESTIMATED"
                    },
                    "lastUpdateSubmitDate": "2014-05-19",
                    "lastUpdatePostDateStruct": {
                        "date": "2014-05-22",
                        "type": "ESTIMATED"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR"
                    },
                    "leadSponsor": {
                        "name": "Novartis Pharmaceuticals",
                        "class": "INDUSTRY"
                    }
                },
                "oversightModule": {
                    "oversightHasDmc": false
                },
                "descriptionModule": {
                    "briefSummary": "This study will assess the efficacy and safety of QVA149 compared to tiotropium plus formoterol in patients with moderate to severe COPD."
                },
                "conditionsModule": {
                    "conditions": [
                        "Chronic Obstructive Pulmonary Disease (COPD)"
                    ],
                    "keywords": [
                        "QVA149",
                        "Health related quality of life",
                        "Formoterol",
                        "Tiotropium",
                        "COPD"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "PHASE3"
                    ],
                    "designInfo": {
                        "allocation": "RANDOMIZED",
                        "interventionModel": "PARALLEL",
                        "primaryPurpose": "TREATMENT",
                        "maskingInfo": {
                            "masking": "DOUBLE",
                            "whoMasked": [
                                "PARTICIPANT",
                                "INVESTIGATOR"
                            ]
                        }
                    },
                    "enrollmentInfo": {
                        "count": 934,
                        "type": "ACTUAL"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "QVA149 plus placebo to tiotropium and placebo to formoterol",
                            "type": "EXPERIMENTAL",
                            "description": "QVA149 110/50\u00b5g, once daily for inhalation use plus placebo to tiotropium, once daily for inhalation use and placebo to formoterol, twice daily for inhalation use.",
                            "interventionNames": [
                                "Drug: QVA149",
                                "Drug: Placebo to tiotropium",
                                "Drug: Placebo to formoterol"
                            ]
                        },
                        {
                            "label": "Tiotropium plus Formoterol and placebo to QVA149",
                            "type": "ACTIVE_COMPARATOR",
                            "description": "Tiotropium 18\u00b5g, once daily for inhalation use plus Formoterol 12\u00b5g, twice daily for inhalation use and placebo to QVA149, once daily for inhalation use.",
                            "interventionNames": [
                                "Drug: Tiotropium",
                                "Drug: Formoterol",
                                "Drug: Placebo to QVA149"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "DRUG",
                            "name": "QVA149",
                            "description": "QVA149 110/50\u00b5g, once daily (q.d.) is administered via a single-dose dry powder inhaler",
                            "armGroupLabels": [
                                "QVA149 plus placebo to tiotropium and placebo to formoterol"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "Placebo to tiotropium",
                            "description": "Placebo to tiotropium capsules daily (q.d.) for inhalation, delivered via proprietary inhaler (Handihaler\u00ae). Placebo tiotropium inhalation capsules were matched in size and color to tiotropium 18 \u03bcg q.d. inhalation capsules",
                            "armGroupLabels": [
                                "QVA149 plus placebo to tiotropium and placebo to formoterol"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "Placebo to formoterol",
                            "description": "Placebo to formoterol capsules twice daily (b.i.d) delivered via Aerolizer\u00ae device. Placebo formoterol inhalation capsules were equally matched in size, shape and color to formoterol 12 \u03bcg b.i.d. inhalation capsules.",
                            "armGroupLabels": [
                                "QVA149 plus placebo to tiotropium and placebo to formoterol"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "Tiotropium",
                            "description": "Tiotropium 18\u00b5g, once daily is administered via the manufacturer's proprietary inhalation device.",
                            "armGroupLabels": [
                                "Tiotropium plus Formoterol and placebo to QVA149"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "Formoterol",
                            "description": "Formoterol 12\u00b5g, twice daily is administered via the manufacturer's proprietary inhalation device.",
                            "armGroupLabels": [
                                "Tiotropium plus Formoterol and placebo to QVA149"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "Placebo to QVA149",
                            "description": "Placebo to QVA149 is administered via a single-dose dry powder inhaler. Placebo QVA149 inhalation capsules were equally matched in size, shape and color to QVA149 110/50 \u03bcg q.d. inhalation capsules",
                            "armGroupLabels": [
                                "Tiotropium plus Formoterol and placebo to QVA149"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "St. George's Respiratory Questionnaire (SGRQ-C) Total Score After 26 Weeks of Treatment (Non-inferiority Analysis).",
                            "description": "SGRQ is a health related quality of life questionnaire consisting of 40 items in three areas: symptoms (respiratory symptoms and severity), activity (activities that cause or are limited by breathlessness) and impacts (social functioning and psychological disturbances due to airway disease). The total score is 0 to 100 with a higher score indicating poorer health status. For patients who completed the study but with missing SGRQ-C during treatment, the missing SGRQ-C were replaced by the last observation carried forward (LOCF). Symptom scores were expected to improve over treatment, therefore the replacement of missing values with earlier measurements did not result in overoptimistic imputation and this procedure could be regarded as conservative.",
                            "timeFrame": "Baseline, week 26"
                        }
                    ],
                    "secondaryOutcomes": [
                        {
                            "measure": "St. George's Respiratory Questionnaire (SGRQ-C) Total Score After 26 Weeks of Treatment (Superiority Analysis).",
                            "description": "SGRQ is a health related quality of life questionnaire consisting of 40 items in three areas: symptoms (respiratory symptoms and severity), activity (activities that cause or are limited by breathlessness) and impacts (social functioning and psychological disturbances due to airway disease). The total score is 0 to 100 with a higher score indicating poorer health status. For patients who completed the study but with missing SGRQ-C during treatment, the missing SGRQ-C were replaced by the last observation carried forward (LOCF). Symptom scores were expected to improve over treatment, therefore the replacement of missing values with earlier measurements did not result in overoptimistic imputation and this procedure could be regarded as conservative. Superiority of QVA 110/50 \u03bcg to tiotropium 18 \u03bcg q.d. plus formoterol 12 \u03bcg b.i.d. in terms of health related quality of life as assessed by St George's Respiratory Questionnaire (SGRQ-C) after 26 weeks of treatment",
                            "timeFrame": "Baseline, week 26"
                        },
                        {
                            "measure": "Transition Dyspnea Index (TDI) Focal Score After 26 Weeks of Treatment.",
                            "description": "Baseline Dyspnea Index (BDI)/Transition Dyspnea Index (TDI) focal score is based on three domains: functional impairment, magnitude of task and magnitude of effort and captures changes from baseline. BDI was measured at day 1 prior to the first dose with domain scores ranging from 0=very severe to 4=no impairment and a total score ranging from 0 to 12(best). TDI captures changes from baseline. Each domain is scored from -3=major deterioration to 3=major improvement to give an overall TDI focal score of -9 to 9. Higher numbers indicate a better score. missing values were replaced by the latest observed value (LOCF)",
                            "timeFrame": "Week 26"
                        },
                        {
                            "measure": "Percent of Participants With at Least One Exacerbation Requiring Systemic Corticosteroids and/or Antibiotics Over 26 Weeks",
                            "description": "The percent of participants with at least one moderate exacerbation within the 26 weeks that required systemic corticosteroids and/or antibiotics during the treatment",
                            "timeFrame": "Week 26"
                        },
                        {
                            "measure": "Percent of Participants With at Least One Exacerbation Requiring Hospitalization",
                            "description": "The percent of patients with at least one severe exacerbation within the 26 weeks that required hospitalization. COPD exacerbations were considered to be severe if hospitalization were required.",
                            "timeFrame": "Week 26"
                        },
                        {
                            "measure": "Time- Event Analysis, Number of Participants With at Least One COPD Exacerbation (Moderate or Severe) During the Treatment Period",
                            "description": "The number of participants with at least one moderate or severe COPD exacerbation. COPD exacerbations are considered to be moderate if treatment with systemic corticosteroids and/or antibiotics was required. COPD exacerbations are considered to be severe if hospitalizations were required.",
                            "timeFrame": "Week 26"
                        },
                        {
                            "measure": "Trough FEV1 at Baseline and Week 26",
                            "description": "Trough FEV1 is the mean value of FEV1 (forced expiratory volume in one second) measured at 23:15h and 23:45h after the morning doses. The baseline value was measured at day 1 prior to the first dose.",
                            "timeFrame": "Baseline, Week 26"
                        },
                        {
                            "measure": "FEV1 30 Min After the Morning Dose at Baseline and Week 26",
                            "description": "FEV1 30min is the forced expiratory volume in one second measured 30 min after the morning dose.",
                            "timeFrame": "Baseline, Week 26"
                        },
                        {
                            "measure": "Symptoms Score Reported by the Patients Using Part I \"Symptoms\" of SGRO-C",
                            "description": "Part I of the SGRQ-C covers \"symptoms\" and is concerned with respiratory symptoms, their frequency and severity. Each questionnaire response has a unique empirically derived \"weight\". A score was calculated from these weights. The lowest possible value is zero and the highest 100. A higher value corresponds to greater impairment of health status.",
                            "timeFrame": "Baseline, Week 26"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n* Male or female adults aged \u2265 40 yrs\n* Patients with moderate to severe chronic obstructive pulmonary disease (GOLD 2010 guidelines)\n* Smoking history of at least 10 pack years\n* Post-bronchodilator FEV1 \\< 80% and \u226530% of the predicted normal value and post-bronchodilator FEV1/FVC (forced vital capacity) \\<70%\n\nExclusion Criteria:\n\n* Pregnant women or nursing mothers or women of child-bearing potential not using adequate contraception\n* Patients with a history of long QT syndrome\n* Patients with Type I or uncontrolled Type II diabetes\n* Patients who have had a COPD exacerbation or respiratory tract infection within 6 weeks prior to screening\n* Patients with any history of asthma\n* Patients with pulmonary lobectomy, lung volume reduction surgery, or lung transplantation\n* Patients with concomitant pulmonary disease\n* Patients requiring long term oxygen therapy (\\>15 h a day)\n\nOther protocol-defined inclusion/exclusion criteria may apply.",
                    "healthyVolunteers": false,
                    "sex": "ALL",
                    "minimumAge": "40 Years",
                    "stdAges": [
                        "ADULT",
                        "OLDER_ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "overallOfficials": [
                        {
                            "name": "Novartis Pharmaceuticals",
                            "affiliation": "Novartis Pharmaceuticals",
                            "role": "STUDY_DIRECTOR"
                        }
                    ],
                    "locations": [
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Koblenz",
                            "state": "NRW",
                            "zip": "56068",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 50.35357,
                                "lon": 7.57883
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Cottbus",
                            "state": "Sachsen",
                            "zip": "03050",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.75769,
                                "lon": 14.32888
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Aschaffenburg",
                            "zip": "63739",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 49.97704,
                                "lon": 9.15214
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Augsburg",
                            "zip": "86156",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 48.37154,
                                "lon": 10.89851
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Bad Neustadt",
                            "zip": "97616",
                            "country": "Germany"
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Bad Woerishofen",
                            "zip": "86825",
                            "country": "Germany"
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Bamberg",
                            "zip": "96049",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 49.89873,
                                "lon": 10.90067
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Bensheim",
                            "zip": "64625",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 49.68369,
                                "lon": 8.61839
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Bergisch Gladbach",
                            "zip": "51429",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 50.9856,
                                "lon": 7.13298
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Berlin",
                            "zip": "10115",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 52.52437,
                                "lon": 13.41053
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Berlin",
                            "zip": "10367",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 52.52437,
                                "lon": 13.41053
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Berlin",
                            "zip": "10717",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 52.52437,
                                "lon": 13.41053
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Berlin",
                            "zip": "10789",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 52.52437,
                                "lon": 13.41053
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Berlin",
                            "zip": "10969",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 52.52437,
                                "lon": 13.41053
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Berlin",
                            "zip": "12043",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 52.52437,
                                "lon": 13.41053
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Berlin",
                            "zip": "12099",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 52.52437,
                                "lon": 13.41053
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Berlin",
                            "zip": "12165",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 52.52437,
                                "lon": 13.41053
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Berlin",
                            "zip": "12203",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 52.52437,
                                "lon": 13.41053
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Berlin",
                            "zip": "12687",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 52.52437,
                                "lon": 13.41053
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Berlin",
                            "zip": "13057",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 52.52437,
                                "lon": 13.41053
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Berlin",
                            "zip": "13086",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 52.52437,
                                "lon": 13.41053
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Berlin",
                            "zip": "13156",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 52.52437,
                                "lon": 13.41053
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Berlin",
                            "zip": "13465",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 52.52437,
                                "lon": 13.41053
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Berlin",
                            "zip": "13507",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 52.52437,
                                "lon": 13.41053
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Berlin",
                            "zip": "14050",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 52.52437,
                                "lon": 13.41053
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Berlin",
                            "zip": "14059",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 52.52437,
                                "lon": 13.41053
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Bielefeld",
                            "zip": "33617",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 52.03333,
                                "lon": 8.53333
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Bochum",
                            "zip": "44787",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.48165,
                                "lon": 7.21648
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Bonn",
                            "zip": "53119",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 50.73438,
                                "lon": 7.09549
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Bonn",
                            "zip": "53123",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 50.73438,
                                "lon": 7.09549
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Borna",
                            "zip": "04552",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.12416,
                                "lon": 12.49639
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Chemnitz",
                            "zip": "09130",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 50.8357,
                                "lon": 12.92922
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Delitzsch",
                            "zip": "04509",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.52546,
                                "lon": 12.34284
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Donaustauf",
                            "zip": "93093",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 49.03258,
                                "lon": 12.20459
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Dortmund",
                            "zip": "44135",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.51494,
                                "lon": 7.466
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Dresden",
                            "zip": "01069",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.05089,
                                "lon": 13.73832
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Dresden",
                            "zip": "01307",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.05089,
                                "lon": 13.73832
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Dueren",
                            "zip": "52349",
                            "country": "Germany"
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Duisburg",
                            "zip": "47057",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.43247,
                                "lon": 6.76516
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "D\u00fcsseldorf",
                            "zip": "40489",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.22172,
                                "lon": 6.77616
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Eggenfelden",
                            "zip": "84307",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 48.40509,
                                "lon": 12.75752
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Eisenach",
                            "zip": "99817",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 50.9807,
                                "lon": 10.31522
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Erlangen",
                            "zip": "91052",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 49.59099,
                                "lon": 11.00783
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Eschwege",
                            "zip": "37269",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.18386,
                                "lon": 10.05329
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Essen",
                            "zip": "45138",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.45657,
                                "lon": 7.01228
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Essen",
                            "zip": "45276",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.45657,
                                "lon": 7.01228
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Euskirchen",
                            "zip": "53879",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 50.66057,
                                "lon": 6.78722
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Forchheim",
                            "zip": "91301",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 49.71754,
                                "lon": 11.05877
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Frankfurt",
                            "zip": "60389",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 50.11552,
                                "lon": 8.68417
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Frankfurt",
                            "zip": "60596",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 50.11552,
                                "lon": 8.68417
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Fulda",
                            "zip": "36039",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 50.55162,
                                "lon": 9.67518
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Gauting",
                            "zip": "82131",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 48.06919,
                                "lon": 11.37703
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Geesthacht",
                            "zip": "22502",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 53.43575,
                                "lon": 10.3779
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Gelnhausen",
                            "zip": "63571",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 50.20164,
                                "lon": 9.18742
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Gelsenkirchen",
                            "zip": "45879",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.50508,
                                "lon": 7.09655
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Grosshansdorf",
                            "zip": "22947",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 53.66667,
                                "lon": 10.28333
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Gummersbach",
                            "zip": "51643",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.02608,
                                "lon": 7.56473
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "G\u00f6ttingen",
                            "zip": "37075",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.53443,
                                "lon": 9.93228
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "G\u00fcstrow",
                            "zip": "18273",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 53.7972,
                                "lon": 12.17337
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Hagen",
                            "zip": "59065",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.36081,
                                "lon": 7.47168
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Halberstadt",
                            "zip": "38820",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.89562,
                                "lon": 11.05622
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Halle",
                            "zip": "06108",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.48159,
                                "lon": 11.97948
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Hamburg",
                            "zip": "20354",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 53.57532,
                                "lon": 10.01534
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Hamburg",
                            "zip": "20357",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 53.57532,
                                "lon": 10.01534
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Hamburg",
                            "zip": "22299",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 53.57532,
                                "lon": 10.01534
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Hamburg",
                            "zip": "22527",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 53.57532,
                                "lon": 10.01534
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Hannover M\u00fcnden",
                            "zip": "34346",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 52.37052,
                                "lon": 9.73322
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Hannover",
                            "zip": "30163",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 52.37052,
                                "lon": 9.73322
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Hannover",
                            "zip": "30317",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 52.37052,
                                "lon": 9.73322
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Hannover",
                            "zip": "30419",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 52.37052,
                                "lon": 9.73322
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Heidelberg",
                            "zip": "69115",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 49.40768,
                                "lon": 8.69079
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Heidelberg",
                            "zip": "69117",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 49.40768,
                                "lon": 8.69079
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Hettstedt",
                            "zip": "06333",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.6503,
                                "lon": 11.51146
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Hildesheim",
                            "zip": "31134",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 52.15077,
                                "lon": 9.95112
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "H\u00f6chstadt",
                            "zip": "91315",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 49.70617,
                                "lon": 10.81329
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Kamenz",
                            "zip": "01917",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.26798,
                                "lon": 14.09374
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Kamen",
                            "zip": "59174",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.59231,
                                "lon": 7.6638
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Kassel",
                            "zip": "34121",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.31667,
                                "lon": 9.5
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Koeln",
                            "zip": "51069",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 50.93333,
                                "lon": 6.95
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Krefeld",
                            "zip": "47798",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.33645,
                                "lon": 6.55382
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "K\u00f6ln",
                            "zip": "51605",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 50.93333,
                                "lon": 6.95
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Landsberg",
                            "zip": "86899",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.52698,
                                "lon": 12.16076
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Leipzig",
                            "zip": "04103",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.33962,
                                "lon": 12.37129
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Leipzig",
                            "zip": "04207",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.33962,
                                "lon": 12.37129
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Leipzig",
                            "zip": "04275",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.33962,
                                "lon": 12.37129
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Leipzig",
                            "zip": "04357",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.33962,
                                "lon": 12.37129
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Luedenscheid",
                            "zip": "58507",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.21977,
                                "lon": 7.6273
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "L\u00fcbeck",
                            "zip": "23558",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 53.86893,
                                "lon": 10.68729
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Mainz",
                            "zip": "55116",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 49.98419,
                                "lon": 8.2791
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Mainz",
                            "zip": "55131",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 49.98419,
                                "lon": 8.2791
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Mannheim",
                            "zip": "68165",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 49.4891,
                                "lon": 8.46694
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Marburg",
                            "zip": "35037",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 50.80904,
                                "lon": 8.77069
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Menden",
                            "zip": "58706",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.44337,
                                "lon": 7.77825
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Minden",
                            "zip": "32423",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 52.28953,
                                "lon": 8.91455
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Muenchen",
                            "zip": "80539",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.60698,
                                "lon": 13.31243
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Muenchen",
                            "zip": "81677",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.60698,
                                "lon": 13.31243
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "M\u00fcnchen",
                            "zip": "80335",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 48.13743,
                                "lon": 11.57549
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "M\u00fcnster",
                            "zip": "48145",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.96236,
                                "lon": 7.62571
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "M\u00fcnster",
                            "zip": "48147",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.96236,
                                "lon": 7.62571
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Neu Isenburg",
                            "zip": "63263",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 50.04832,
                                "lon": 8.69406
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Neu-Ulm",
                            "zip": "89231",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 48.39279,
                                "lon": 10.01112
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Neum\u00fcnster",
                            "zip": "24534",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 54.07477,
                                "lon": 9.98195
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Neunkirchen",
                            "zip": "66539",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 49.34449,
                                "lon": 7.18045
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Neuruppin",
                            "zip": "16816",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 52.92815,
                                "lon": 12.80311
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Neuss",
                            "zip": "41462",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.19807,
                                "lon": 6.68504
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Oranienburg",
                            "zip": "16515",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 52.75577,
                                "lon": 13.24197
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Oschatz",
                            "zip": "04758",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.30001,
                                "lon": 13.10984
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Oschersleben",
                            "zip": "39387",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 52.03039,
                                "lon": 11.22898
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Osnabr\u00fcck",
                            "zip": "49074",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 52.27264,
                                "lon": 8.0498
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Peine",
                            "zip": "31224",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 52.31928,
                                "lon": 10.2352
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Potsdam",
                            "zip": "14467",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 52.39886,
                                "lon": 13.06566
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Potsdam",
                            "zip": "14469",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 52.39886,
                                "lon": 13.06566
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Potsdam",
                            "zip": "14478",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 52.39886,
                                "lon": 13.06566
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Prien a. Chiemsee",
                            "zip": "83209",
                            "country": "Germany"
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Radebeul",
                            "zip": "01445",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.10654,
                                "lon": 13.66047
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Rathenow",
                            "zip": "14712",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 52.60659,
                                "lon": 12.33696
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Ratingen",
                            "zip": "40878",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.29724,
                                "lon": 6.84929
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Reinfeld",
                            "zip": "23858",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 53.83184,
                                "lon": 10.49126
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Rheine",
                            "zip": "48431",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 52.28509,
                                "lon": 7.44055
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Roth",
                            "zip": "91154",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 49.24762,
                                "lon": 11.09111
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "R\u00fcdersdorf",
                            "zip": "15562",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.1,
                                "lon": 11.45
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "R\u00fcsselsheim",
                            "zip": "65428",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 49.98955,
                                "lon": 8.42251
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Saarbruecken",
                            "zip": "66111",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 49.23262,
                                "lon": 7.0098
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Saarlouis",
                            "zip": "66740",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 49.31366,
                                "lon": 6.75154
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Schleswig",
                            "zip": "24837",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 54.52156,
                                "lon": 9.5586
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Schwabach",
                            "zip": "91126",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 49.33047,
                                "lon": 11.02346
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Siegen",
                            "zip": "57072",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 50.87481,
                                "lon": 8.02431
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Singen",
                            "zip": "76224",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 47.75935,
                                "lon": 8.8403
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Solingen",
                            "zip": "42651",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.17343,
                                "lon": 7.0845
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Solingen",
                            "zip": "42665",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.17343,
                                "lon": 7.0845
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Sonneberg",
                            "zip": "96515",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 50.3592,
                                "lon": 11.17463
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Stade",
                            "zip": "21680",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 53.59337,
                                "lon": 9.47629
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Teterow",
                            "zip": "17166",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 53.77545,
                                "lon": 12.57487
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Teuchern",
                            "zip": "06682",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.12094,
                                "lon": 12.0241
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Ulm",
                            "zip": "89073",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 48.39841,
                                "lon": 9.99155
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "V\u00f6hringen",
                            "zip": "89269",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 48.27839,
                                "lon": 10.08236
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Wedel",
                            "zip": "22880",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 53.58374,
                                "lon": 9.69835
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Weyhe",
                            "zip": "28844",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 52.96667,
                                "lon": 8.66667
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Wiesloch",
                            "zip": "69168",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 49.29504,
                                "lon": 8.69846
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Wissen",
                            "zip": "57537",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 50.77915,
                                "lon": 7.73466
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Witten",
                            "zip": "58452",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.44362,
                                "lon": 7.35258
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Wuppertal",
                            "zip": "42117",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.27027,
                                "lon": 7.16755
                            }
                        },
                        {
                            "facility": "Novartis Investigative Site",
                            "city": "Zerbst",
                            "zip": "39261",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.9662,
                                "lon": 12.08517
                            }
                        }
                    ]
                }
            },
            "resultsSection": {
                "participantFlowModule": {
                    "groups": [
                        {
                            "id": "FG000",
                            "title": "QVA149 Plus Placebo to Tiotropium and Placebo to Formoterol",
                            "description": "QVA149 110/50\u00b5g, once daily for inhalation use plus placebo to tiotropium, once daily for inhalation use and placebo to formoterol, twice daily for inhalation use."
                        },
                        {
                            "id": "FG001",
                            "title": "Tiotropium Plus Formoterol and Placebo to QVA149",
                            "description": "Tiotropium 18\u00b5g, once daily for inhalation use plus Formoterol 12\u00b5g, twice daily for inhalation use and placebo to QVA149, once daily for inhalation use."
                        }
                    ],
                    "periods": [
                        {
                            "title": "Overall Study",
                            "milestones": [
                                {
                                    "type": "STARTED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "476"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "458"
                                        }
                                    ]
                                },
                                {
                                    "type": "Full Analysis Set (FAS)",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "476"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "458"
                                        }
                                    ]
                                },
                                {
                                    "type": "Per Protocol Set (PPS)",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "373"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "374"
                                        }
                                    ]
                                },
                                {
                                    "type": "COMPLETED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "415"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "406"
                                        }
                                    ]
                                },
                                {
                                    "type": "NOT COMPLETED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "61"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "52"
                                        }
                                    ]
                                }
                            ],
                            "dropWithdraws": [
                                {
                                    "type": "Lost to Follow-up",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "2"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "4"
                                        }
                                    ]
                                },
                                {
                                    "type": "Administrative problems",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "0"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "1"
                                        }
                                    ]
                                },
                                {
                                    "type": "Death",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "3"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "3"
                                        }
                                    ]
                                },
                                {
                                    "type": "Patient's inability to use the device",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "0"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "1"
                                        }
                                    ]
                                },
                                {
                                    "type": "Adverse Event",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "36"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "27"
                                        }
                                    ]
                                },
                                {
                                    "type": "Abnormal laboratory value(s)",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "1"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "0"
                                        }
                                    ]
                                },
                                {
                                    "type": "Abnormal test procedure result(s)",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "1"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "1"
                                        }
                                    ]
                                },
                                {
                                    "type": "Unsatisfactory therapeutic effect",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "6"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "0"
                                        }
                                    ]
                                },
                                {
                                    "type": "Protocol Violation",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "3"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "5"
                                        }
                                    ]
                                },
                                {
                                    "type": "Withdrawal by Subject",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "9"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "10"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "baselineCharacteristicsModule": {
                    "groups": [
                        {
                            "id": "BG000",
                            "title": "QVA149 Plus Placebo to Tiotropium and Placebo to Formoterol",
                            "description": "QVA149 110/50\u00b5g, once daily for inhalation use plus placebo to tiotropium, once daily for inhalation use and placebo to formoterol, twice daily for inhalation use."
                        },
                        {
                            "id": "BG001",
                            "title": "Tiotropium Plus Formoterol and Placebo to QVA149",
                            "description": "Tiotropium 18\u00b5g, once daily for inhalation use plus Formoterol 12\u00b5g, twice daily for inhalation use and placebo to QVA149, once daily for inhalation use."
                        },
                        {
                            "id": "BG002",
                            "title": "Total",
                            "description": "Total of all reporting groups"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "BG000",
                                    "value": "476"
                                },
                                {
                                    "groupId": "BG001",
                                    "value": "458"
                                },
                                {
                                    "groupId": "BG002",
                                    "value": "934"
                                }
                            ]
                        }
                    ],
                    "measures": [
                        {
                            "title": "Age, Continuous",
                            "paramType": "MEAN",
                            "dispersionType": "STANDARD_DEVIATION",
                            "unitOfMeasure": "Years",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "62.6",
                                                    "spread": "8.43"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "63.1",
                                                    "spread": "8.15"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "62.9",
                                                    "spread": "8.29"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Sex: Female, Male",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "title": "Female",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "159"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "160"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "319"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Male",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "317"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "298"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "615"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "outcomeMeasuresModule": {
                    "outcomeMeasures": [
                        {
                            "type": "PRIMARY",
                            "title": "St. George's Respiratory Questionnaire (SGRQ-C) Total Score After 26 Weeks of Treatment (Non-inferiority Analysis).",
                            "description": "SGRQ is a health related quality of life questionnaire consisting of 40 items in three areas: symptoms (respiratory symptoms and severity), activity (activities that cause or are limited by breathlessness) and impacts (social functioning and psychological disturbances due to airway disease). The total score is 0 to 100 with a higher score indicating poorer health status. For patients who completed the study but with missing SGRQ-C during treatment, the missing SGRQ-C were replaced by the last observation carried forward (LOCF). Symptom scores were expected to improve over treatment, therefore the replacement of missing values with earlier measurements did not result in overoptimistic imputation and this procedure could be regarded as conservative.",
                            "populationDescription": "Full analysis set (FAS): all randomized patients who received at least one dose of randomized study drug. Following the ITT principle, patients were analyzed according to the treatment they were assigned to. The FAS was used for all efficacy variables unless otherwise stated.",
                            "reportingStatus": "POSTED",
                            "paramType": "MEAN",
                            "dispersionType": "Standard Deviation",
                            "unitOfMeasure": "Score on a scale",
                            "timeFrame": "Baseline, week 26",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "QVA149 Plus Placebo to Tiotropium and Placebo to Formoterol",
                                    "description": "QVA149 110/50\u00b5g, once daily for inhalation use plus placebo to tiotropium, once daily for inhalation use and placebo to formoterol, twice daily for inhalation use."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Tiotropium Plus Formoterol and Placebo to QVA149",
                                    "description": "Tiotropium 18\u00b5g, once daily for inhalation use plus Formoterol 12\u00b5g, twice daily for inhalation use and placebo to QVA149, once daily for inhalation use."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "476"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "458"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "title": "Baseline (n=452,441)",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "44.70",
                                                    "spread": "17.718"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "45.68",
                                                    "spread": "17.720"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Week 26 (n=475,456)",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "41.30",
                                                    "spread": "19.923"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "43.19",
                                                    "spread": "19.284"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "St. George's Respiratory Questionnaire (SGRQ-C) Total Score After 26 Weeks of Treatment (Superiority Analysis).",
                            "description": "SGRQ is a health related quality of life questionnaire consisting of 40 items in three areas: symptoms (respiratory symptoms and severity), activity (activities that cause or are limited by breathlessness) and impacts (social functioning and psychological disturbances due to airway disease). The total score is 0 to 100 with a higher score indicating poorer health status. For patients who completed the study but with missing SGRQ-C during treatment, the missing SGRQ-C were replaced by the last observation carried forward (LOCF). Symptom scores were expected to improve over treatment, therefore the replacement of missing values with earlier measurements did not result in overoptimistic imputation and this procedure could be regarded as conservative. Superiority of QVA 110/50 \u03bcg to tiotropium 18 \u03bcg q.d. plus formoterol 12 \u03bcg b.i.d. in terms of health related quality of life as assessed by St George's Respiratory Questionnaire (SGRQ-C) after 26 weeks of treatment",
                            "populationDescription": "Full analysis set (FAS): all randomized patients who received at least one dose of randomized study drug. Following the ITT principle, patients were analyzed according to the treatment they were assigned to. The FAS was used for all efficacy variables unless otherwise stated",
                            "reportingStatus": "POSTED",
                            "paramType": "MEAN",
                            "dispersionType": "Standard Deviation",
                            "unitOfMeasure": "Score on a scale",
                            "timeFrame": "Baseline, week 26",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "QVA149 Plus Placebo to Tiotropium and Placebo to Formoterol",
                                    "description": "QVA149 110/50\u00b5g, once daily for inhalation use plus placebo to tiotropium, once daily for inhalation use and placebo to formoterol, twice daily for inhalation use."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Tiotropium Plus Formoterol and Placebo to QVA149",
                                    "description": "Tiotropium 18\u00b5g, once daily for inhalation use plus Formoterol 12\u00b5g, twice daily for inhalation use and placebo to QVA149, once daily for inhalation use."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "476"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "458"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "title": "Baseline (n=452,441)",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "44.70",
                                                    "spread": "17.718"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "45.68",
                                                    "spread": "17.720"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Week 26 (n=475,456)",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "41.30",
                                                    "spread": "19.923"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "43.19",
                                                    "spread": "19.284"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Transition Dyspnea Index (TDI) Focal Score After 26 Weeks of Treatment.",
                            "description": "Baseline Dyspnea Index (BDI)/Transition Dyspnea Index (TDI) focal score is based on three domains: functional impairment, magnitude of task and magnitude of effort and captures changes from baseline. BDI was measured at day 1 prior to the first dose with domain scores ranging from 0=very severe to 4=no impairment and a total score ranging from 0 to 12(best). TDI captures changes from baseline. Each domain is scored from -3=major deterioration to 3=major improvement to give an overall TDI focal score of -9 to 9. Higher numbers indicate a better score. missing values were replaced by the latest observed value (LOCF)",
                            "populationDescription": "Full analysis set (FAS): all randomized patients who received at least one dose of randomized study drug. Following the ITT principle, patients were analyzed according to the treatment they were assigned to. The FAS was used for all efficacy variables unless otherwise stated",
                            "reportingStatus": "POSTED",
                            "paramType": "MEAN",
                            "dispersionType": "Standard Deviation",
                            "unitOfMeasure": "Units on a scale",
                            "timeFrame": "Week 26",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "QVA149 Plus Placebo to Tiotropium and Placebo to Formoterol",
                                    "description": "QVA149 110/50\u00b5g, once daily for inhalation use plus placebo to tiotropium, once daily for inhalation use and placebo to formoterol, twice daily for inhalation use."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Tiotropium Plus Formoterol and Placebo to QVA149",
                                    "description": "Tiotropium 18\u00b5g, once daily for inhalation use plus Formoterol 12\u00b5g, twice daily for inhalation use and placebo to QVA149, once daily for inhalation use."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "462"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "443"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "1.34",
                                                    "spread": "3.440"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "0.87",
                                                    "spread": "3.439"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Percent of Participants With at Least One Exacerbation Requiring Systemic Corticosteroids and/or Antibiotics Over 26 Weeks",
                            "description": "The percent of participants with at least one moderate exacerbation within the 26 weeks that required systemic corticosteroids and/or antibiotics during the treatment",
                            "populationDescription": "Full analysis set (FAS): all randomized patients who received at least one dose of randomized study drug. Following the ITT principle, patients were analyzed according to the treatment they were assigned to. The FAS was used for all efficacy variables unless otherwise stated",
                            "reportingStatus": "POSTED",
                            "paramType": "NUMBER",
                            "unitOfMeasure": "Percent of participants",
                            "timeFrame": "Week 26",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "QVA149 Plus Placebo to Tiotropium and Placebo to Formoterol",
                                    "description": "QVA149 110/50\u00b5g, once daily for inhalation use plus placebo to tiotropium, once daily for inhalation use and placebo to formoterol, twice daily for inhalation use."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Tiotropium Plus Formoterol and Placebo to QVA149",
                                    "description": "Tiotropium 18\u00b5g, once daily for inhalation use plus Formoterol 12\u00b5g, twice daily for inhalation use and placebo to QVA149, once daily for inhalation use."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "476"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "458"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "10.9"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "13.3"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Percent of Participants With at Least One Exacerbation Requiring Hospitalization",
                            "description": "The percent of patients with at least one severe exacerbation within the 26 weeks that required hospitalization. COPD exacerbations were considered to be severe if hospitalization were required.",
                            "populationDescription": "Full analysis set (FAS): all randomized patients who received at least one dose of randomized study drug. Following the ITT principle, patients were analyzed according to the treatment they were assigned to. The FAS was used for all efficacy variables unless otherwise stated",
                            "reportingStatus": "POSTED",
                            "paramType": "NUMBER",
                            "unitOfMeasure": "Percent of participants",
                            "timeFrame": "Week 26",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "QVA149 Plus Placebo to Tiotropium and Placebo to Formoterol",
                                    "description": "QVA149 110/50\u00b5g, once daily for inhalation use plus placebo to tiotropium, once daily for inhalation use and placebo to formoterol, twice daily for inhalation use."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Tiotropium Plus Formoterol and Placebo to QVA149",
                                    "description": "Tiotropium 18\u00b5g, once daily for inhalation use plus Formoterol 12\u00b5g, twice daily for inhalation use and placebo to QVA149, once daily for inhalation use."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "476"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "458"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.1"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "2.4"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Time- Event Analysis, Number of Participants With at Least One COPD Exacerbation (Moderate or Severe) During the Treatment Period",
                            "description": "The number of participants with at least one moderate or severe COPD exacerbation. COPD exacerbations are considered to be moderate if treatment with systemic corticosteroids and/or antibiotics was required. COPD exacerbations are considered to be severe if hospitalizations were required.",
                            "populationDescription": "Full analysis set (FAS): all randomized patients who received at least one dose of randomized study drug. Following the ITT principle, patients were analyzed according to the treatment they were assigned to. The FAS was used for all efficacy variables unless otherwise stated",
                            "reportingStatus": "POSTED",
                            "paramType": "NUMBER",
                            "unitOfMeasure": "Participants",
                            "timeFrame": "Week 26",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "QVA149 Plus Placebo to Tiotropium and Placebo to Formoterol",
                                    "description": "QVA149 110/50\u00b5g, once daily for inhalation use plus placebo to tiotropium, once daily for inhalation use and placebo to formoterol, twice daily for inhalation use."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Tiotropium Plus Formoterol and Placebo to QVA149",
                                    "description": "Tiotropium 18\u00b5g, once daily for inhalation use plus Formoterol 12\u00b5g, twice daily for inhalation use and placebo to QVA149, once daily for inhalation use."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "476"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "458"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "62"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "70"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Trough FEV1 at Baseline and Week 26",
                            "description": "Trough FEV1 is the mean value of FEV1 (forced expiratory volume in one second) measured at 23:15h and 23:45h after the morning doses. The baseline value was measured at day 1 prior to the first dose.",
                            "populationDescription": "Full analysis set (FAS): all randomized patients who received at least one dose of randomized study drug. Following the ITT principle, patients were analyzed according to the treatment they were assigned to. The FAS was used for all efficacy variables unless otherwise stated",
                            "reportingStatus": "POSTED",
                            "paramType": "MEAN",
                            "dispersionType": "Standard Deviation",
                            "unitOfMeasure": "Liters",
                            "timeFrame": "Baseline, Week 26",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "QVA149 Plus Placebo to Tiotropium and Placebo to Formoterol",
                                    "description": "QVA149 110/50\u00b5g, once daily for inhalation use plus placebo to tiotropium, once daily for inhalation use and placebo to formoterol, twice daily for inhalation use."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Tiotropium Plus Formoterol and Placebo to QVA149",
                                    "description": "Tiotropium 18\u00b5g, once daily for inhalation use plus Formoterol 12\u00b5g, twice daily for inhalation use and placebo to QVA149, once daily for inhalation use."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "476"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "458"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "title": "Baseline",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "1.329",
                                                    "spread": "0.4806"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "1.313",
                                                    "spread": "0.4525"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Week 26",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "1.495",
                                                    "spread": "0.5060"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "1.409",
                                                    "spread": "0.4878"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "FEV1 30 Min After the Morning Dose at Baseline and Week 26",
                            "description": "FEV1 30min is the forced expiratory volume in one second measured 30 min after the morning dose.",
                            "populationDescription": "Full analysis set (FAS): all randomized patients who received at least one dose of randomized study drug. Following the ITT principle, patients were analyzed according to the treatment they were assigned to. The FAS was used for all efficacy variables unless otherwise stated",
                            "reportingStatus": "POSTED",
                            "paramType": "MEAN",
                            "dispersionType": "Standard Deviation",
                            "unitOfMeasure": "Liters",
                            "timeFrame": "Baseline, Week 26",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "QVA149 Plus Placebo to Tiotropium and Placebo to Formoterol",
                                    "description": "QVA149 110/50\u00b5g, once daily for inhalation use plus placebo to tiotropium, once daily for inhalation use and placebo to formoterol, twice daily for inhalation use."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Tiotropium Plus Formoterol and Placebo to QVA149",
                                    "description": "Tiotropium 18\u00b5g, once daily for inhalation use plus Formoterol 12\u00b5g, twice daily for inhalation use and placebo to QVA149, once daily for inhalation use."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "476"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "458"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "title": "Baseline (n=475,458)",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "1.517",
                                                    "spread": "0.5025"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "1.495",
                                                    "spread": "0.4860"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Week 26 (n=476,458)",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "1.605",
                                                    "spread": "0.5356"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "1.565",
                                                    "spread": "0.5124"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Symptoms Score Reported by the Patients Using Part I \"Symptoms\" of SGRO-C",
                            "description": "Part I of the SGRQ-C covers \"symptoms\" and is concerned with respiratory symptoms, their frequency and severity. Each questionnaire response has a unique empirically derived \"weight\". A score was calculated from these weights. The lowest possible value is zero and the highest 100. A higher value corresponds to greater impairment of health status.",
                            "populationDescription": "Full analysis set (FAS): all randomized patients who received at least one dose of randomized study drug. Following the ITT principle, patients were analyzed according to the treatment they were assigned to. The FAS was used for all efficacy variables unless otherwise stated",
                            "reportingStatus": "POSTED",
                            "paramType": "MEAN",
                            "dispersionType": "Standard Deviation",
                            "unitOfMeasure": "Score on a scale",
                            "timeFrame": "Baseline, Week 26",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "QVA149 Plus Placebo to Tiotropium and Placebo to Formoterol",
                                    "description": "QVA149 110/50\u00b5g, once daily for inhalation use plus placebo to tiotropium, once daily for inhalation use and placebo to formoterol, twice daily for inhalation use."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Tiotropium Plus Formoterol and Placebo to QVA149",
                                    "description": "Tiotropium 18\u00b5g, once daily for inhalation use plus Formoterol 12\u00b5g, twice daily for inhalation use and placebo to QVA149, once daily for inhalation use."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "476"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "458"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "title": "Baseline (n=473,457)",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "64.10",
                                                    "spread": "19.884"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "64.29",
                                                    "spread": "19.768"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Week 26 (n=476,458)",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "58.31",
                                                    "spread": "21.764"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "60.16",
                                                    "spread": "20.678"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "adverseEventsModule": {
                    "frequencyThreshold": "3",
                    "eventGroups": [
                        {
                            "id": "EG000",
                            "title": "QVA149 Plus Placebo to Tiotropium and Placebo to Formoterol",
                            "description": "QVA149 110/50\u00b5g, once daily for inhalation use plus placebo to tiotropium, once daily for inhalation use and placebo to formoterol, twice daily for inhalation use.",
                            "seriousNumAffected": 30,
                            "seriousNumAtRisk": 476,
                            "otherNumAffected": 72,
                            "otherNumAtRisk": 476
                        },
                        {
                            "id": "EG001",
                            "title": "Tiotropium Plus Formoterol and Placebo to QVA149",
                            "description": "Tiotropium 18\u00b5g, once daily for inhalation use plus Formoterol 12\u00b5g, twice daily for inhalation use and placebo to QVA149, once daily for inhalation use.",
                            "seriousNumAffected": 24,
                            "seriousNumAtRisk": 458,
                            "otherNumAffected": 79,
                            "otherNumAtRisk": 458
                        }
                    ],
                    "seriousEvents": [
                        {
                            "term": "Acute myocardial infarction",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Atrial flutter",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Cardiac arrest",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Cardiac failure",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Cardiac failure chronic",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Congestive cardiomyopathy",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Cor pulmonale",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Myocardial infarction",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 3,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Myocarditis",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Stress cardiomyopathy",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Tachycardia",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Amblyopia",
                            "organSystem": "Eye disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Cataract cortical",
                            "organSystem": "Eye disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Cataract nuclear",
                            "organSystem": "Eye disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Diplopia",
                            "organSystem": "Eye disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Visual acuity reduced",
                            "organSystem": "Eye disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Inguinal hernia",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Intestinal polyp",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Cardiac death",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Death",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Cholecystitis",
                            "organSystem": "Hepatobiliary disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Anaphylactic reaction",
                            "organSystem": "Immune system disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Drug hypersensitivity",
                            "organSystem": "Immune system disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Gastroenteritis",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Pneumonia",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 4,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Cervical vertebral fracture",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Chest injury",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Contusion",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Humerus fracture",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Joint injury",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Rib fracture",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 2,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Road traffic accident",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Spinal fracture",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Back pain",
                            "organSystem": "Musculoskeletal and connective tissue disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Cervical spinal stenosis",
                            "organSystem": "Musculoskeletal and connective tissue disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Intervertebral disc protrusion",
                            "organSystem": "Musculoskeletal and connective tissue disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 2,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Osteochondrosis",
                            "organSystem": "Musculoskeletal and connective tissue disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Rhabdomyolysis",
                            "organSystem": "Musculoskeletal and connective tissue disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Spinal column stenosis",
                            "organSystem": "Musculoskeletal and connective tissue disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Synovitis",
                            "organSystem": "Musculoskeletal and connective tissue disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Breast cancer",
                            "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Lung neoplasm malignant",
                            "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Oesophageal carcinoma",
                            "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Oropharyngeal cancer stage unspecified",
                            "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Brain injury",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Cerebral ischaemia",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Cerebrovascular accident",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Myoclonus",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Nystagmus",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Depression",
                            "organSystem": "Psychiatric disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Haematuria",
                            "organSystem": "Renal and urinary disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Renal failure",
                            "organSystem": "Renal and urinary disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Dyspnoea",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 3,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Haemothorax",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Pneumothorax",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Pulmonary embolism",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 2,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Respiratory failure",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Inguinal hernia repair",
                            "organSystem": "Surgical and medical procedures",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Laryngeal fistula repair",
                            "organSystem": "Surgical and medical procedures",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Mastectomy",
                            "organSystem": "Surgical and medical procedures",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Umbilical hernia repair",
                            "organSystem": "Surgical and medical procedures",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Peripheral arterial occlusive disease",
                            "organSystem": "Vascular disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 458
                                }
                            ]
                        }
                    ],
                    "otherEvents": [
                        {
                            "term": "Nasopharyngitis",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 42,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 53,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Cough",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 26,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 20,
                                    "numAtRisk": 458
                                }
                            ]
                        },
                        {
                            "term": "Dyspnoea",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "16.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 9,
                                    "numAtRisk": 476
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 15,
                                    "numAtRisk": 458
                                }
                            ]
                        }
                    ]
                },
                "moreInfoModule": {
                    "certainAgreement": {
                        "piSponsorEmployee": false,
                        "restrictionType": "OTHER",
                        "restrictiveAgreement": true,
                        "otherDetails": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety"
                    },
                    "pointOfContact": {
                        "title": "Study Director",
                        "organization": "Novartis Pharnaceuticals",
                        "email": "trialandresults.registries@novartis.com",
                        "phone": "862-778-8300"
                    }
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2023-11-09",
                    "modelPredictions": {
                        "bmiLimits": {
                            "minBmi": 0.0,
                            "maxBmi": 101.0
                        }
                    }
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D000008171",
                            "term": "Lung Diseases"
                        },
                        {
                            "id": "D000008173",
                            "term": "Lung Diseases, Obstructive"
                        },
                        {
                            "id": "D000029424",
                            "term": "Pulmonary Disease, Chronic Obstructive"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D000012140",
                            "term": "Respiratory Tract Diseases"
                        },
                        {
                            "id": "D000002908",
                            "term": "Chronic Disease"
                        },
                        {
                            "id": "D000020969",
                            "term": "Disease Attributes"
                        },
                        {
                            "id": "D000010335",
                            "term": "Pathologic Processes"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M10860",
                            "name": "Lung Diseases, Obstructive",
                            "asFound": "Obstructive Pulmonary Disease",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M23139",
                            "name": "Pulmonary Disease, Chronic Obstructive",
                            "asFound": "Chronic Obstructive Pulmonary Disease",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M10858",
                            "name": "Lung Diseases",
                            "asFound": "Pulmonary Disease",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M14667",
                            "name": "Respiratory Tract Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M5837",
                            "name": "Chronic Disease",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M22390",
                            "name": "Disease Attributes",
                            "relevance": "LOW"
                        },
                        {
                            "id": "T1303",
                            "name": "Chronic Graft Versus Host Disease",
                            "relevance": "LOW"
                        },
                        {
                            "id": "T6034",
                            "name": "Quality of Life",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BC08",
                            "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        },
                        {
                            "abbrev": "BC23",
                            "name": "Symptoms and General Pathology"
                        },
                        {
                            "abbrev": "Rare",
                            "name": "Rare Diseases"
                        },
                        {
                            "abbrev": "BXM",
                            "name": "Behaviors and Mental Disorders"
                        }
                    ]
                },
                "interventionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D000006024",
                            "term": "Glycopyrrolate"
                        },
                        {
                            "id": "D000068759",
                            "term": "Formoterol Fumarate"
                        },
                        {
                            "id": "D000069447",
                            "term": "Tiotropium Bromide"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D000001993",
                            "term": "Bronchodilator Agents"
                        },
                        {
                            "id": "D000001337",
                            "term": "Autonomic Agents"
                        },
                        {
                            "id": "D000018373",
                            "term": "Peripheral Nervous System Agents"
                        },
                        {
                            "id": "D000045505",
                            "term": "Physiological Effects of Drugs"
                        },
                        {
                            "id": "D000018927",
                            "term": "Anti-Asthmatic Agents"
                        },
                        {
                            "id": "D000019141",
                            "term": "Respiratory System Agents"
                        },
                        {
                            "id": "D000058666",
                            "term": "Adrenergic beta-2 Receptor Agonists"
                        },
                        {
                            "id": "D000000318",
                            "term": "Adrenergic beta-Agonists"
                        },
                        {
                            "id": "D000000322",
                            "term": "Adrenergic Agonists"
                        },
                        {
                            "id": "D000018663",
                            "term": "Adrenergic Agents"
                        },
                        {
                            "id": "D000018377",
                            "term": "Neurotransmitter Agents"
                        },
                        {
                            "id": "D000045504",
                            "term": "Molecular Mechanisms of Pharmacological Action"
                        },
                        {
                            "id": "D000010276",
                            "term": "Parasympatholytics"
                        },
                        {
                            "id": "D000018680",
                            "term": "Cholinergic Antagonists"
                        },
                        {
                            "id": "D000018678",
                            "term": "Cholinergic Agents"
                        },
                        {
                            "id": "D000000759",
                            "term": "Adjuvants, Anesthesia"
                        },
                        {
                            "id": "D000018727",
                            "term": "Muscarinic Antagonists"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M304",
                            "name": "Formoterol Fumarate",
                            "asFound": "Calcium",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M416",
                            "name": "Tiotropium Bromide",
                            "asFound": "Cell Transplantation",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M8820",
                            "name": "Glycopyrrolate",
                            "asFound": "Laser System",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M4931",
                            "name": "Bromides",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M4959",
                            "name": "Bronchodilator Agents",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M20653",
                            "name": "Anti-Asthmatic Agents",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M20827",
                            "name": "Respiratory System Agents",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M20436",
                            "name": "Adrenergic Agents",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M3360",
                            "name": "Adrenergic beta-Agonists",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M3363",
                            "name": "Adrenergic Agonists",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M20194",
                            "name": "Neurotransmitter Agents",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M12879",
                            "name": "Parasympatholytics",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M20450",
                            "name": "Cholinergic Antagonists",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M20448",
                            "name": "Cholinergic Agents",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M3797",
                            "name": "Anesthetics",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M3779",
                            "name": "Adjuvants, Anesthesia",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M20491",
                            "name": "Muscarinic Antagonists",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "Resp",
                            "name": "Respiratory System Agents"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Drugs and Chemicals"
                        },
                        {
                            "abbrev": "AdjAn",
                            "name": "Adjuvants, Anesthesia"
                        },
                        {
                            "abbrev": "AntiConv",
                            "name": "Anticonvulsants"
                        },
                        {
                            "abbrev": "CNSDep",
                            "name": "Central Nervous System Depressants"
                        }
                    ]
                }
            },
            "hasResults": true
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT03689712",
                    "orgStudyIdInfo": {
                        "id": "GTI-4419-301"
                    },
                    "organization": {
                        "fullName": "Galera Therapeutics, Inc.",
                        "class": "INDUSTRY"
                    },
                    "briefTitle": "ROMAN: Phase 3 Trial Investigating the Effects of GC4419 on Radiation Induced Oral Mucositis in Head/Neck Cancer Patients",
                    "officialTitle": "ROMAN: Reduction in Oral Mucositis With Avasopasem Manganese (GC4419) - Phase 3 Trial in Patients Receiving Chemoradiotherapy for Locally-Advanced, Non-Metastatic Head and Neck Cancer"
                },
                "statusModule": {
                    "statusVerifiedDate": "2023-10",
                    "overallStatus": "COMPLETED",
                    "startDateStruct": {
                        "date": "2018-10-03",
                        "type": "ACTUAL"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2021-08-13",
                        "type": "ACTUAL"
                    },
                    "completionDateStruct": {
                        "date": "2023-08-25",
                        "type": "ACTUAL"
                    },
                    "studyFirstSubmitDate": "2018-09-27",
                    "studyFirstSubmitQcDate": "2018-09-27",
                    "studyFirstPostDateStruct": {
                        "date": "2018-09-28",
                        "type": "ACTUAL"
                    },
                    "resultsFirstSubmitDate": "2023-02-15",
                    "resultsFirstSubmitQcDate": "2023-04-12",
                    "resultsFirstPostDateStruct": {
                        "date": "2023-04-13",
                        "type": "ACTUAL"
                    },
                    "lastUpdateSubmitDate": "2023-10-19",
                    "lastUpdatePostDateStruct": {
                        "date": "2023-10-24",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR"
                    },
                    "leadSponsor": {
                        "name": "Galera Therapeutics, Inc.",
                        "class": "INDUSTRY"
                    }
                },
                "oversightModule": {
                    "oversightHasDmc": true,
                    "isFdaRegulatedDrug": true,
                    "isFdaRegulatedDevice": false
                },
                "descriptionModule": {
                    "briefSummary": "The purpose of the phase 3, clinical study is to determine if GC4419 (avasopasem manganese) administered prior to intensity-modulated radiation therapy (IMRT) reduces the severity of radiation induced oral mucositis in patients who have been diagnosed with locally advanced, non-metastatic squamous cell carcinoma of the head and neck."
                },
                "conditionsModule": {
                    "conditions": [
                        "Oral Mucositis"
                    ],
                    "keywords": [
                        "Oral Mucositis",
                        "Superoxide Dismutase Mimetic",
                        "Cisplatin",
                        "Intensity-Modulated Radiation Therapy",
                        "Chemoradiation",
                        "OM",
                        "IMRT",
                        "Head and Neck Cancer",
                        "Squamous Cell Carcinoma",
                        "SCC",
                        "Oral Cavity",
                        "Oropharnyx",
                        "Mouth Sores",
                        "avasopasem mangenese"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "PHASE3"
                    ],
                    "designInfo": {
                        "allocation": "RANDOMIZED",
                        "interventionModel": "PARALLEL",
                        "primaryPurpose": "SUPPORTIVE_CARE",
                        "maskingInfo": {
                            "masking": "QUADRUPLE",
                            "whoMasked": [
                                "PARTICIPANT",
                                "CARE_PROVIDER",
                                "INVESTIGATOR",
                                "OUTCOMES_ASSESSOR"
                            ]
                        }
                    },
                    "enrollmentInfo": {
                        "count": 455,
                        "type": "ACTUAL"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "GC4419 (avasopasem manganese) 90 mg",
                            "type": "EXPERIMENTAL",
                            "interventionNames": [
                                "Drug: GC4419 90mg"
                            ]
                        },
                        {
                            "label": "Placebo",
                            "type": "PLACEBO_COMPARATOR",
                            "interventionNames": [
                                "Drug: Placebo"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "DRUG",
                            "name": "GC4419 90mg",
                            "description": "60 minute IV infusion",
                            "armGroupLabels": [
                                "GC4419 (avasopasem manganese) 90 mg"
                            ],
                            "otherNames": [
                                "avasopasem manganese"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "Placebo",
                            "description": "60 minute IV infusion",
                            "armGroupLabels": [
                                "Placebo"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "Cumulative Incidence of Severe Oral Mucositis",
                            "description": "Cumulative incidence of severe oral mucositis is defined as the proportion of subjects with any occurrence of WHO Grade 3 to 4 OM, during the Study Treatment Period. Incidence of severe OM is defined as any occurrence of WHO Grade 3 or 4 OM through the last IMRT fraction after the start of IMRT. Incidence was imputed using multiple imputation for subjects with incomplete follow-up for severe OM through 60 Gy who did not have an occurrence of severe OM before the last IMRT fraction.",
                            "timeFrame": "From the first IMRT fraction through the end of the study treatment period (completion of study drug administration, IMRT and chemotherapy), which is estimated to be 7 weeks."
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n* squamous cell carcinoma of the head and neck\n* treatment plan to receive IMRT delivered as single daily fractions of 2.0 to 2.2 Gy with a cumulative radiation dose of 60-72 Gy\n* Treatment plan to receive standard cisplatin monotherapy\n* Age 18 years or older\n* Eastern Cooperative Oncology Group (ECOG) performance status \u2264 2\n* Adequate hematologic, renal and liver function\n* Negative serum pregnancy test\n* Use of effective contraception\n\nExclusion Criteria:\n\n* Tumor of the lips, larynx, hypopharynx, nasopharynx, sinuses, or salivary glands\n* Metastatic disease\n* Prior radiotherapy to the region of the study cancer or adjacent anatomical\n* Prior induction chemotherapy\n* Receiving any approved or investigational anti-cancer agent other than those provided for in this study\n* Concurrent participation in another interventional clinical study\n* Inability to eat soft solid food at baseline\n* Malignant tumors other than HNC within the last 5 years\n* Active infectious disease excluding oral candidiasis\n* Presence of oral mucositis at baseline\n* Known history of HIV or active hepatitis B/C\n* Female patients who are pregnant or breastfeeding\n* Known allergies or intolerance to cisplatin and similar platinum-containing compounds\n* Requirement for concurrent treatment with nitrates or other drugs that may create a risk for a precipitous decrease in blood pressure",
                    "healthyVolunteers": false,
                    "sex": "ALL",
                    "minimumAge": "18 Years",
                    "stdAges": [
                        "ADULT",
                        "OLDER_ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "overallOfficials": [
                        {
                            "name": "Gene Kennedy, MD",
                            "affiliation": "Galera Therapeutics",
                            "role": "STUDY_CHAIR"
                        }
                    ],
                    "locations": [
                        {
                            "facility": "Banner MD Anderson Cancer Center",
                            "city": "Gilbert",
                            "state": "Arizona",
                            "zip": "85234",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.35283,
                                "lon": -111.78903
                            }
                        },
                        {
                            "facility": "Fowler Family Center for Cancer",
                            "city": "Jonesboro",
                            "state": "Arkansas",
                            "zip": "72401",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 35.8423,
                                "lon": -90.70428
                            }
                        },
                        {
                            "facility": "The Oncology Institute of Hope & Innovation",
                            "city": "Corona",
                            "state": "California",
                            "zip": "92882",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.87529,
                                "lon": -117.56644
                            }
                        },
                        {
                            "facility": "Chan Soon-Shiong Institute for Medicine",
                            "city": "Costa Mesa",
                            "state": "California",
                            "zip": "92627",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.64113,
                                "lon": -117.91867
                            }
                        },
                        {
                            "facility": "Long Beach Veteran Affairs Healthcare System",
                            "city": "Long Beach",
                            "state": "California",
                            "zip": "90822",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.76696,
                                "lon": -118.18923
                            }
                        },
                        {
                            "facility": "USC Norris Cancer Center",
                            "city": "Los Angeles",
                            "state": "California",
                            "zip": "90033",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.05223,
                                "lon": -118.24368
                            }
                        },
                        {
                            "facility": "Cedars-Sinai Medical Center",
                            "city": "Los Angeles",
                            "state": "California",
                            "zip": "90048",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.05223,
                                "lon": -118.24368
                            }
                        },
                        {
                            "facility": "Clinical Trials and Research Associates, Inc.",
                            "city": "Montebello",
                            "state": "California",
                            "zip": "90640",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.00946,
                                "lon": -118.10535
                            }
                        },
                        {
                            "facility": "Hoag Memorial Hospital Presbyterian",
                            "city": "Newport Beach",
                            "state": "California",
                            "zip": "92663",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.61891,
                                "lon": -117.92895
                            }
                        },
                        {
                            "facility": "Compassionate Cancer Care",
                            "city": "Riverside",
                            "state": "California",
                            "zip": "92501",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.95335,
                                "lon": -117.39616
                            }
                        },
                        {
                            "facility": "Sharp Clinical Oncology Research",
                            "city": "San Diego",
                            "state": "California",
                            "zip": "92123",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 32.71533,
                                "lon": -117.15726
                            }
                        },
                        {
                            "facility": "The Oncology Institute of Hope & Innovation",
                            "city": "Whittier",
                            "state": "California",
                            "zip": "90603",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.97918,
                                "lon": -118.03284
                            }
                        },
                        {
                            "facility": "Dignity Health Research Institute",
                            "city": "Woodland",
                            "state": "California",
                            "zip": "95695",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 38.67852,
                                "lon": -121.7733
                            }
                        },
                        {
                            "facility": "St. Mary's Hospital Regional Medical Center",
                            "city": "Grand Junction",
                            "state": "Colorado",
                            "zip": "81501",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.06387,
                                "lon": -108.55065
                            }
                        },
                        {
                            "facility": "Bay Pines VA HealthCare System",
                            "city": "Bay Pines",
                            "state": "Florida",
                            "zip": "33744",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 27.81419,
                                "lon": -82.77816
                            }
                        },
                        {
                            "facility": "Boca Raton Regional Hospital, Lynn Cancer Institute",
                            "city": "Boca Raton",
                            "state": "Florida",
                            "zip": "33486",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 26.3669,
                                "lon": -80.13033
                            }
                        },
                        {
                            "facility": "Mayo Clinic Florida",
                            "city": "Jacksonville",
                            "state": "Florida",
                            "zip": "32224",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 30.33218,
                                "lon": -81.65565
                            }
                        },
                        {
                            "facility": "Cancer Specialists of North Florida",
                            "city": "Jacksonville",
                            "state": "Florida",
                            "zip": "32256",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 30.33218,
                                "lon": -81.65565
                            }
                        },
                        {
                            "facility": "Lakeland Regional Cancer Center",
                            "city": "Lakeland",
                            "state": "Florida",
                            "zip": "33805",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 28.03947,
                                "lon": -81.9498
                            }
                        },
                        {
                            "facility": "BRCR Global",
                            "city": "Plantation",
                            "state": "Florida",
                            "zip": "33322",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 26.13421,
                                "lon": -80.23184
                            }
                        },
                        {
                            "facility": "Winship Cancer Institute of Emory University",
                            "city": "Atlanta",
                            "state": "Georgia",
                            "zip": "30322",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.749,
                                "lon": -84.38798
                            }
                        },
                        {
                            "facility": "IACT Health",
                            "city": "Columbus",
                            "state": "Georgia",
                            "zip": "31904",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 32.46098,
                                "lon": -84.98771
                            }
                        },
                        {
                            "facility": "Northwestern University Feinberg School of Medicine",
                            "city": "Chicago",
                            "state": "Illinois",
                            "zip": "60611",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.85003,
                                "lon": -87.65005
                            }
                        },
                        {
                            "facility": "SwedishAmerican Regional Cancer Center",
                            "city": "Rockford",
                            "state": "Illinois",
                            "zip": "61114",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 42.27113,
                                "lon": -89.094
                            }
                        },
                        {
                            "facility": "Parkview Research Center",
                            "city": "Fort Wayne",
                            "state": "Indiana",
                            "zip": "46845",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.1306,
                                "lon": -85.12886
                            }
                        },
                        {
                            "facility": "Goshen Center for Cancer Care",
                            "city": "Goshen",
                            "state": "Indiana",
                            "zip": "46526",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.58227,
                                "lon": -85.83444
                            }
                        },
                        {
                            "facility": "The University of Iowa Hospitals & Clinics",
                            "city": "Iowa City",
                            "state": "Iowa",
                            "zip": "52242",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.66113,
                                "lon": -91.53017
                            }
                        },
                        {
                            "facility": "Appalachian Regional Healthcare, INC.",
                            "city": "Hazard",
                            "state": "Kentucky",
                            "zip": "41701",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 37.24954,
                                "lon": -83.19323
                            }
                        },
                        {
                            "facility": "University of Louisville/James Graham Brown Cancer Center",
                            "city": "Louisville",
                            "state": "Kentucky",
                            "zip": "40202",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 38.25424,
                                "lon": -85.75941
                            }
                        },
                        {
                            "facility": "Norton Cancer Institute",
                            "city": "Louisville",
                            "state": "Kentucky",
                            "zip": "40241",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 38.25424,
                                "lon": -85.75941
                            }
                        },
                        {
                            "facility": "MetroWest Medical Center",
                            "city": "Framingham",
                            "state": "Massachusetts",
                            "zip": "01702",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 42.27926,
                                "lon": -71.41617
                            }
                        },
                        {
                            "facility": "University of Michigan",
                            "city": "Ann Arbor",
                            "state": "Michigan",
                            "zip": "48109",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 42.27756,
                                "lon": -83.74088
                            }
                        },
                        {
                            "facility": "Minneapolis VA Healthcare System",
                            "city": "Minneapolis",
                            "state": "Minnesota",
                            "zip": "55417",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 44.97997,
                                "lon": -93.26384
                            }
                        },
                        {
                            "facility": "Hattiesburg Clinic Hematology/Oncology",
                            "city": "Hattiesburg",
                            "state": "Mississippi",
                            "zip": "39401",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 31.32712,
                                "lon": -89.29034
                            }
                        },
                        {
                            "facility": "Henry Ford Allegiance Health Hematology Oncology",
                            "city": "Jackson",
                            "state": "Mississippi",
                            "zip": "49201",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 32.29876,
                                "lon": -90.18481
                            }
                        },
                        {
                            "facility": "Ellis Fischel Cancer Center - University of Missouri",
                            "city": "Columbia",
                            "state": "Missouri",
                            "zip": "65212",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 38.95171,
                                "lon": -92.33407
                            }
                        },
                        {
                            "facility": "Delbert Day Cancer Institute, Phelps County Regional Medical Center",
                            "city": "Rolla",
                            "state": "Missouri",
                            "zip": "65401",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 37.95143,
                                "lon": -91.77127
                            }
                        },
                        {
                            "facility": "Mosaic Life Care/Heartland Regional Medical Center",
                            "city": "Saint Joseph",
                            "state": "Missouri",
                            "zip": "64507",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.76861,
                                "lon": -94.84663
                            }
                        },
                        {
                            "facility": "Cox Medical Center",
                            "city": "Springfield",
                            "state": "Missouri",
                            "zip": "65807",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 37.21533,
                                "lon": -93.29824
                            }
                        },
                        {
                            "facility": "St. Vincent Frontier Cancer Center",
                            "city": "Billings",
                            "state": "Montana",
                            "zip": "59102",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 45.78329,
                                "lon": -108.50069
                            }
                        },
                        {
                            "facility": "Benefis Sletten Cancer institute",
                            "city": "Great Falls",
                            "state": "Montana",
                            "zip": "59405",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 47.50024,
                                "lon": -111.30081
                            }
                        },
                        {
                            "facility": "CHI Health St. Francis",
                            "city": "Grand Island",
                            "state": "Nebraska",
                            "zip": "68803",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.92501,
                                "lon": -98.34201
                            }
                        },
                        {
                            "facility": "Renown Regional Medical Center",
                            "city": "Reno",
                            "state": "Nevada",
                            "zip": "89502",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.52963,
                                "lon": -119.8138
                            }
                        },
                        {
                            "facility": "Exeter Hospital",
                            "city": "Exeter",
                            "state": "New Hampshire",
                            "zip": "03833",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 42.98148,
                                "lon": -70.94783
                            }
                        },
                        {
                            "facility": "Hunterdon Hematology Oncology, LLC",
                            "city": "Flemington",
                            "state": "New Jersey",
                            "zip": "08822",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.51233,
                                "lon": -74.85933
                            }
                        },
                        {
                            "facility": "Summit Medical Group",
                            "city": "Florham Park",
                            "state": "New Jersey",
                            "zip": "07932",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.78788,
                                "lon": -74.38821
                            }
                        },
                        {
                            "facility": "Jersey Shore University Medical Center",
                            "city": "Neptune",
                            "state": "New Jersey",
                            "zip": "07753",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.20011,
                                "lon": -74.02792
                            }
                        },
                        {
                            "facility": "New York Oncology Hematology, P.C.",
                            "city": "Albany",
                            "state": "New York",
                            "zip": "12206",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 42.65258,
                                "lon": -73.75623
                            }
                        },
                        {
                            "facility": "NY Cancer and Blood Specialists",
                            "city": "East Setauket",
                            "state": "New York",
                            "zip": "11733",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.94149,
                                "lon": -73.10594
                            }
                        },
                        {
                            "facility": "New York- Presbyterian Queens/ Weill Cornell",
                            "city": "Flushing",
                            "state": "New York",
                            "zip": "11355",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.76538,
                                "lon": -73.81736
                            }
                        },
                        {
                            "facility": "Wilmot Cancer Institute - Univeristy of Rochester",
                            "city": "Rochester",
                            "state": "New York",
                            "zip": "14642",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 43.15478,
                                "lon": -77.61556
                            }
                        },
                        {
                            "facility": "School of Dental Medicine at East Carolina University",
                            "city": "Greenville",
                            "state": "North Carolina",
                            "zip": "27834",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 35.61266,
                                "lon": -77.36635
                            }
                        },
                        {
                            "facility": "Wake Forest Baptist Health",
                            "city": "Winston-Salem",
                            "state": "North Carolina",
                            "zip": "27157",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 36.09986,
                                "lon": -80.24422
                            }
                        },
                        {
                            "facility": "Summa Health",
                            "city": "Akron",
                            "state": "Ohio",
                            "zip": "44304",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.08144,
                                "lon": -81.51901
                            }
                        },
                        {
                            "facility": "University Hospitals Seidman Cancer Center",
                            "city": "Cleveland",
                            "state": "Ohio",
                            "zip": "44106",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.4995,
                                "lon": -81.69541
                            }
                        },
                        {
                            "facility": "The Ohio State University",
                            "city": "Columbus",
                            "state": "Ohio",
                            "zip": "43210",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.96118,
                                "lon": -82.99879
                            }
                        },
                        {
                            "facility": "Willamette Valley Cancer Institue and Research Center",
                            "city": "Eugene",
                            "state": "Oregon",
                            "zip": "97401",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 44.05207,
                                "lon": -123.08675
                            }
                        },
                        {
                            "facility": "VA Portland Health Care System",
                            "city": "Portland",
                            "state": "Oregon",
                            "zip": "97239",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 45.52345,
                                "lon": -122.67621
                            }
                        },
                        {
                            "facility": "St. Luke's Hospital Cancer Center",
                            "city": "Easton",
                            "state": "Pennsylvania",
                            "zip": "18045",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.68843,
                                "lon": -75.22073
                            }
                        },
                        {
                            "facility": "Gettysburg Cancer Center",
                            "city": "Gettysburg",
                            "state": "Pennsylvania",
                            "zip": "17325",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.83093,
                                "lon": -77.2311
                            }
                        },
                        {
                            "facility": "Thomas Jefferson University Hospital",
                            "city": "Philadelphia",
                            "state": "Pennsylvania",
                            "zip": "19107",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.95233,
                                "lon": -75.16379
                            }
                        },
                        {
                            "facility": "Fox Chase Cancer Center",
                            "city": "Philadelphia",
                            "state": "Pennsylvania",
                            "zip": "19111",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.95233,
                                "lon": -75.16379
                            }
                        },
                        {
                            "facility": "Anmed Health Cancer Center",
                            "city": "Anderson",
                            "state": "South Carolina",
                            "zip": "29621",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.50344,
                                "lon": -82.65013
                            }
                        },
                        {
                            "facility": "Charleston Cancer Center",
                            "city": "Charleston",
                            "state": "South Carolina",
                            "zip": "29406",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 32.77657,
                                "lon": -79.93092
                            }
                        },
                        {
                            "facility": "St. Francis Cancer Center",
                            "city": "Greenville",
                            "state": "South Carolina",
                            "zip": "29607",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.85262,
                                "lon": -82.39401
                            }
                        },
                        {
                            "facility": "Spartanburg Medical Center",
                            "city": "Spartanburg",
                            "state": "South Carolina",
                            "zip": "29303",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.94957,
                                "lon": -81.93205
                            }
                        },
                        {
                            "facility": "Mountain States Health Alliance Research Dept",
                            "city": "Johnson City",
                            "state": "Tennessee",
                            "zip": "37604",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 36.31344,
                                "lon": -82.35347
                            }
                        },
                        {
                            "facility": "Tennessee Cancer Specialists",
                            "city": "Knoxville",
                            "state": "Tennessee",
                            "zip": "37909",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 35.96064,
                                "lon": -83.92074
                            }
                        },
                        {
                            "facility": "University of Tennessee Medical Center",
                            "city": "Knoxville",
                            "state": "Tennessee",
                            "zip": "37920",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 35.96064,
                                "lon": -83.92074
                            }
                        },
                        {
                            "facility": "Texas Oncology - Beaumont Mamie McFaddin Ward Cancer Center",
                            "city": "Beaumont",
                            "state": "Texas",
                            "zip": "77702",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 30.08605,
                                "lon": -94.10185
                            }
                        },
                        {
                            "facility": "Texas Oncology- Dallas Presbyterian Hospital",
                            "city": "Dallas",
                            "state": "Texas",
                            "zip": "75231",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 32.78306,
                                "lon": -96.80667
                            }
                        },
                        {
                            "facility": "Texas Oncology-Baylor Charles A. Sammons Cancer Center",
                            "city": "Dallas",
                            "state": "Texas",
                            "zip": "75246",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 32.78306,
                                "lon": -96.80667
                            }
                        },
                        {
                            "facility": "Texas Oncology - Denton South",
                            "city": "Denton",
                            "state": "Texas",
                            "zip": "76210",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.21484,
                                "lon": -97.13307
                            }
                        },
                        {
                            "facility": "Texas Oncology - El Paso Cancer Treatment Center",
                            "city": "El Paso",
                            "state": "Texas",
                            "zip": "79902",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 31.75872,
                                "lon": -106.48693
                            }
                        },
                        {
                            "facility": "SAMMC",
                            "city": "Fort Sam Houston",
                            "state": "Texas",
                            "zip": "78234",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 29.45746,
                                "lon": -98.4472
                            }
                        },
                        {
                            "facility": "Texas Oncology-McAllen",
                            "city": "McAllen",
                            "state": "Texas",
                            "zip": "78503",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 26.20341,
                                "lon": -98.23001
                            }
                        },
                        {
                            "facility": "Texas Oncology - McKinney",
                            "city": "McKinney",
                            "state": "Texas",
                            "zip": "75071",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.19762,
                                "lon": -96.61527
                            }
                        },
                        {
                            "facility": "Texas Oncology, Plano West",
                            "city": "Plano",
                            "state": "Texas",
                            "zip": "75093",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.01984,
                                "lon": -96.69889
                            }
                        },
                        {
                            "facility": "Baylor Scott & White- Round Rock",
                            "city": "Round Rock",
                            "state": "Texas",
                            "zip": "78665",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 30.50826,
                                "lon": -97.6789
                            }
                        },
                        {
                            "facility": "Texas Oncology - Sugar Land",
                            "city": "Sugar Land",
                            "state": "Texas",
                            "zip": "77479",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 29.61968,
                                "lon": -95.63495
                            }
                        },
                        {
                            "facility": "Texas Oncology - Waco",
                            "city": "Waco",
                            "state": "Texas",
                            "zip": "76712",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 31.54933,
                                "lon": -97.14667
                            }
                        },
                        {
                            "facility": "Fort Belvoir Community Hospital",
                            "city": "Fort Belvoir",
                            "state": "Virginia",
                            "zip": "22060",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 38.7119,
                                "lon": -77.14589
                            }
                        },
                        {
                            "facility": "Oncology and Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care",
                            "city": "Roanoke",
                            "state": "Virginia",
                            "zip": "24014",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 37.27097,
                                "lon": -79.94143
                            }
                        },
                        {
                            "facility": "Providence Regional Cancer Partnership",
                            "city": "Everett",
                            "state": "Washington",
                            "zip": "98201",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 47.97898,
                                "lon": -122.20208
                            }
                        },
                        {
                            "facility": "Cancer Care Northwest",
                            "city": "Spokane",
                            "state": "Washington",
                            "zip": "99216",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 47.65966,
                                "lon": -117.42908
                            }
                        },
                        {
                            "facility": "West Virginia University",
                            "city": "Morgantown",
                            "state": "West Virginia",
                            "zip": "26506",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.62953,
                                "lon": -79.9559
                            }
                        },
                        {
                            "facility": "BC Cancer Center - Vancouver",
                            "city": "Vancouver",
                            "state": "British Columbia",
                            "zip": "V574E6",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 49.24966,
                                "lon": -123.11934
                            }
                        },
                        {
                            "facility": "CIUSS de L'Est-de-I'lle de Montreal - Hopital Maisonneuve- Rosemont",
                            "city": "Montr\u00e9al",
                            "state": "Quebec",
                            "zip": "H1T 2M4",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 45.50884,
                                "lon": -73.58781
                            }
                        },
                        {
                            "facility": "McGill University Health Center- Cedars Cancer Center",
                            "city": "Montr\u00e9al",
                            "state": "Quebec",
                            "zip": "H4A 3J1",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 45.50884,
                                "lon": -73.58781
                            }
                        },
                        {
                            "facility": "CHU de Quebec - Universite Laval",
                            "city": "Qu\u00e9bec",
                            "state": "Quebec",
                            "zip": "G1R 2J6",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 46.81228,
                                "lon": -71.21454
                            }
                        },
                        {
                            "facility": "Centre Int\u00e9gr\u00e9 Universitaire de Sant\u00e9 et de Services Sociaux du Saguenay-Lac-Saint-Jean",
                            "city": "Chicoutimi",
                            "zip": "G7H 5H6",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 48.41963,
                                "lon": -71.06369
                            }
                        },
                        {
                            "facility": "Juravinski Cancer Centre",
                            "city": "Hamilton",
                            "zip": "L8V 5C2",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 43.25011,
                                "lon": -79.84963
                            }
                        },
                        {
                            "facility": "Centre Hospitalier Universitaire de Montreal (CHUM)",
                            "city": "Montr\u00e9al",
                            "zip": "H2X OC1",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 45.50884,
                                "lon": -73.58781
                            }
                        },
                        {
                            "facility": "Jewish General Hospital",
                            "city": "Montr\u00e9al",
                            "zip": "H3T 1E2",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 45.50884,
                                "lon": -73.58781
                            }
                        },
                        {
                            "facility": "Northeast Cancer Centre of Health Sciences North",
                            "city": "Sudbury",
                            "zip": "P3E 5J1",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 46.49,
                                "lon": -80.99001
                            }
                        },
                        {
                            "facility": "Centre Int\u00e9gr\u00e9 Universitaire de Sant\u00e9 et de Services Sociaux de la Mauricie et du Centre du Qu\u00e9bec",
                            "city": "Trois-Rivi\u00e8res",
                            "zip": "G8Z3R9",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 46.34515,
                                "lon": -72.5477
                            }
                        },
                        {
                            "facility": "Clinical Research Puerto Rico",
                            "city": "San Juan",
                            "zip": "00909",
                            "country": "Puerto Rico",
                            "geoPoint": {
                                "lat": 18.46633,
                                "lon": -66.10572
                            }
                        }
                    ]
                },
                "referencesModule": {
                    "references": [
                        {
                            "type": "BACKGROUND",
                            "citation": "Anderson CM, Lee CM, Kelley JR, et al. ROMAN: Phase 3 trial of avasopasem manganese (GC4419) for severe oral mucositis (SOM) in patients receiving chemoradiotherapy (CRT) for locally advanced, nonmetastatic head and neck cancer (LAHNC). Journal of Clinical Oncology 2022 40:16_suppl, 6005-6005"
                        },
                        {
                            "type": "BACKGROUND",
                            "citation": "Saunders D, Lee C, Kelley J, et al. ROMAN: Phase 3 trial of avasopasem to reduce chemoradiotherapy (CRT)-related severe oral mucositis (SOM) in patients with head and neck cancer (HNC). Support Care Cancer 30 (Suppl 1), 1-207 (2022)."
                        },
                        {
                            "pmid": "34145168",
                            "type": "DERIVED",
                            "citation": "Squillace S, Salvemini D. Nitroxidative stress in pain and opioid-induced adverse effects: therapeutic opportunities. Pain. 2022 Feb 1;163(2):205-213. doi: 10.1097/j.pain.0000000000002347. No abstract available."
                        },
                        {
                            "pmid": "31618127",
                            "type": "DERIVED",
                            "citation": "Anderson CM, Lee CM, Saunders DP, Curtis A, Dunlap N, Nangia C, Lee AS, Gordon SM, Kovoor P, Arevalo-Araujo R, Bar-Ad V, Peddada A, Colvett K, Miller D, Jain AK, Wheeler J, Blakaj D, Bonomi M, Agarwala SS, Garg M, Worden F, Holmlund J, Brill JM, Downs M, Sonis ST, Katz S, Buatti JM. Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer. J Clin Oncol. 2019 Dec 1;37(34):3256-3265. doi: 10.1200/JCO.19.01507. Epub 2019 Oct 16. Erratum In: J Clin Oncol. 2020 Jan 20;38(3):288."
                        }
                    ]
                },
                "ipdSharingStatementModule": {
                    "ipdSharing": "NO"
                }
            },
            "resultsSection": {
                "participantFlowModule": {
                    "groups": [
                        {
                            "id": "FG000",
                            "title": "GC4419 (Avasopasem Manganese) 90 mg",
                            "description": "GC4419 (avasopasem manganese): 60 minute IV infusion"
                        },
                        {
                            "id": "FG001",
                            "title": "Placebo",
                            "description": "Placebo: 60 minute IV infusion"
                        }
                    ],
                    "periods": [
                        {
                            "title": "Overall Study",
                            "milestones": [
                                {
                                    "type": "STARTED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "270"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "185"
                                        }
                                    ]
                                },
                                {
                                    "type": "Intent to Treat Population",
                                    "comment": "Intent-to-Treat (ITT) population includes all randomized subjects who received at least one dose of GC4419/Placebo, with the exception of the 28 subjects whose treatment course was discontinued during the Sponsor's voluntary suspension of dosing.",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "241"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "166"
                                        }
                                    ]
                                },
                                {
                                    "type": "COMPLETED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "105"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "74"
                                        }
                                    ]
                                },
                                {
                                    "type": "NOT COMPLETED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "165"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "111"
                                        }
                                    ]
                                }
                            ],
                            "dropWithdraws": [
                                {
                                    "type": "Adverse Event",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "1"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "0"
                                        }
                                    ]
                                },
                                {
                                    "type": "Death",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "20"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "10"
                                        }
                                    ]
                                },
                                {
                                    "type": "Lost to Follow-up",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "6"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "6"
                                        }
                                    ]
                                },
                                {
                                    "type": "Other",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "1"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "0"
                                        }
                                    ]
                                },
                                {
                                    "type": "Patient Non-Compliance",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "0"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "1"
                                        }
                                    ]
                                },
                                {
                                    "type": "Withdrawal by Subject",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "20"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "4"
                                        }
                                    ]
                                },
                                {
                                    "type": "Patients Continuing in Long Term Follow Up",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "88"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "71"
                                        }
                                    ]
                                },
                                {
                                    "type": "Randomized but not Treated",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "13"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "7"
                                        }
                                    ]
                                },
                                {
                                    "type": "Subject Dosing Suspended due to Product Issue",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "16"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "12"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "baselineCharacteristicsModule": {
                    "populationDescription": "Intent-to-Treat (ITT) population includes all randomized subjects who received at least one dose of GC4419/Placebo, with the exception of the 28 subjects whose treatment course was discontinued during the Sponsor's voluntary suspension of dosing.",
                    "groups": [
                        {
                            "id": "BG000",
                            "title": "GC4419 (Avasopasem Manganese)",
                            "description": "GC4419 (avasopasem manganese): 60 minute IV infusion"
                        },
                        {
                            "id": "BG001",
                            "title": "Placebo",
                            "description": "Placebo: 60 minute IV infusion"
                        },
                        {
                            "id": "BG002",
                            "title": "Total",
                            "description": "Total of all reporting groups"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "BG000",
                                    "value": "241"
                                },
                                {
                                    "groupId": "BG001",
                                    "value": "166"
                                },
                                {
                                    "groupId": "BG002",
                                    "value": "407"
                                }
                            ]
                        }
                    ],
                    "measures": [
                        {
                            "title": "Age, Categorical",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "title": "<=18 years",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "0"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Between 18 and 65 years",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "163"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "111"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "274"
                                                }
                                            ]
                                        },
                                        {
                                            "title": ">=65 years",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "78"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "55"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "133"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Sex: Female, Male",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "title": "Female",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "39"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "17"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "56"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Male",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "202"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "149"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "351"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Ethnicity (NIH/OMB)",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "title": "Hispanic or Latino",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "8"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "9"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Not Hispanic or Latino",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "222"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "160"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "382"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Unknown or Not Reported",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "11"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "5"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "16"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Race (NIH/OMB)",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "title": "American Indian or Alaska Native",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "2"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "2"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Asian",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "1"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Native Hawaiian or Other Pacific Islander",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "1"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Black or African American",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "10"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "2"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "12"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "White",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "219"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "158"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "377"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "More than one race",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "3"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "3"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Unknown or Not Reported",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "7"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "4"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "11"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Region of Enrollment",
                            "paramType": "NUMBER",
                            "unitOfMeasure": "participants",
                            "classes": [
                                {
                                    "title": "Canada",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "33"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "24"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "57"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "United States",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "208"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "142"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "350"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "outcomeMeasuresModule": {
                    "outcomeMeasures": [
                        {
                            "type": "PRIMARY",
                            "title": "Cumulative Incidence of Severe Oral Mucositis",
                            "description": "Cumulative incidence of severe oral mucositis is defined as the proportion of subjects with any occurrence of WHO Grade 3 to 4 OM, during the Study Treatment Period. Incidence of severe OM is defined as any occurrence of WHO Grade 3 or 4 OM through the last IMRT fraction after the start of IMRT. Incidence was imputed using multiple imputation for subjects with incomplete follow-up for severe OM through 60 Gy who did not have an occurrence of severe OM before the last IMRT fraction.",
                            "populationDescription": "The Intent to treat population consisted of all randomized subjects who received at least 1 dose of avasopasem manganese or placebo (with the exception of subjects whose treatment course was discontinued due to the sponsor's voluntary suspension of dosing)",
                            "reportingStatus": "POSTED",
                            "paramType": "NUMBER",
                            "unitOfMeasure": "percentage of patients",
                            "timeFrame": "From the first IMRT fraction through the end of the study treatment period (completion of study drug administration, IMRT and chemotherapy), which is estimated to be 7 weeks.",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "GC4419 (Avasopasem Manganese) 90mg",
                                    "description": "GC4419: 60 minute IV infusion"
                                },
                                {
                                    "id": "OG001",
                                    "title": "Placebo",
                                    "description": "Placebo: 60 minute IV infusion"
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "241"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "166"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "53.8"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "64.0"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "adverseEventsModule": {
                    "frequencyThreshold": "3",
                    "timeFrame": "Adverse events were collected from the first dose of GC4419 (avasopasem manganese)/Placebo until 30 days following the last dose of GC4419 (avasopasem manganese)/Placebo, IMRT, or chemotherapy (whichever was later). Timeframe for collection of adverse events was approximately 10 weeks",
                    "eventGroups": [
                        {
                            "id": "EG000",
                            "title": "GC4419 (Avasopasem Manganese) 90 mg",
                            "description": "GC4419 90mg: 60 minute IV infusion",
                            "deathsNumAffected": 20,
                            "deathsNumAtRisk": 241,
                            "seriousNumAffected": 81,
                            "seriousNumAtRisk": 241,
                            "otherNumAffected": 240,
                            "otherNumAtRisk": 241
                        },
                        {
                            "id": "EG001",
                            "title": "Placebo",
                            "description": "Placebo: 60 minute IV infusion",
                            "deathsNumAffected": 10,
                            "deathsNumAtRisk": 166,
                            "seriousNumAffected": 52,
                            "seriousNumAtRisk": 166,
                            "otherNumAffected": 166,
                            "otherNumAtRisk": 166
                        }
                    ],
                    "seriousEvents": [
                        {
                            "term": "Febrile Neutropenia",
                            "organSystem": "Blood and lymphatic system disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 17,
                                    "numAffected": 15,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 9,
                                    "numAffected": 8,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Dehydration",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 8,
                                    "numAffected": 7,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 3,
                                    "numAffected": 3,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Sepsis",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 4,
                                    "numAffected": 4,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 5,
                                    "numAffected": 4,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Failure to Thrive",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 3,
                                    "numAffected": 3,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 6,
                                    "numAffected": 6,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Pulmonary Embolism",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 7,
                                    "numAffected": 7,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 2,
                                    "numAffected": 2,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Pneumonia",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 7,
                                    "numAffected": 3,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Acute Kidney Injury",
                            "organSystem": "Renal and urinary disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 7,
                                    "numAffected": 5,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Nausea",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 5,
                                    "numAffected": 5,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 2,
                                    "numAffected": 2,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Pyrexia",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 6,
                                    "numAffected": 6,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Vomiting",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 4,
                                    "numAffected": 4,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 6,
                                    "numAffected": 6,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Atrial Fibrillation",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 3,
                                    "numAffected": 2,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Hyponatremia",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 3,
                                    "numAffected": 1,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Dysphagia",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 3,
                                    "numAffected": 3,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 4,
                                    "numAffected": 2,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Lung Infection",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 2,
                                    "numAffected": 2,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 2,
                                    "numAffected": 2,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Asethenia",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 2,
                                    "numAffected": 2,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Decreased Appetite",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 2,
                                    "numAffected": 2,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Deep Vein Thrombosis",
                            "organSystem": "Vascular disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 2,
                                    "numAffected": 2,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Device Malfunction",
                            "organSystem": "Product Issues",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 3,
                                    "numAffected": 3,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Hypotension",
                            "organSystem": "Vascular disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 3,
                                    "numAffected": 3,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Hypoxia",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 2,
                                    "numAffected": 2,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Malnutrition",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 2,
                                    "numAffected": 2,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Pancreatitis",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 2,
                                    "numAffected": 2,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Pneumonia Aspiration",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 2,
                                    "numAffected": 2,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Acute Respiratory Failure",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 2,
                                    "numAffected": 1,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Cardiac failure congestive",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 2,
                                    "numAffected": 2,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Cerebrovascular Accident",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 2,
                                    "numAffected": 1,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Constipation",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 2,
                                    "numAffected": 2,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Hepatitis viral",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 2,
                                    "numAffected": 2,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Hypokalemia",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 2,
                                    "numAffected": 2,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Non-Cardiac Chest Pain",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Odynophagia",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Weight Decreased",
                            "organSystem": "Investigations",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 2,
                                    "numAffected": 2,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Abdominal Wall Abscess",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Accidental Overdose",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Acute myocardial infarction",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Bactaraemia",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Bronchitis",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Cardiac Arrest",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Cardio-respiratory Arrest",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Cholecystitis Acute",
                            "organSystem": "Hepatobiliary disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Corona Virus Infection",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Death",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Delirium",
                            "organSystem": "Psychiatric disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Depression",
                            "organSystem": "Psychiatric disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Device Occulsion",
                            "organSystem": "Product Issues",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Device Related Infection",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Diarrhoea",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Euglycaemic Diabetic Ketoacidosis",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Gastrostomy Tube Removal",
                            "organSystem": "Surgical and medical procedures",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Gastrostomy Tube Site Complication",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Haematemesis",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Haemorrhoidal Haemorrhage",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Hypercoagulation",
                            "organSystem": "Blood and lymphatic system disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Hypernatraemia",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Hypoglycaemia",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Hypomagnesaemia",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Hypovolaemia",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Laryngeal Oedema",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Lipase Increased",
                            "organSystem": "Investigations",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Metastases to Peritoneum",
                            "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Muscle Haemorrhage",
                            "organSystem": "Musculoskeletal and connective tissue disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Nephrolithiasis",
                            "organSystem": "Renal and urinary disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Neutropenic Sepsis",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Oropharyngeal Candidiasis",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Parotitis",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Presyncope",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Sinus Bradycardia",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Skin Ulcer",
                            "organSystem": "Skin and subcutaneous tissue disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Staphylococcal Sepsis",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Stoma Site Infection",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Syncope",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Tremor",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Tumour Haemorrhage",
                            "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Upper Gastrointestinal Haemorrhage",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Urinary Tract Infection",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 166
                                }
                            ]
                        }
                    ],
                    "otherEvents": [
                        {
                            "term": "Lymphopenia",
                            "organSystem": "Blood and lymphatic system disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 465,
                                    "numAffected": 212,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 329,
                                    "numAffected": 155,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Nausea",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 449,
                                    "numAffected": 207,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 319,
                                    "numAffected": 137,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Oropharyngeal Pain",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 280,
                                    "numAffected": 146,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 251,
                                    "numAffected": 113,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Fatigue",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 278,
                                    "numAffected": 170,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 238,
                                    "numAffected": 124,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Constipation",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 236,
                                    "numAffected": 154,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 194,
                                    "numAffected": 102,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Radiation Skin Injury",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 222,
                                    "numAffected": 126,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 181,
                                    "numAffected": 104,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Vomiting",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 259,
                                    "numAffected": 135,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 137,
                                    "numAffected": 77,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Weight Decreased",
                            "organSystem": "Investigations",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 222,
                                    "numAffected": 116,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 148,
                                    "numAffected": 80,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Paresthesia",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 212,
                                    "numAffected": 36,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 41,
                                    "numAffected": 15,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Dysgeusia",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 192,
                                    "numAffected": 137,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 167,
                                    "numAffected": 119,
                                    "numAtRisk": 166
                                }
                            ]
                        },
                        {
                            "term": "Dry Mouth",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA version 21",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 163,
                                    "numAffected": 129,
                                    "numAtRisk": 241
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 152,
                                    "numAffected": 104,
                                    "numAtRisk": 166
                                }
                            ]
                        }
                    ]
                },
                "moreInfoModule": {
                    "certainAgreement": {
                        "piSponsorEmployee": false,
                        "restrictionType": "OTHER",
                        "restrictiveAgreement": true,
                        "otherDetails": "A copy of the proposed manuscript (or other document) for publication, presentation or other disclosure must be forwarded to the sponsor not less than 30 days prior to submission or presentation and the Principal Investigator shall comply with Sponsor's requests to delete or revise references to Confidential Information and consider all other comments of Sponsor in good faith."
                    },
                    "pointOfContact": {
                        "title": "Megan Holm",
                        "organization": "Galera Therapeutics",
                        "email": "mholm@galeratx.com",
                        "phone": "484-615-2036"
                    }
                }
            },
            "documentSection": {
                "largeDocumentModule": {
                    "largeDocs": [
                        {
                            "typeAbbrev": "Prot_SAP",
                            "hasProtocol": true,
                            "hasSap": true,
                            "hasIcf": false,
                            "label": "Study Protocol and Statistical Analysis Plan",
                            "date": "2020-07-13",
                            "uploadDate": "2022-12-21T14:47",
                            "filename": "Prot_SAP_000.pdf",
                            "size": 1589673
                        }
                    ]
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2023-11-09",
                    "submissionTracking": {
                        "firstMcpInfo": {
                            "postDateStruct": {
                                "date": "2023-03-14",
                                "type": "ACTUAL"
                            }
                        }
                    },
                    "modelPredictions": {
                        "bmiLimits": {
                            "minBmi": 0.0,
                            "maxBmi": 101.0
                        }
                    }
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D000006258",
                            "term": "Head and Neck Neoplasms"
                        },
                        {
                            "id": "D000052016",
                            "term": "Mucositis"
                        },
                        {
                            "id": "D000013280",
                            "term": "Stomatitis"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D000009371",
                            "term": "Neoplasms by Site"
                        },
                        {
                            "id": "D000009369",
                            "term": "Neoplasms"
                        },
                        {
                            "id": "D000005759",
                            "term": "Gastroenteritis"
                        },
                        {
                            "id": "D000005767",
                            "term": "Gastrointestinal Diseases"
                        },
                        {
                            "id": "D000004066",
                            "term": "Digestive System Diseases"
                        },
                        {
                            "id": "D000009059",
                            "term": "Mouth Diseases"
                        },
                        {
                            "id": "D000009057",
                            "term": "Stomatognathic Diseases"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M5224",
                            "name": "Carcinoma",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M5240",
                            "name": "Carcinoma, Squamous Cell",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M9038",
                            "name": "Head and Neck Neoplasms",
                            "asFound": "Neck Cancer",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M26645",
                            "name": "Mucositis",
                            "asFound": "Mucositis",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M15760",
                            "name": "Stomatitis",
                            "asFound": "Oral Mucositis",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M20903",
                            "name": "Oral Ulcer",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M8565",
                            "name": "Gastroenteritis",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M8573",
                            "name": "Gastrointestinal Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M6945",
                            "name": "Digestive System Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M11709",
                            "name": "Mouth Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M11707",
                            "name": "Stomatognathic Diseases",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BC04",
                            "name": "Neoplasms"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        },
                        {
                            "abbrev": "BC06",
                            "name": "Digestive System Diseases"
                        },
                        {
                            "abbrev": "BC07",
                            "name": "Mouth and Tooth Diseases"
                        }
                    ]
                },
                "interventionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D000008345",
                            "term": "Manganese"
                        },
                        {
                            "id": "C000707700",
                            "term": "Avasopasem manganese"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D000014131",
                            "term": "Trace Elements"
                        },
                        {
                            "id": "D000018977",
                            "term": "Micronutrients"
                        },
                        {
                            "id": "D000045505",
                            "term": "Physiological Effects of Drugs"
                        },
                        {
                            "id": "D000016166",
                            "term": "Free Radical Scavengers"
                        },
                        {
                            "id": "D000000975",
                            "term": "Antioxidants"
                        },
                        {
                            "id": "D000045504",
                            "term": "Molecular Mechanisms of Pharmacological Action"
                        },
                        {
                            "id": "D000020011",
                            "term": "Protective Agents"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M5872",
                            "name": "Cisplatin",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M15954",
                            "name": "Superoxide Dismutase",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M11025",
                            "name": "Manganese",
                            "asFound": "Birth control",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M347188",
                            "name": "Avasopasem manganese",
                            "asFound": "Cervical smear",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M20699",
                            "name": "Micronutrients",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M16575",
                            "name": "Trace Elements",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M3982",
                            "name": "Antioxidants",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M21559",
                            "name": "Protective Agents",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "ANeo",
                            "name": "Antineoplastic Agents"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Drugs and Chemicals"
                        },
                        {
                            "abbrev": "Micro",
                            "name": "Micronutrients"
                        }
                    ]
                }
            },
            "hasResults": true
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT05319912",
                    "orgStudyIdInfo": {
                        "id": "WTX101-102"
                    },
                    "secondaryIdInfos": [
                        {
                            "id": "CA13895",
                            "type": "OTHER",
                            "domain": "Celerion"
                        }
                    ],
                    "organization": {
                        "fullName": "Alexion Pharmaceuticals, Inc.",
                        "class": "INDUSTRY"
                    },
                    "briefTitle": "A Study of ALXN1840 (Coated and Non-coated) Administered With And Without Omeprazole In Healthy Adults",
                    "officialTitle": "A Phase 1, Single-Center, Randomized, 3-Period Crossover Study in Healthy Volunteers to Evaluate the Absorption of WTX101 After Single Dose Administration of an Enteric Coated Formulation With and Without Food and a Non-Coated Formulation Coadministered With a Proton Pump Inhibitor Without Food"
                },
                "statusModule": {
                    "statusVerifiedDate": "2022-09",
                    "overallStatus": "COMPLETED",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2014-04-07",
                        "type": "ACTUAL"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2014-05-29",
                        "type": "ACTUAL"
                    },
                    "completionDateStruct": {
                        "date": "2014-05-29",
                        "type": "ACTUAL"
                    },
                    "studyFirstSubmitDate": "2022-04-01",
                    "studyFirstSubmitQcDate": "2022-04-01",
                    "studyFirstPostDateStruct": {
                        "date": "2022-04-08",
                        "type": "ACTUAL"
                    },
                    "resultsFirstSubmitDate": "2022-09-15",
                    "resultsFirstSubmitQcDate": "2022-09-15",
                    "resultsFirstPostDateStruct": {
                        "date": "2023-08-02",
                        "type": "ACTUAL"
                    },
                    "lastUpdateSubmitDate": "2022-09-15",
                    "lastUpdatePostDateStruct": {
                        "date": "2023-08-02",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR"
                    },
                    "leadSponsor": {
                        "name": "Alexion Pharmaceuticals, Inc.",
                        "class": "INDUSTRY"
                    }
                },
                "oversightModule": {
                    "oversightHasDmc": false,
                    "isFdaRegulatedDrug": true,
                    "isFdaRegulatedDevice": false
                },
                "descriptionModule": {
                    "briefSummary": "This was single-center, open-label, randomized, 3-period, 3-treatment, 6-sequence crossover study evaluating the PK of single doses of WTX101 in healthy participants based on the measurement of plasma total Mo concentration."
                },
                "conditionsModule": {
                    "conditions": [
                        "Healthy"
                    ],
                    "keywords": [
                        "ALXN1840",
                        "WTX101",
                        "Omeprazole"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "PHASE1"
                    ],
                    "designInfo": {
                        "allocation": "RANDOMIZED",
                        "interventionModel": "CROSSOVER",
                        "primaryPurpose": "BASIC_SCIENCE",
                        "maskingInfo": {
                            "masking": "NONE"
                        }
                    },
                    "enrollmentInfo": {
                        "count": 18,
                        "type": "ACTUAL"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "Sequence 1: ABC",
                            "type": "EXPERIMENTAL",
                            "description": "Participants received each treatment on 1 occasion:\n\nPeriod 1 (Treatment A): ALXN1840 tablets following an overnight fast. Period 2 (Treatment B): ALXN1840 tablets after the start of a high-fat breakfast, preceded by an overnight fast. Period 3 (Treatment C): Omeprazole once daily in the morning of Days -5 to -1 following an overnight fast, omeprazole at Hour -1 on Day 1 following an overnight fast, and ALXN1840 non-coated capsules at Hour 0 on Day 1.\n\nThere was a washout period of at least 14 days between each ALXN1840 dosing.",
                            "interventionNames": [
                                "Drug: ALXN1840 Enteric-coated Tablet",
                                "Drug: ALXN1840 Non-coated Capsule",
                                "Drug: Omeprazole"
                            ]
                        },
                        {
                            "label": "Sequence 2: ACB",
                            "type": "EXPERIMENTAL",
                            "description": "Participants received each treatment on 1 occasion:\n\nPeriod 1 (Treatment A): ALXN1840 tablets following an overnight fast. Period 2 (Treatment C): Omeprazole once daily in the morning of Days -5 to -1 following an overnight fast, omeprazole at Hour -1 on Day 1 following an overnight fast, and ALXN1840 non-coated capsules at Hour 0 on Day 1. Period 3 (Treatment B): ALXN1840 tablets after the start of a high-fat breakfast, preceded by an overnight fast.\n\nThere was a washout period of at least 14 days between each ALXN1840 dosing.",
                            "interventionNames": [
                                "Drug: ALXN1840 Enteric-coated Tablet",
                                "Drug: ALXN1840 Non-coated Capsule",
                                "Drug: Omeprazole"
                            ]
                        },
                        {
                            "label": "Sequence 3: BAC",
                            "type": "EXPERIMENTAL",
                            "description": "Participants received each treatment on 1 occasion:\n\nPeriod 1 (Treatment B): ALXN1840 tablets after the start of a high-fat breakfast, preceded by an overnight fast. Period 2 (Treatment A): ALXN1840 tablets following an overnight fast. Period 3 (Treatment C): Omeprazole once daily in the morning of Days -5 to -1 following an overnight fast, omeprazole at Hour -1 on Day 1 following an overnight fast, and ALXN1840 non-coated capsules at Hour 0 on Day 1.\n\nThere was a washout period of at least 14 days between each ALXN1840 dosing.",
                            "interventionNames": [
                                "Drug: ALXN1840 Enteric-coated Tablet",
                                "Drug: ALXN1840 Non-coated Capsule",
                                "Drug: Omeprazole"
                            ]
                        },
                        {
                            "label": "Sequence 4: BCA",
                            "type": "EXPERIMENTAL",
                            "description": "Participants received each treatment on 1 occasion:\n\nPeriod 1 (Treatment B): ALXN1840 tablets after the start of a high-fat breakfast, preceded by an overnight fast. Period 2 (Treatment C): Omeprazole once daily in the morning of Days -5 to -1 following an overnight fast, omeprazole at Hour -1 on Day 1 following an overnight fast, and ALXN1840 non-coated capsules at Hour 0 on Day 1. Period 3 (Treatment A): ALXN1840 tablets following an overnight fast.\n\nThere was a washout period of at least 14 days between each ALXN1840 dosing.",
                            "interventionNames": [
                                "Drug: ALXN1840 Enteric-coated Tablet",
                                "Drug: ALXN1840 Non-coated Capsule",
                                "Drug: Omeprazole"
                            ]
                        },
                        {
                            "label": "Sequence 5: CAB",
                            "type": "EXPERIMENTAL",
                            "description": "Participants received each treatment on 1 occasion:\n\nPeriod 1 (Treatment C): Omeprazole once daily in the morning of Days -5 to -1 following an overnight fast, omeprazole at Hour -1 on Day 1 following an overnight fast, and ALXN1840 non-coated capsules at Hour 0 on Day 1. Period 2 (Treatment A): ALXN1840 tablets following an overnight fast. Period 3 (Treatment B): ALXN1840 tablets after the start of a high-fat breakfast, preceded by an overnight fast.\n\nThere was a washout period of at least 14 days between each ALXN1840 dosing.",
                            "interventionNames": [
                                "Drug: ALXN1840 Enteric-coated Tablet",
                                "Drug: ALXN1840 Non-coated Capsule",
                                "Drug: Omeprazole"
                            ]
                        },
                        {
                            "label": "Sequence 6: CBA",
                            "type": "EXPERIMENTAL",
                            "description": "Participants received each treatment on 1 occasion:\n\nPeriod 1 (Treatment C): Omeprazole once daily in the morning of Days -5 to -1 following an overnight fast, omeprazole at Hour -1 on Day 1 following an overnight fast, and ALXN1840 non-coated capsules at Hour 0 on Day 1. Period 2 (Treatment B): ALXN1840 tablets after the start of a high-fat breakfast, preceded by an overnight fast. Period 3 (Treatment A): ALXN1840 tablets following an overnight fast.\n\nThere was a washout period of at least 14 days between each ALXN1840 dosing.",
                            "interventionNames": [
                                "Drug: ALXN1840 Enteric-coated Tablet",
                                "Drug: ALXN1840 Non-coated Capsule",
                                "Drug: Omeprazole"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "DRUG",
                            "name": "ALXN1840 Enteric-coated Tablet",
                            "description": "ALXN1840 (60 milligrams) was administered orally as EC tablets at Hour 0 on Day 1.",
                            "armGroupLabels": [
                                "Sequence 1: ABC",
                                "Sequence 2: ACB",
                                "Sequence 3: BAC",
                                "Sequence 4: BCA",
                                "Sequence 5: CAB",
                                "Sequence 6: CBA"
                            ],
                            "otherNames": [
                                "WTX101 (formerly)",
                                "Bis-choline tetrathiomolybdate",
                                "Tiomolibdate choline"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "ALXN1840 Non-coated Capsule",
                            "description": "ALXN1840 (60 milligrams) was administered orally as non-coated capsules at Hour 0 on Day 1.",
                            "armGroupLabels": [
                                "Sequence 1: ABC",
                                "Sequence 2: ACB",
                                "Sequence 3: BAC",
                                "Sequence 4: BCA",
                                "Sequence 5: CAB",
                                "Sequence 6: CBA"
                            ],
                            "otherNames": [
                                "WTX101 (formerly)",
                                "Bis-choline tetrathiomolybdate",
                                "Tiomolibdate choline"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "Omeprazole",
                            "description": "Omeprazole (20 milligrams) was administered orally as a delayed-release capsule in the morning of Days -5 to -1 and at Hour -1 on Day 1.",
                            "armGroupLabels": [
                                "Sequence 1: ABC",
                                "Sequence 2: ACB",
                                "Sequence 3: BAC",
                                "Sequence 4: BCA",
                                "Sequence 5: CAB",
                                "Sequence 6: CBA"
                            ],
                            "otherNames": [
                                "Prilosec"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "Area Under the Plasma Concentration Versus Time Curve, From Time 0 to the Last Measurable Concentration (AUC0-t) of Total Molybdenum (Mo)",
                            "description": "AUC0-t was calculated by the linear trapezoidal method.",
                            "timeFrame": "Predose (0 hour) up to 192 hours postdose"
                        },
                        {
                            "measure": "Maximum Measured Plasma Concentration (Cmax) of Total Mo",
                            "timeFrame": "Predose (0 hour) up to 192 hours postdose"
                        },
                        {
                            "measure": "Number of Participants With Treatment-Emergent Adverse Events (TEAEs)",
                            "description": "An adverse event (AE) was defined as any untoward medical occurrence in a participant administered with the study drug and which did not necessarily have a causal relationship with the study drug. An AE could therefore be any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease temporally associated with the use of study drug, whether or not related to study drug. A TEAE was defined as an AE that started or worsened at the time of or after study drug administration. An AE that occurred during the washout period between drugs was considered treatment emergent to the last drug given. A summary of all Serious Adverse Events and Other Adverse Events (nonserious) regardless of causality is located in the 'Reported Adverse Events' Section.",
                            "timeFrame": "Day 1 through 14 days following final dose (up to Day 43)"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n* Non-smoker\n* Medically healthy with no clinically significant laboratory profiles, vital signs, or electrocardiograms.\n* Body mass index \u2265 18 and \u2264 32.0 kilograms/meter squared.\n* Willing and able to adhere to contraception requirements.\n\nExclusion Criteria:\n\n* Participant was mentally or legally incapacitated\n* History or presence of clinically significant medical or psychiatric condition or disease.\n* History of any illness that might have interfered with drug absorption.\n* History or presence of hypersensitivity or idiosyncratic reaction to the study medications, study medication excipients.\n* History or presence of alcoholism or drug abuse.\n* Female participants who were pregnant or lactating.\n* Positive results at screening for human immunodeficiency virus, hepatitis B surface antigen, or hepatitis C virus.\n* Serum ceruloplasmin and copper values outside of the normal range at screening.\n* On a diet incompatible with the on-study diet within the 28 days prior to the first ALXN1840 dose and throughout the study; unable to consume the contents of a high-fat breakfast.\n* Participation in a previous clinical trial with ALXN1840.",
                    "healthyVolunteers": true,
                    "sex": "ALL",
                    "minimumAge": "19 Years",
                    "maximumAge": "55 Years",
                    "stdAges": [
                        "ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "locations": [
                        {
                            "facility": "Clinical Trial Site",
                            "city": "Lincoln",
                            "state": "Nebraska",
                            "zip": "68502",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.8,
                                "lon": -96.66696
                            }
                        }
                    ]
                }
            },
            "resultsSection": {
                "participantFlowModule": {
                    "preAssignmentDetails": "Participants were randomized to one of 6 treatment sequences.",
                    "groups": [
                        {
                            "id": "FG000",
                            "title": "Treatment Sequence 1: ABC",
                            "description": "Participants received each treatment on 1 occasion:\n\nPeriod 1 (Treatment A): ALXN1840 60 milligrams (mg) (2 x 30 mg enteric-coated \\[EC\\] tablets) at Hour 0 on Day 1 following an overnight fast. Period 2 (Treatment B): ALXN1840 60 mg (2 x 30 mg EC tablets) at Hour 0 on Day 1, 30 minutes after the start of a high-fat breakfast, preceded by an overnight fast. Period 3 (Treatment C): Omeprazole 20 mg (1 x 20 mg delayed-release capsule) once daily (QD) in the morning of Days -5 to -1 following an overnight fast, omeprazole 20 mg delayed-release capsule at Hour -1 on Day 1 following an overnight fast, and ALXN1840 60 mg (2 x 30 mg non-coated capsules) at Hour 0 on Day 1.\n\nThere was a washout period of at least 14 days between each ALXN1840 dosing."
                        },
                        {
                            "id": "FG001",
                            "title": "Treatment Sequence 2: ACB",
                            "description": "Participants received each treatment on 1 occasion:\n\nPeriod 1 (Treatment A): ALXN1840 60 mg (2 x 30 mg EC tablets) at Hour 0 on Day 1 following an overnight fast. Period 2 (Treatment C): Omeprazole 20 mg (1 x 20 mg delayed-release capsule) QD in the morning of Days -5 to -1 following an overnight fast, omeprazole 20 mg delayed-release capsule at Hour -1 on Day 1 following an overnight fast, and ALXN1840 60 mg (2 x 30 mg non-coated capsules) at Hour 0 on Day 1. Period 3 (Treatment B): ALXN1840 60 mg (2 x 30 mg EC tablets) at Hour 0 on Day 1, 30 minutes after the start of a high-fat breakfast, preceded by an overnight fast.\n\nThere was a washout period of at least 14 days between each ALXN1840 dosing."
                        },
                        {
                            "id": "FG002",
                            "title": "Treatment Sequence 3: BAC",
                            "description": "Participants received each treatment on 1 occasion:\n\nPeriod 1 (Treatment B): ALXN1840 60 mg (2 x 30 mg EC tablets) at Hour 0 on Day 1, 30 minutes after the start of a high-fat breakfast, preceded by an overnight fast. Period 2 (Treatment A): ALXN1840 60 mg (2 x 30 mg EC tablets) at Hour 0 on Day 1 following an overnight fast. Period 3 (Treatment C): Omeprazole 20 mg (1 x 20 mg delayed-release capsule) QD in the morning of Days -5 to -1 following an overnight fast, omeprazole 20 mg delayed-release capsule at Hour -1 on Day 1 following an overnight fast, and ALXN1840 60 mg (2 x 30 mg non-coated capsules) at Hour 0 on Day 1.\n\nThere was a washout period of at least 14 days between each ALXN1840 dosing."
                        },
                        {
                            "id": "FG003",
                            "title": "Treatment Sequence 4: BCA",
                            "description": "Participants received each treatment on 1 occasion:\n\nPeriod 1 (Treatment B): ALXN1840 60 mg (2 x 30 mg EC tablets) at Hour 0 on Day 1, 30 minutes after the start of a high-fat breakfast, preceded by an overnight fast. Period 2 (Treatment C): Omeprazole 20 mg (1 x 20 mg delayed-release capsule) QD in the morning of Days -5 to -1 following an overnight fast, omeprazole 20 mg delayed-release capsule at Hour -1 on Day 1 following an overnight fast, and ALXN1840 60 mg (2 x 30 mg non-coated capsules) at Hour 0 on Day 1. Period 3 (Treatment A): ALXN1840 60 mg (2 x 30 mg EC tablets) at Hour 0 on Day 1 following an overnight fast.\n\nThere was a washout period of at least 14 days between each ALXN1840 dosing."
                        },
                        {
                            "id": "FG004",
                            "title": "Treatment Sequence 5: CAB",
                            "description": "Participants received each treatment on 1 occasion:\n\nPeriod 1 (Treatment C): Omeprazole 20 mg (1 x 20 mg delayed-release capsule) QD in the morning of Days -5 to -1 following an overnight fast, omeprazole 20 mg delayed-release capsule at Hour -1 on Day 1 following an overnight fast, and ALXN1840 60 mg (2 x 30 mg non-coated capsules) at Hour 0 on Day 1. Period 2 (Treatment A): ALXN1840 60 mg (2 x 30 mg EC tablets) at Hour 0 on Day 1 following an overnight fast. Period 3 (Treatment B): ALXN1840 60 mg (2 x 30 mg EC tablets) at Hour 0 on Day 1, 30 minutes after the start of a high-fat breakfast, preceded by an overnight fast.\n\nThere was a washout period of at least 14 days between each ALXN1840 dosing."
                        },
                        {
                            "id": "FG005",
                            "title": "Treatment Sequence 6: CBA",
                            "description": "Participants received each treatment on 1 occasion:\n\nPeriod 1 (Treatment C): Omeprazole 20 mg (1 x 20 mg delayed-release capsule) QD in the morning of Days -5 to -1 following an overnight fast, omeprazole 20 mg delayed-release capsule at Hour -1 on Day 1 following an overnight fast, and ALXN1840 60 mg (2 x 30 mg non-coated capsules) at Hour 0 on Day 1. Period 2 (Treatment B): ALXN1840 60 mg (2 x 30 mg EC tablets) at Hour 0 on Day 1, 30 minutes after the start of a high-fat breakfast, preceded by an overnight fast. Period 3 (Treatment A): ALXN1840 60 mg (2 x 30 mg EC tablets) at Hour 0 on Day 1 following an overnight fast.\n\nThere was a washout period of at least 14 days between each ALXN1840 dosing."
                        }
                    ],
                    "periods": [
                        {
                            "title": "Overall Study",
                            "milestones": [
                                {
                                    "type": "STARTED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "3"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "3"
                                        },
                                        {
                                            "groupId": "FG002",
                                            "numSubjects": "3"
                                        },
                                        {
                                            "groupId": "FG003",
                                            "numSubjects": "3"
                                        },
                                        {
                                            "groupId": "FG004",
                                            "numSubjects": "3"
                                        },
                                        {
                                            "groupId": "FG005",
                                            "numSubjects": "3"
                                        }
                                    ]
                                },
                                {
                                    "type": "Received at Least 1 Dose of Study Drug",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "3"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "3"
                                        },
                                        {
                                            "groupId": "FG002",
                                            "numSubjects": "3"
                                        },
                                        {
                                            "groupId": "FG003",
                                            "numSubjects": "3"
                                        },
                                        {
                                            "groupId": "FG004",
                                            "numSubjects": "3"
                                        },
                                        {
                                            "groupId": "FG005",
                                            "numSubjects": "3"
                                        }
                                    ]
                                },
                                {
                                    "type": "COMPLETED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "3"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "3"
                                        },
                                        {
                                            "groupId": "FG002",
                                            "numSubjects": "3"
                                        },
                                        {
                                            "groupId": "FG003",
                                            "numSubjects": "3"
                                        },
                                        {
                                            "groupId": "FG004",
                                            "numSubjects": "3"
                                        },
                                        {
                                            "groupId": "FG005",
                                            "numSubjects": "3"
                                        }
                                    ]
                                },
                                {
                                    "type": "NOT COMPLETED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "0"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "0"
                                        },
                                        {
                                            "groupId": "FG002",
                                            "numSubjects": "0"
                                        },
                                        {
                                            "groupId": "FG003",
                                            "numSubjects": "0"
                                        },
                                        {
                                            "groupId": "FG004",
                                            "numSubjects": "0"
                                        },
                                        {
                                            "groupId": "FG005",
                                            "numSubjects": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "baselineCharacteristicsModule": {
                    "populationDescription": "All enrolled participants.",
                    "groups": [
                        {
                            "id": "BG000",
                            "title": "Treatment Sequence 1: ABC",
                            "description": "Participants received each treatment on 1 occasion:\n\nPeriod 1 (Treatment A): ALXN1840 60 mg (2 x 30 mg EC tablets) at Hour 0 on Day 1 following an overnight fast. Period 2 (Treatment B): ALXN1840 60 mg (2 x 30 mg EC tablets) at Hour 0 on Day 1, 30 minutes after the start of a high-fat breakfast, preceded by an overnight fast. Period 3 (Treatment C): Omeprazole 20 mg (1 x 20 mg delayed-release capsule) QD in the morning of Days -5 to -1 following an overnight fast, omeprazole 20 mg delayed-release capsule at Hour -1 on Day 1 following an overnight fast, and ALXN1840 60 mg (2 x 30 mg non-coated capsules) at Hour 0 on Day 1.\n\nThere was a washout period of at least 14 days between each ALXN1840 dosing."
                        },
                        {
                            "id": "BG001",
                            "title": "Treatment Sequence 2: ACB",
                            "description": "Participants received each treatment on 1 occasion:\n\nPeriod 1 (Treatment A): ALXN1840 60 mg (2 x 30 mg EC tablets) at Hour 0 on Day 1 following an overnight fast. Period 2 (Treatment C): Omeprazole 20 mg (1 x 20 mg delayed-release capsule) QD in the morning of Days -5 to -1 following an overnight fast, omeprazole 20 mg delayed-release capsule at Hour -1 on Day 1 following an overnight fast, and ALXN1840 60 mg (2 x 30 mg non-coated capsules) at Hour 0 on Day 1. Period 3 (Treatment B): ALXN1840 60 mg (2 x 30 mg EC tablets) at Hour 0 on Day 1, 30 minutes after the start of a high-fat breakfast, preceded by an overnight fast.\n\nThere was a washout period of at least 14 days between each ALXN1840 dosing."
                        },
                        {
                            "id": "BG002",
                            "title": "Treatment Sequence 3: BAC",
                            "description": "Participants received each treatment on 1 occasion:\n\nPeriod 1 (Treatment B): ALXN1840 60 mg (2 x 30 mg EC tablets) at Hour 0 on Day 1, 30 minutes after the start of a high-fat breakfast, preceded by an overnight fast. Period 2 (Treatment A): ALXN1840 60 mg (2 x 30 mg EC tablets) at Hour 0 on Day 1 following an overnight fast. Period 3 (Treatment C): Omeprazole 20 mg (1 x 20 mg delayed-release capsule) QD in the morning of Days -5 to -1 following an overnight fast, omeprazole 20 mg delayed-release capsule at Hour -1 on Day 1 following an overnight fast, and ALXN1840 60 mg (2 x 30 mg non-coated capsules) at Hour 0 on Day 1.\n\nThere was a washout period of at least 14 days between each ALXN1840 dosing."
                        },
                        {
                            "id": "BG003",
                            "title": "Treatment Sequence 4: BCA",
                            "description": "Participants received each treatment on 1 occasion:\n\nPeriod 1 (Treatment B): ALXN1840 60 mg (2 x 30 mg EC tablets) at Hour 0 on Day 1, 30 minutes after the start of a high-fat breakfast, preceded by an overnight fast. Period 2 (Treatment C): Omeprazole 20 mg (1 x 20 mg delayed-release capsule) QD in the morning of Days -5 to -1 following an overnight fast, omeprazole 20 mg delayed-release capsule at Hour -1 on Day 1 following an overnight fast, and ALXN1840 60 mg (2 x 30 mg non-coated capsules) at Hour 0 on Day 1. Period 3 (Treatment A): ALXN1840 60 mg (2 x 30 mg EC tablets) at Hour 0 on Day 1 following an overnight fast.\n\nThere was a washout period of at least 14 days between each ALXN1840 dosing."
                        },
                        {
                            "id": "BG004",
                            "title": "Treatment Sequence 5: CAB",
                            "description": "Participants received each treatment on 1 occasion:\n\nPeriod 1 (Treatment C): Omeprazole 20 mg (1 x 20 mg delayed-release capsule) QD in the morning of Days -5 to -1 following an overnight fast, omeprazole 20 mg delayed-release capsule at Hour -1 on Day 1 following an overnight fast, and ALXN1840 60 mg (2 x 30 mg non-coated capsules) at Hour 0 on Day 1. Period 2 (Treatment A): ALXN1840 60 mg (2 x 30 mg EC tablets) at Hour 0 on Day 1 following an overnight fast. Period 3 (Treatment B): ALXN1840 60 mg (2 x 30 mg EC tablets) at Hour 0 on Day 1, 30 minutes after the start of a high-fat breakfast, preceded by an overnight fast.\n\nThere was a washout period of at least 14 days between each ALXN1840 dosing."
                        },
                        {
                            "id": "BG005",
                            "title": "Treatment Sequence 6: CBA",
                            "description": "Participants received each treatment on 1 occasion:\n\nPeriod 1 (Treatment C): Omeprazole 20 mg (1 x 20 mg delayed-release capsule) QD in the morning of Days -5 to -1 following an overnight fast, omeprazole 20 mg delayed-release capsule at Hour -1 on Day 1 following an overnight fast, and ALXN1840 60 mg (2 x 30 mg non-coated capsules) at Hour 0 on Day 1. Period 2 (Treatment B): ALXN1840 60 mg (2 x 30 mg EC tablets) at Hour 0 on Day 1, 30 minutes after the start of a high-fat breakfast, preceded by an overnight fast. Period 3 (Treatment A): ALXN1840 60 mg (2 x 30 mg EC tablets) at Hour 0 on Day 1 following an overnight fast.\n\nThere was a washout period of at least 14 days between each ALXN1840 dosing."
                        },
                        {
                            "id": "BG006",
                            "title": "Total",
                            "description": "Total of all reporting groups"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "BG000",
                                    "value": "3"
                                },
                                {
                                    "groupId": "BG001",
                                    "value": "3"
                                },
                                {
                                    "groupId": "BG002",
                                    "value": "3"
                                },
                                {
                                    "groupId": "BG003",
                                    "value": "3"
                                },
                                {
                                    "groupId": "BG004",
                                    "value": "3"
                                },
                                {
                                    "groupId": "BG005",
                                    "value": "3"
                                },
                                {
                                    "groupId": "BG006",
                                    "value": "18"
                                }
                            ]
                        }
                    ],
                    "measures": [
                        {
                            "title": "Age, Continuous",
                            "paramType": "MEAN",
                            "dispersionType": "STANDARD_DEVIATION",
                            "unitOfMeasure": "years",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "42.3",
                                                    "spread": "15.95"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "33.7",
                                                    "spread": "16.07"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "25.7",
                                                    "spread": "3.06"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "38.0",
                                                    "spread": "13.00"
                                                },
                                                {
                                                    "groupId": "BG004",
                                                    "value": "40.7",
                                                    "spread": "11.37"
                                                },
                                                {
                                                    "groupId": "BG005",
                                                    "value": "31.7",
                                                    "spread": "10.97"
                                                },
                                                {
                                                    "groupId": "BG006",
                                                    "value": "35.3",
                                                    "spread": "12.04"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Sex: Female, Male",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "title": "Female",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "2"
                                                },
                                                {
                                                    "groupId": "BG004",
                                                    "value": "3"
                                                },
                                                {
                                                    "groupId": "BG005",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG006",
                                                    "value": "6"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Male",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "3"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "3"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "3"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG004",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG005",
                                                    "value": "2"
                                                },
                                                {
                                                    "groupId": "BG006",
                                                    "value": "12"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "outcomeMeasuresModule": {
                    "outcomeMeasures": [
                        {
                            "type": "PRIMARY",
                            "title": "Area Under the Plasma Concentration Versus Time Curve, From Time 0 to the Last Measurable Concentration (AUC0-t) of Total Molybdenum (Mo)",
                            "description": "AUC0-t was calculated by the linear trapezoidal method.",
                            "populationDescription": "Pharmacokinetic (PK) analysis population included all enrolled participants who completed the study and had sufficient data for the determination of PK parameters.",
                            "reportingStatus": "POSTED",
                            "paramType": "MEAN",
                            "dispersionType": "Standard Deviation",
                            "unitOfMeasure": "hours*ng/mL",
                            "timeFrame": "Predose (0 hour) up to 192 hours postdose",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Treatment A: ALXN1840 (Fasted)",
                                    "description": "ALXN1840 60 mg (2 x 30 mg EC tablets) at Hour 0 on Day 1 following an overnight fast."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Treatment B: ALXN1840 (Fed)",
                                    "description": "ALXN1840 60 mg (2 x 30 mg EC tablets) at Hour 0 on Day 1, 30 minutes after the start of a high-fat breakfast, preceded by an overnight fast."
                                },
                                {
                                    "id": "OG002",
                                    "title": "Treatment C: Omeprazole + ALXN1840 (Fasted)",
                                    "description": "Omeprazole 20 mg (1 x 20 mg delayed-release capsule) QD in the morning of Days -5 to -1 following an overnight fast, omeprazole 20 mg delayed-release capsule at Hour -1 on Day 1 following an overnight fast, and ALXN1840 60 mg (2 x 30 mg non-coated capsules) at Hour 0 on Day 1."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "18"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "17"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "18"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "16026",
                                                    "spread": "5635"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "5740",
                                                    "spread": "4681"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "19809",
                                                    "spread": "3509"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG002"
                                    ],
                                    "groupDescription": "Analysis was performed using analysis of variance (ANOVA).",
                                    "nonInferiorityType": "OTHER",
                                    "paramType": "Geometric Mean Ratio (%)",
                                    "paramValue": "75.81",
                                    "ciPctValue": "90",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "52.23",
                                    "ciUpperLimit": "110.02"
                                },
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "groupDescription": "Analysis was performed using ANOVA.",
                                    "nonInferiorityType": "OTHER",
                                    "paramType": "Geometric Mean Ratio (%)",
                                    "paramValue": "25.20",
                                    "ciPctValue": "90",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "17.21",
                                    "ciUpperLimit": "36.89"
                                }
                            ]
                        },
                        {
                            "type": "PRIMARY",
                            "title": "Maximum Measured Plasma Concentration (Cmax) of Total Mo",
                            "populationDescription": "PK analysis population included all enrolled participants who completed the study and had sufficient data for the determination of PK parameters.",
                            "reportingStatus": "POSTED",
                            "paramType": "MEAN",
                            "dispersionType": "Standard Deviation",
                            "unitOfMeasure": "ng/mL",
                            "timeFrame": "Predose (0 hour) up to 192 hours postdose",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Treatment A: ALXN1840 (Fasted)",
                                    "description": "ALXN1840 60 mg (2 x 30 mg EC tablets) at Hour 0 on Day 1 following an overnight fast."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Treatment B: ALXN1840 (Fed)",
                                    "description": "ALXN1840 60 mg (2 x 30 mg EC tablets) at Hour 0 on Day 1, 30 minutes after the start of a high-fat breakfast, preceded by an overnight fast."
                                },
                                {
                                    "id": "OG002",
                                    "title": "Treatment C: Omeprazole + ALXN1840 (Fasted)",
                                    "description": "Omeprazole 20 mg (1 x 20 mg delayed-release capsule) QD in the morning of Days -5 to -1 following an overnight fast, omeprazole 20 mg delayed-release capsule at Hour -1 on Day 1 following an overnight fast, and ALXN1840 60 mg (2 x 30 mg non-coated capsules) at Hour 0 on Day 1."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "18"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "17"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "18"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "376",
                                                    "spread": "98.0"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "187",
                                                    "spread": "118"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "442",
                                                    "spread": "69.6"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG002"
                                    ],
                                    "groupDescription": "Analysis was performed using ANOVA.",
                                    "nonInferiorityType": "OTHER",
                                    "paramType": "Geometric Mean Ratio (%)",
                                    "paramValue": "82.65",
                                    "ciPctValue": "90",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "63.91",
                                    "ciUpperLimit": "106.90"
                                },
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "groupDescription": "Analysis was performed using ANOVA.",
                                    "nonInferiorityType": "OTHER",
                                    "paramType": "Geometric Mean Ratio (%)",
                                    "paramValue": "40.49",
                                    "ciPctValue": "90",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "31.12",
                                    "ciUpperLimit": "52.68"
                                }
                            ]
                        },
                        {
                            "type": "PRIMARY",
                            "title": "Number of Participants With Treatment-Emergent Adverse Events (TEAEs)",
                            "description": "An adverse event (AE) was defined as any untoward medical occurrence in a participant administered with the study drug and which did not necessarily have a causal relationship with the study drug. An AE could therefore be any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease temporally associated with the use of study drug, whether or not related to study drug. A TEAE was defined as an AE that started or worsened at the time of or after study drug administration. An AE that occurred during the washout period between drugs was considered treatment emergent to the last drug given. A summary of all Serious Adverse Events and Other Adverse Events (nonserious) regardless of causality is located in the 'Reported Adverse Events' Section.",
                            "populationDescription": "All enrolled participants who received at least 1 dose of study drug.",
                            "reportingStatus": "POSTED",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "timeFrame": "Day 1 through 14 days following final dose (up to Day 43)",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Treatment A: ALXN1840 (Fasted)",
                                    "description": "ALXN1840 60 mg (2 x 30 mg EC tablets) at Hour 0 on Day 1 following an overnight fast."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Treatment B: ALXN1840 (Fed)",
                                    "description": "ALXN1840 60 mg (2 x 30 mg EC tablets) at Hour 0 on Day 1, 30 minutes after the start of a high-fat breakfast, preceded by an overnight fast."
                                },
                                {
                                    "id": "OG002",
                                    "title": "Treatment C: Omeprazole + ALXN1840 (Fasted)",
                                    "description": "Omeprazole 20 mg (1 x 20 mg delayed-release capsule) QD in the morning of Days -5 to -1 following an overnight fast, omeprazole 20 mg delayed-release capsule at Hour -1 on Day 1 following an overnight fast, and ALXN1840 60 mg (2 x 30 mg non-coated capsules) at Hour 0 on Day 1."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "18"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "18"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "18"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "4"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "2"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "6"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "adverseEventsModule": {
                    "frequencyThreshold": "0",
                    "timeFrame": "Day 1 through 14 days following final dose (up to Day 43)",
                    "description": "All enrolled participants who received at least 1 dose of study drug.",
                    "eventGroups": [
                        {
                            "id": "EG000",
                            "title": "Treatment A: ALXN1840 (Fasted)",
                            "description": "ALXN1840 60 mg (2 x 30 mg EC tablets) at Hour 0 on Day 1 following an overnight fast.",
                            "seriousNumAffected": 0,
                            "seriousNumAtRisk": 18,
                            "otherNumAffected": 4,
                            "otherNumAtRisk": 18
                        },
                        {
                            "id": "EG001",
                            "title": "Treatment B: ALXN1840 (Fed)",
                            "description": "ALXN1840 60 mg (2 x 30 mg EC tablets) at Hour 0 on Day 1, 30 minutes after the start of a high-fat breakfast, preceded by an overnight fast.",
                            "seriousNumAffected": 0,
                            "seriousNumAtRisk": 18,
                            "otherNumAffected": 2,
                            "otherNumAtRisk": 18
                        },
                        {
                            "id": "EG002",
                            "title": "Treatment C: Omeprazole + ALXN1840 (Fasted)",
                            "description": "Omeprazole 20 mg (1 x 20 mg delayed-release capsule) QD in the morning of Days -5 to -1 following an overnight fast, omeprazole 20 mg delayed-release capsule at Hour -1 on Day 1 following an overnight fast, and ALXN1840 60 mg (2 x 30 mg non-coated capsules) at Hour 0 on Day 1.",
                            "seriousNumAffected": 0,
                            "seriousNumAtRisk": 18,
                            "otherNumAffected": 6,
                            "otherNumAtRisk": 18
                        }
                    ],
                    "otherEvents": [
                        {
                            "term": "Dysphonia",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA 16.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 18
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 18
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 18
                                }
                            ]
                        },
                        {
                            "term": "Nasal congestion",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA 16.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 18
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 18
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 18
                                }
                            ]
                        },
                        {
                            "term": "Nasal dryness",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA 16.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 18
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 18
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 18
                                }
                            ]
                        },
                        {
                            "term": "Rhinorrhoea",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA 16.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 18
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 18
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 18
                                }
                            ]
                        },
                        {
                            "term": "Abdominal distension",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA 16.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 18
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 18
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 18
                                }
                            ]
                        },
                        {
                            "term": "Diarrhoea",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA 16.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 18
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 18
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 18
                                }
                            ]
                        },
                        {
                            "term": "Nausea",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA 16.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 18
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 18
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 18
                                }
                            ]
                        },
                        {
                            "term": "Contusion",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA 16.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 18
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 18
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 18
                                }
                            ]
                        },
                        {
                            "term": "Laceration",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA 16.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 18
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 18
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 18
                                }
                            ]
                        },
                        {
                            "term": "Headache",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA 16.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 18
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 18
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 18
                                }
                            ]
                        },
                        {
                            "term": "Somnolence",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA 16.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 18
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 18
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 18
                                }
                            ]
                        },
                        {
                            "term": "Eye haemorrhage",
                            "organSystem": "Eye disorders",
                            "sourceVocabulary": "MedDRA 16.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 18
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 18
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 18
                                }
                            ]
                        },
                        {
                            "term": "Upper respiratory tract infection",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA 16.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 18
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 18
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 18
                                }
                            ]
                        }
                    ]
                },
                "moreInfoModule": {
                    "certainAgreement": {
                        "piSponsorEmployee": false,
                        "restrictiveAgreement": true
                    },
                    "pointOfContact": {
                        "title": "Alexion Pharmaceuticals Inc.",
                        "organization": "Alexion Pharmaceuticals Inc.",
                        "email": "clinicaltrials@alexion.com",
                        "phone": "+1 855-752-2356"
                    }
                }
            },
            "documentSection": {
                "largeDocumentModule": {
                    "largeDocs": [
                        {
                            "typeAbbrev": "Prot",
                            "hasProtocol": true,
                            "hasSap": false,
                            "hasIcf": false,
                            "label": "Study Protocol",
                            "date": "2014-02-24",
                            "uploadDate": "2022-09-15T11:22",
                            "filename": "Prot_000.pdf",
                            "size": 1424740
                        },
                        {
                            "typeAbbrev": "SAP",
                            "hasProtocol": false,
                            "hasSap": true,
                            "hasIcf": false,
                            "label": "Statistical Analysis Plan",
                            "date": "2014-05-22",
                            "uploadDate": "2022-09-15T11:22",
                            "filename": "SAP_001.pdf",
                            "size": 1486641
                        }
                    ]
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2023-11-09",
                    "modelPredictions": {
                        "bmiLimits": {
                            "minBmi": 18.0,
                            "maxBmi": 32.0
                        }
                    }
                },
                "interventionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D000008982",
                            "term": "Molybdenum"
                        },
                        {
                            "id": "C000020809",
                            "term": "Tetrathiomolybdate"
                        },
                        {
                            "id": "D000002794",
                            "term": "Choline"
                        },
                        {
                            "id": "D000009853",
                            "term": "Omeprazole"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D000000897",
                            "term": "Anti-Ulcer Agents"
                        },
                        {
                            "id": "D000005765",
                            "term": "Gastrointestinal Agents"
                        },
                        {
                            "id": "D000054328",
                            "term": "Proton Pump Inhibitors"
                        },
                        {
                            "id": "D000004791",
                            "term": "Enzyme Inhibitors"
                        },
                        {
                            "id": "D000045504",
                            "term": "Molecular Mechanisms of Pharmacological Action"
                        },
                        {
                            "id": "D000008082",
                            "term": "Lipotropic Agents"
                        },
                        {
                            "id": "D000000960",
                            "term": "Hypolipidemic Agents"
                        },
                        {
                            "id": "D000000963",
                            "term": "Antimetabolites"
                        },
                        {
                            "id": "D000057847",
                            "term": "Lipid Regulating Agents"
                        },
                        {
                            "id": "D000018697",
                            "term": "Nootropic Agents"
                        },
                        {
                            "id": "D000002614",
                            "term": "Chelating Agents"
                        },
                        {
                            "id": "D000064449",
                            "term": "Sequestering Agents"
                        },
                        {
                            "id": "D000020533",
                            "term": "Angiogenesis Inhibitors"
                        },
                        {
                            "id": "D000043924",
                            "term": "Angiogenesis Modulating Agents"
                        },
                        {
                            "id": "D000006133",
                            "term": "Growth Substances"
                        },
                        {
                            "id": "D000045505",
                            "term": "Physiological Effects of Drugs"
                        },
                        {
                            "id": "D000006131",
                            "term": "Growth Inhibitors"
                        },
                        {
                            "id": "D000000970",
                            "term": "Antineoplastic Agents"
                        },
                        {
                            "id": "D000014131",
                            "term": "Trace Elements"
                        },
                        {
                            "id": "D000018977",
                            "term": "Micronutrients"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M27320",
                            "name": "Proton Pump Inhibitors",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M12475",
                            "name": "Omeprazole",
                            "asFound": "Methotrexate",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M5724",
                            "name": "Choline",
                            "asFound": "Functioning",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M170850",
                            "name": "Tetrathiomolybdate",
                            "asFound": "Neuromyelitis",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M11637",
                            "name": "Molybdenum",
                            "asFound": "Neuromyelitis",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M3878",
                            "name": "Antacids",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M3909",
                            "name": "Anti-Ulcer Agents",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M8571",
                            "name": "Gastrointestinal Agents",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M7641",
                            "name": "Enzyme Inhibitors",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M3968",
                            "name": "Hypolipidemic Agents",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M3971",
                            "name": "Antimetabolites",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M28573",
                            "name": "Lipid Regulating Agents",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M20464",
                            "name": "Nootropic Agents",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M5550",
                            "name": "Chelating Agents",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M22008",
                            "name": "Angiogenesis Inhibitors",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M8921",
                            "name": "Growth Inhibitors",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M20699",
                            "name": "Micronutrients",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M16575",
                            "name": "Trace Elements",
                            "relevance": "LOW"
                        },
                        {
                            "id": "T443",
                            "name": "Choline",
                            "asFound": "Functioning",
                            "relevance": "HIGH"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "All",
                            "name": "All Drugs and Chemicals"
                        },
                        {
                            "abbrev": "Gast",
                            "name": "Gastrointestinal Agents"
                        },
                        {
                            "abbrev": "NootAg",
                            "name": "Nootropic Agents"
                        },
                        {
                            "abbrev": "Lipd",
                            "name": "Lipid Regulating Agents"
                        },
                        {
                            "abbrev": "ANeo",
                            "name": "Antineoplastic Agents"
                        },
                        {
                            "abbrev": "Micro",
                            "name": "Micronutrients"
                        },
                        {
                            "abbrev": "Vi",
                            "name": "Vitamins"
                        }
                    ]
                }
            },
            "hasResults": true
        }
    ],
    "nextPageToken": "NF0g5JuFlA"
}